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1 Summary 
The importance of regulatory T cells (Tregs) in maintaining lymphocyte homeostasis 
is best appreciated in mice and humans lacking these cells. FoxP3 KO (scurfy) mice 
and patients with immunodysregulation polyendocrinopathy enteropathy X-linked 
(IPEX) syndrome suffer from excessive lymphocyte activation, lymphocytic 
infiltration into peripheral organs, and colitis leading to death at an early age. In 
healthy mice and humans, Tregs control homeostatic proliferation of conventional T 
and B cells and prevent colitis. Tregs have been classified based on their activation 
status, expression of surface markers and their ability to migrate to certain tissues. In 
humans, the proportion of activated and resting Tregs vary with age and the presence 
immunological disorders. While Tregs have been shown to express self-reactive and 
foreign-antigen reactive T cell receptors (TCRs), it’s not clear how their antigen 
specificity determines their regulatory function.  
In this study, we identified two Treg cell populations, which are differentially 
selected, based on their affinity for self-antigens; we further investigate their self-
reactivity in vitro and assessed their different regulatory properties using three disease 
models in vivo.  
To investigate Treg cell development in the thymus, we made use of a FoxP3 
transgenic (FoxP3tg) mouse. This strain expresses 16 tandem copies of the genomic 
FoxP3 gene and the transgene is correctly expressed in T lineage cells. The transgene 
is not expressed in DP thymocytes; while up to 30% of CD4SP thymocytes are 
FoxP3+. This contrasts B6 mice, which contain 3% FoxP3+ thymocytes among the 
CD4SP population. In the periphery of FoxP3tg animals, ~ 90% of all CD4+ T cells 
are FoxP3+ and express some Treg markers. 
In contrast to B6 mice where the majority of Treg cells are Helios+, the majority of 
FoxP3tg Treg cells are Helios negative. Even though the frequencies of Helios+ Treg 
cells in FoxP3tg and B6 mice are different, the cell numbers of Helios+ Treg cells is 
similar in both mice. Interestingly, the Helios+ Treg cells of both strains express 
similar surface markers. In this FoxP3tg strain, positively selected CD4+ T cells are 
thought to be diverted into the Treg lineage as a consequence of expressing the 
FoxP3tg; this likely generated the increased numbers of Helios- Treg cells.  
Back-crossing the FoxP3tg to a Rag-/- mouse expressing a monoclonal class II MHC 
restricted TCR (B3K506), generated mice, where the Helios+ Treg population 
disappears but the Helios- Treg population remains. Based on these findings, we 
Summary 
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hypothesize that the generation of Helios+ Treg cells in B6 requires negative 
selection. This implies that Helios+ Treg cells express a high-affinity self-reactive 
TCR repertoire.  
In co-cultures of CD4+ T cells with autologous dendritic cells (autoMLR), Helios+ 
Treg cells expressed high levels of CD25 and proliferated. This required recognition 
of MHC II antigens on the APCs and IL-2, which is secreted by conventional CD4+ T 
cells in these cultures. Helios- Treg cells express lower amounts of CD25 and 
proliferated much less extensively, while conventional CD4+ T cells do not 
proliferate under these conditions. The data are consistent with the idea that Helios+ 
Treg cells recognize MHCII-self-antigens presented and therefore upregulate CD25, 
allowing these cells to “profit” the most from the limiting amount of IL-2 secreted by 
conventional CD4+ T cells.  
We then compared the ability of Triplehigh (GITRhigh, PD1high, CD25high) Treg cells, 
reflecting the Helios+ Treg cells, and Triplelow (GITRlow, PD1low, CD25low) Treg cells, 
reflecting the Helios- Treg cells, to suppress the development of scurfy-like disease in 
FoxP3DTR mice, acutely depleted of Treg cells. Transferring B6.Triplehigh Treg cells 
markedly reduced lymphoproliferation observed in acutely Treg cell depleted, 
FoxP3DTR mice. In contrast, transfer of Triplelow Treg cells only poorly prevents the 
lymphoproliferation that follows Treg depletion in these hosts. Conversely, Triplelow 
Treg cells but not Triplehigh Treg cells control colitis in lymphopenic hosts by 
facilitating the conversion of Tconv into peripheral induced Treg cells. Therefore, 
these two Treg cell subpopulations have distinct functional properties.  
In addition, we found Triplehigh and Triplelow Treg like cells in FoxP3 deficient 
(scurfy) mice. Sorted Triplehigh and Triplelow CD4+ T cells from scurfy mice were 
separately transferred into T cell deficient recipients to compare their homing 
properties and their ability to transfer the scurfy phenotype. Our results indicate that 
scurfy Triplehigh CD4+ T cells preferentially home to the peripheral lymph nodes and 
induces skin lesions, whereas scurfy Triplelow CD4+ T cells preferentially home to the 
mesenteric lymph nodes and induce colitis.  
 
Taken together, these data suggests that Treg cells express TCRs with different 
degrees of self-reactivity. High-affinity self-reactive Treg cells are able to control the 
homeostatic proliferation of conventional T cells and B cells while low affinity self-
reactive Treg cells maintain lymphocyte homeostasis in the colon.  
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2 Introduction 
2.1 Innate and adaptive immunity 
The immune system is an extremely complex and potent network consisting of both 
the innate and the adaptive immune system. The activation of the innate immune 
system is the first response upon infections and provides immediate but unspecific 
host defense. The innate immunity is composed of soluble factors (complement, 
cytokines) and innate immune cells containing neutrophils, macrophages, dendritic 
cells (DCs) and natural killer (NK) cells. These cells express so-called pattern-
recognition receptors (PRRs) on their surface, which allows them to recognize a 
broad range of highly conserved pathogen-associated-molecular-patterns (PAMPs) 
expressed by pathogens. This further leads to rapid activation of leukocytes resulting 
in the secretion of cytokines (e.g. Tumor necrosis factor alpha (TNFα), interferons 
(INF) and interleukins (IL)) or phagocytosis of the pathogens. The latter mechanism 
results in the clearance of the pathogen but also links the innate immunity to the 
adoptive immunity by processing the pathogen derived proteins and presenting 
peptide fragments on major histocompatibility complex (MHC) molecules to the cells 
of the adoptive immune system.  
In contrast to the innate immune system, the response of the adoptive immune system 
is much slower and needs several days or weeks to develop. However, the hallmarks 
of the adoptive immune system are antigen-specificity and the development of an 
immunological memory providing an enhanced protection to reinfections, which is 
not covered by the innate immune system. The main components of the adaptive 
immune system are B and T cells. Both cell types make use of an antigen-specific 
receptor that is generated by the pairing of distinct variable chains and the random 
recombination of variable receptor gene segments. B cells develop in the bone 
marrow and recognize extracellular pathogens by their specific B cell receptor (BCR) 
on the cell surface. This leads to the pathogen internalization and further processing 
into peptide fragments. These peptides are then presented on MHC class II molecules 
to T helper cells. Cytokines, released by the activated T helper cells, result in the 
stimulation of B cells, helping them to become plasma cells. These cells then secret 
high amounts of pathogen specific antibodies that promote further clearance of 
extracellular pathogens, also called humoral response.  T cells develop in the thymus 
(section 2.2) in contrast to B cells, are specialized to recognize intracellular pathogens 
via their antigen-specific T cell receptor (TCR).  T cells can recognize these antigens 
Introduction 
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when presented by antigen presenting cells (APC) via major histocompatibility 
complex (MHC) molecules expressed on their surface. The recognition of antigens 
leads to the activation of T cells. Activated T cells either actively clear infected cell 
via cytotoxic lysis, support the humoral response described above, or activates innate 
immune cells by the secretion of various cytokines. Even though the adaptive 
immune system is highly specialized, only the interplay between the innate and the 
adaptive immune system ensures effective host defense from infections induced by 
foreign pathogens. Additionally, a tight control of both systems, but especially the 
adoptive immune system, is important to prevent the induction of self-antigen driven 
autoimmune reactions. (reviewed in 1, 2) 
2.2 T cell development and establishing tolerance 
T cells can be subdivided into two broad populations, which are defined by the 
expression of their co-receptors leading to the recognition of antigens presented by 
different MHC molecules on the surface of APCs. One population expresses the 
cluster of differentiation (CD)8 co-receptor that leads to the interaction with peptides 
presented on MHC class I molecules. MHC class I molecules are expressed on every 
nucleated cell. The other population expresses the CD4 co-receptor that leads to the 
interaction with peptides presented on MHC class II molecules. In contrast to MHC 
class I, MHC class II molecules are only expressed on specialized APCs, including 
macrophages, DCs, B cells and some specialized epithelial cells in the thymus. The 
strength of the adaptive immune system is the generation of T cells with a diverse T 
cell receptor (TCR) repertoire that is highly antigen-specific but self-tolerant. The 
development of the highly specialized T cells occurs in the thymus and is also 
described as the “central tolerance”.3, 4 
2.2.1 The early thymocytes development DN to DP stage 
Early T cell precursors are CD4-CD8- double negative (DN) thymocytes that can be 
further divided into four differentiation stages based on cKit (CD117), CD44 and 
CD25 expression. DN1 cells are defined to be cKit+ CD44+CD25-. In this stage cells 
have the potential to develop into αβ T cells, γδ T cells, NK cells, DCs, macrophages 
and B cells. The further description will focus on the development of αβ T cells. 
During the development into the DN2 stage, thymocytes start the expression of CD25 
and become cKit+ CD44+CD25+. In the transition stage from DN2 into DN3 (cKit-
CD44-CD25+), thymocytes migrate to the sub-capsular zone of the thymus and start 
the rearrangements of TCR-β genes, mediated by the recombination-activating genes 
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(Rag)1 and Rag2. This occurs until a functional β-chain is generated. Due to a 
negative feedback-loop, further rearrangement of this locus is blocked, Rag genes get 
down regulated and thymocytes can proceed to the DN3 stage.5, 6 In this stage, cells 
express the invariant pre-TCRα and assemble to a functional TCRpre-α/β complex 
leading to activation and proliferation of these cells. This induces the further 
progression into the DN4 (cKit-CD44-CD25-) stage, followed by the double positive 
(DP) stage that is characterized by the upregulation of CD4 and CD8 on the surface 
of the thymocytes. In the DP stage, Rag genes become activated again and induce the 
rearrangement of the TCR-α until a functional αβTCR is assembled. The rearranged 
TCR-α replaces the preTCRα from the DN3 stage.4, 7, 8  
2.2.2 Positive and negative selection, educating the developing thymocytes, DP to 
SP stage 
Once the DP stage is reached, thymocytes have to go through a “quality proof” 
process before they are allowed to leave the thymus and emigrate as mature T cells 
into the periphery. About 90% of all developed DP cells, “die by neglect”. The TCR 
expressed on the surface of the neglected cells does not recognize peptide-MHC 
complexes and fails to receive a survival signal. This means that only about 10% of 
all DP αβTCR-expressing thymocytes survive this first positive selection process. 
Only these cells undergo a further positive and negative selection process setting up 
the central tolerance to ensure that developing T cells are functional (restricted by self 
MHC) but not self-reactive (self tolerant).  The general mechanism underlying the 
selection of this highly sophisticated T cell repertoire is based on the affinity of the 
TCR for self-peptide/MHC complexes. Cells expressing TCRs, which bind self-
peptide-MHC complexes too strongly, are negatively selected and undergo apoptosis, 
while cells expressing TCRs that bind self-peptide/MHC complexes specifically, but 
with low affinity, get positively selected and mature to single positive (SP) CD4 and 
CD8 cells, able to emigrate into the periphery  (Fig.1).9 
Figure 1: Thymic selection depends on T cell receptor
affinity for self peptide-MHC complexes.  
Schematic model for the selection of DP in the thymus 
while only positively selected cells emigrate into the
periphery (adapted from 9) 
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2.2.3 The affinity threshold, how thymocytes make the decision 
During the selection process, positively selected DP thymocytes mature to CD4 and 
CD8 single SP thymocytes. The destiny of whether DP thymocytes become CD4 or 
CD8 SP cells is based on the restriction of their TCR to either MHC class I (CD8SP) 
or MHC class II (CD4SP) peptide complexes. The expression of the co-receptor not 
only determines the MHC restriction, it has an even more important role in the further 
selection process. Co-receptors bind to the peptide-MHC complexes and influence the 
TCR affinity for the peptide-MHC complex defined as the “apparent affinity”.9 
However, high apparent affinity results in negative selection, and low apparent 
affinity results in positively selected thymocytes. This does not explain whether a 
self-antigen induces positive or negative selection. That decision is tightly regulated, 
and described by a narrow apparent affinity threshold, where minimal differences in 
affinities can result in either positively or negatively selected thymocytes (Fig.2).10, 11 
 
Our group recently suggested a model of how developing thymocytes can measure 
self-antigen affinity to initiate negative selection and generate self-tolerance.12 The 
affinity threshold for negative selection by peptide-MHC class I10 and peptide-MHC 
class II13 is shown to be similar in the absence of CD8 or CD4 co-receptor expression 
(defined by the dissociation constant: KD=koff/konI), but different when CD4 or CD8 
co-receptor are present (defined by the dwell time τ½II). MHC class II restricted 
thymocytes (τ½= 0.2s) use a shorter dwell time for negative selection than MHC class 
I restricted thymocytes (τ½= 0.9s) and therefore have a lower affinity threshold for 
negative selection.12 The question of why developing CD4 and CD8 thymocytes 
measure self-antigen affinity differently can be based on the difference of Lck 
coupling to the respective co-receptor. Lck, a Src family kinase14, phosphorylates 
Figure 2: Thymic selection depends on the apparent affinity of peptide-MHC complexes for the TCR-co-
receptor pair.  
Schematic model for the apparent affinity threshold (purple) between positive and negative selection (adapted 
from 9) 
I koff= dissociation rate , kon= association rate 
II median dwell time of the antigen-TCR interaction (τ½=ln2/koff) 
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immunoreceptor tyrosine activation motifs (ITAMs) on the ζ or CD3 molecules of the 
TCR when the TCR engages with its high affinity ligand (e.g. negative selecting 
ligand). To induce further downstream signaling e.g. recruitment of Zap7015, ITAMs 
need to be doubly phosphorylated. Recruited Zap70, a protein tyrosine kinase (PTK) 
further phosphorylates downstream molecules inducing determinant outcome. In 
thymocytes, only a few CD4 and CD8 co-receptors are coupled with Lck. Therefore 
an antigen-engaged TCR needs to scan multiple co-receptor molecules to find one 
that is coupled to Lck that can induce the phosphorylation of the ITAMs. The lower 
threshold dwell time for MHC class II restricted thymocytes, compared to MHC class 
I restricted thymocytes, can be explained by the higher frequencies of CD4 than CD8 
co-receptors that are loaded with Lck, and therefore, have increased chance of ITAM 
phosphorylation of the peptide-engaged TCR. This means that the basal chance for 
signal transmission in these cells is higher.12 
2.2.4 Developmental stages of thymocytes are located within different areas of the 
thymus and driven by different APCs 
Progenitor cells from the bone marrow migrate into the thymus near the cortico-
medullary junction. The early development (DN to DP stages) takes place in the 
cortex, which is arranged by a three dimensional scaffold of cortical thymic epithelial 
cells (cTECs). During the later transition stage from DP to SP, thymocytes migrte 
through the outer cortex and scan the cTECs for positively selecting ligands. It is 
suggested that cTECs have specific mechanisms to present “wobbly” binding self-
peptides (generated by β5t-containing thymoproteasomes), leading to a fast TCR off-
rate. This induces a signal that leads to CD4 or CD8 committed SP thymocytes being 
positively selected for peptide-MHC complexes. The SP thymocytes relocate into the 
medulla, the inner area of the thymus, which is mainly composed by medullary TECs 
(mTECs), resident (thymic) and migratory DCs (from the periphery). After reaching 
this area, SP cells stay there for about four to five days before leaving into the 
periphery, given that they do not get negatively selected. During this time, 
thymocytes randomly migrate and scan mTECs and DCs for the presentation of 
peptides. In this stage, mTECs have a profound role in the presentation of tissue-
restricted antigens (TRAs). This is regulated by the expression of the autoimmune 
regulator (AIRE) gene, DCs, especially immigrated from the periphery, can present 
self- but also peripherally derived non-self antigens to the thymocytes. (reviewed in 
16) 
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2.3 Peripheral tolerance 
Even though thymic selection of T cells is a highly efficient and tightly controlled 
mechanism to prevent the development of auto reactive T cells, it is not completely 
efficient, since especially threshold antigens can lead to autoimmune diseases.17 
Furthermore, lymphocytes could only encounter their cognate (self)-antigen in the 
periphery, e.g. food antigens but also antigens, displayed during chronic infections. 
To control these potentially dangerous cells, several mechanisms are used.  
2.3.1 Anergy  
Anergy represents a mechanism where cells, which get an activating TCR signal, turn 
hyporesponsive either due to the lack of an activating, or the presence of an inhibiting 
co-stimulatory signal. Normally, when a T cell becomes activated in presence of a 
TCR signal, a second co-stimulatory signal induced via CD28 ligation to a member of 
the B7 family (CD80/CD86, expressed on the APC) would lead to the secretion of 
cytokines such as IL2. IL2 subsequently signals through the IL2R complex (section 
2.7) and fully activates the PI3K/AKT-mTOR pathway that leads to the proliferation 
of the cell. In case of a lacking CD28 signal, downstream TCR signaling and IL2 
expression get repressed which leads to a non-responding T cell.19 However, the 
presence of a negative co-stimulator e.g. Programmed Dead Receptor (PD1) or 
cytotoxic T-lymphocyte-associated protein 4 (CTLA4) can prevent T cell activation. 
Both molecules are expressed on T cells after high affinity TCR stimulation and have 
an important role in development and function of regulatory T cells (section 2.5) PD1 
interaction with its ligands PDL1 or PDL2 in the presence of a TCR signal can lead to 
the inhibition of the PI3K and Akt pathways which results in the silencing of self-
reactive T cells.20 CTLA4 induced anergy is mediated similarly. While PD1 binds to 
PD ligands, CTLA4 binds with high avidity to B7 family members expressed on 
APCs and induces a negative signal that prevents the cell cycle progression.18 One of 
the key players among APCs are peripheral DCs. Normally, these cells are the 
inducers of immune responses but can also act as regulators for tolerance induction 
and maintenance.21 So called, tolerogenic DCs do not belong to a specific subset, 
rather they are generated by incomplete maturation or induction via anti-
inflammatory or immunosuppressive agents including IL-10, TGFβ1, corticosteroids 
and rapamycin. Tolerogenic DCs differ from “inducing” DCs in the expression of 
surface molecules, e.g. B7 family members or PDL1 and PDL2.22 Another source of 
tolerogenic APCs is found within the lymph node stromal cells (LNSCs). These cells 
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are able to express tissue-specific-antigens. Furthermore, a specialized extra thymic 
AIRE-expressing stroma cell (eTAC), lacking B7 family could support 
anergy/tolerance induction in the periphery.23, 24 
2.3.2 Peripheral deletion 
Peripheral deletion is mediated by Fas or Bim induced apoptosis of self-reactive T 
cells. Fas (CD95), also called “death receptor”, is expressed on T cells while its 
ligand FasL (CD178) is only expressed upon repetitive stimulation with cognate 
antigen and in the presence of IL2. The interaction of Fas with FasL leads to the 
“death inducing signaling complex” (DISC). The ativated Caspase-8 and effector 
caspases then promote the activation induced cell death (AICD). Bim, a member of 
the Bcl2 family, mediates another pathway. This pathway is required to shut down the 
immune response to an acute infection. Bim directly activates Bax/Bak and causes 
permeabilisation of the mitochondrial outer membrane to the induction of apoptosis.25 
2.3.3 Regulatory T cells 
Regulatory T (Treg) cells are highly potent cells in the suppression and prevention of 
autoimmune diseases and maintaining peripheral tolerance. Various subsets of Treg 
cells including, conventional Treg cells, CD8+ Treg cells, Tr1 regulatory cells, Th3 
cells, natural killer like (NKT) cells and even regulatory B cells have been identified 
(reviewed in 26, 27)  
However, within this study we focused only on conventional Treg cells that are 
defined as CD4+FoxP3+ Treg cells (section 2.4). Nevertheless, even within this 
natural Treg population several subpopulations based on their origin e.g. thymic 
(section 2.5.2) or peripheral (section 2.5.3) derived Treg cells, their suppressive 
functions, their migratory properties or their activation status respectively e.g. central, 
memory or effector Treg cells are discussed (section 2.5.6).28-31 The latter are not well 
esatblished populations and the terminology can vary, even while describing the same 
or similar populations. Wherein thymic derived Treg cells (tTreg cells) and peripheral 
derived Treg cells (pTreg cells) are well established in the literature, for terminolgy, 
we have chosen the recently suggested recommendations.32   
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2.4 History and characteristics of regulatory T cells 
The first evidence of a T cell population with suppressive functions was given more 
than 40 years ago. In early days, this population was described as suppressor T cells. 
Nowadays, the term regulatory T cell is used.  
In the early 1970s Gershon and Kondo used different experimental setups to describe 
a population of thymus-derived cells that not only induces immune responses, but 
also can induce tolerance. 33, 34 In parallel, Nishizuka and Sakakura observed the 
induction of autoimmune diseases when mice were thymectomized between day 3 
and day 7 after birth, but not when thymectomy was performed after day 7. This 
suggests that tolerogenic thymus-derived cells can accumulate in the periphery 
between day 3 and day 7 and prevent the induction of autoimmune diseases.35 This 
was proved in an experiment during the early 1980s, in which thymectomized 
neonates were rescued from the induction of autoimmune diseases by the transfer of 
splenocytes, isolated from adult mice. 36 Following these, different studies 
investigating various subpopulations of CD4 cells showed that the transfer of some 
CD4 subpopulations into athymic recipients resulted in multi-organ autoimmunity 
like gastritis, thyroiditis, diabetes or testicular inflammation.37, 38 In the beginning of 
the 1990s the concept of suppressor T cells was revoked. It was assumed that 
suppressor T cells mediate the inhibition of other immune cells by secreting a soluble 
factor called “I-J protein”. The I-J locus was mapped to a region between I-A and I-
E.39, 40 However, cloning of the DNA sequence between the I-A and I-E region has 
shown that the locus did not exist.41  
However, in the mid 1990s, the concept of suppressor T cells came back with the 
revolutionary finding that within the CD4+ T cell population, about 5-10% of cells 
expresses the alpha chain of the IL2 receptor (CD25).42 When CD4+ T cell depleted 
from these CD4+CD25+ T cells were transferred into immune deficient mice (nude 
mice), recipient mice developed multiple organ autoimmune diseases. The subsequent 
injection of CD4+CD25+ T cells could prevent the development of disease. 
Furthermore, the previously described autoimmune diseases, induced by the 
thymoctemy of 3-day old neonates, could be prevented by the administration of 
CD4+CD25+ T cells.  These findings brought the evidence that CD4+CD25+ T cells 
appear after day 3 of age and then accumulate within 14 days to the level, observed in 
adult mice.42, 43 The full recovery of the concept of suppressive T cells was given by 
the findings that in an in vitro model, CD4+CD25+ T cells are able to suppress the 
proliferation and the production of IL2 of activated CD4+ T cells in a contact-
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dependent manner.44 Even though, Treg cells were re-established in the concept of 
peripheral tolerance, CD25 was not a reliable marker since CD4+ T cells upregulate 
CD25 expression when stimulated.45 Therefore, research for additional surface 
markers for more precise definition of Treg cells was performed and adhesion 
molecule L-selectin (CD62L)46, CTLA447 and Glucocorticoid-Induced Tumor 
necrosis factor receptor (GITR) were identified to play a crucial role in the function 
of CD4+CD25+ Treg cells. However, all these markers are not exclusively expressed 
on Treg cells, but also on activated T cells.  
The breakthrough discovery for the characterization and the more specific 
identification of Treg cells was made less than 15 years ago. The human autoimmune 
disease IPEX (Immune dysregulation Polyendocrinopathy Enteropathy X linked 
syndrome) was linked with the scurfy mouse, which shows a similar phenotype 
(section 2.8.1).48 The underlying defect, causing this severe disease, is a mutation in 
the transcription factor Forkhead box protein 3 (FoxP3) gene leading to the 
deficiency or dysfunction of Treg cells. Prove was given by the fact that scurfy mice 
were rescued from disease development when they were treated with Treg cells 
within three days of age.49 
The importance of FoxP3 acting as a master regulator for the regulatory properties of 
Treg cells was shown by the rescue of scurfy mice by the transgenic (tg) expression 
of FoxP3, driven by its own promoter.48 Furthermore, T cells isolated from wild type 
FoxP3tg mice, including CD4+CD25- and CD8+ Tcells, showed suppressive functions 
in vitro.50 Additionally, retroviral infection of CD4+CD25- T cells with FoxP3 
resulted in the acquisition of a regulatory phenotype. These cells were potent in 
suppressing activation of non-transfected CD4+CD25- T cells in vitro and in vivo.49, 51 
Based on these findings, and that FoxP3 is not upregulated in activated CD4+ T cells, 
at least in mice, FoxP3 was defined as the key marker for Treg cells. Furthermore, 
any genetic or environmental modification leading to defective FoxP3 expression or 
downregulation of FoxP3 resulted in the loss of suppression and the development of 
inflammation.52-54 
Due to the importance of learning more about the mechanisms and functions of Treg 
cells several genetically engineered mice were established and were also used within 
this study. Mice expressing fluorescent proteins as reporters for FoxP3 are used to 
study FoxP3 expression ex vivo. This enables the sorting of highly pure Treg cells 
populations. By using these reporter mice it was also confirmed that most 
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CD4+CD25+ cells co-express FoxP3 and other previously described markers like 
CTLA4 and GITR.55  
Additionally, mice, in which FoxP3 expressing cells can be selectively depleted by 
the injection of diphtheria toxin (DTx), show a scurfy like phenotype after induced 
depletion. These mice are an important tool to study e.g. immune regulation in the 
absence of Treg cells or for in vivo suppression assays to asses suppressive functions 
of different Treg cell populations as we were performing in our study.52, 53 
2.5 Origin, TCR repertoire and characteristic markers of Treg cells 
The undisputed role in the maintenance of immune homeostasis by Treg cells was 
shown when FoxP3 deficiency was linked with the severe autoimmune diseases IPEX 
and scurfy in human and mice. From that time on Treg cells were investigated for 
their characteristic markers, their developmental origin, their side of action and their 
TCR repertoire. 
2.5.1 Characteristic Treg cell markers 
Within the last 15 to 20 years, Treg cells and a lot of different markers were 
investigated. In this section, the characteristics of the markers FoxP3, CD25, GITR 
and PD1 will be highlighted. 
2.5.1.1 FoxP3 
FoxP3 is a transcription factor of the forkhead/winged-helix family, located on the X 
chromosome48 and highly conserved within mammalian species.56 FoxP3 acts as a 
transcriptional regulator mediated by direct or indirect DNA binding and can activate 
or repress transcription of the target gene.57 As described above, FoxP3 has a central 
role in the development and function of Treg cells.  The maintenance of FoxP3 
expression is required to preserve the Treg phenotype.58 In this context, FoxP3 was 
shown to directly regulate the expression of Treg-associated markers like CD25, 
GITR and CTLA4 but not the entire Treg signature.59 This was investigated by 
signature analysis of in vitro induced, retroviral induced and naturally FoxP3 
expressing CD4+ Treg cells.59 Similarly, transgenic overexpression of FoxP3 was 
found to be sufficient to induce suppressive function, but cannot fully induce the 
phenotype observed in naturally arising Treg cells.50 Different from acting as an 
activator, FoxP3 represses IL2 expression by direct interactions with the nuclear 
factor of activated T cells (NFAT) at the IL2 gene promoter.60 Structurally, the FoxP3 
gene contains different cis-regulatory elements that have a central role in the 
differentiation and stability of Treg cells. Next to the FoxP3 promoter, which was 
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shown to have a rather weak transactivation activity, three conserved non-coding 
sequence (CNS) regions are important for its regulation.  
The CNS1 region acts as a binding site for the transcription factor Smad3 and NFAT, 
and was identified to be critical for the FoxP3 induction during the peripheral 
differentiation of Treg cells. In contrast, the development of Treg cell in the thymus is 
not affected. Additionally, it was shown, that binding of Smad3 and NFAT to the 
CNS1 region is important for the TGFβ mediated conversion in vitro.61 Moreover, 
CNS1 deficient mice are not able to induce peripheral Treg (pTreg) cells and suffer 
from allergic type Th2 inflammation at mucosal interfaces like the lung and gut.62,63, 
64 The CNS2 region contains a CpG island which is demethylaed in fully committed 
thymic derived Treg cells and methylated in conventional T cells and peripheral 
induced Treg cells.65 CNS2 knockout mice are suffering from a mild 
lymphoproliferative disorder but not from a severe autoimmune disease. Furthermore, 
the CNS2 region is not required for the induction of FoxP3 expression but for its 
maintenance, especially in a proinflammatory environment and after TCR mediated 
activation.66,67 The stabilization of FoxP3 expression, especially after TCR activation, 
is influenced by IL2 mediated signaling and the subsequent Stat5 activation 
downstream of the IL2 receptor. Stat5 can bind to the CNS2 region and this probably 
facilitates Stat5 to bind the FoxP3 promoter.68 Additionally, it was suggested that 
FoxP3 has the potential to maintain its own expression through binding to the CNS2 
region, but this only occurs on the demethylated CNS2 region.64 The CNS3 region 
was shown to bind the transcription factor c-Rel after TCR, CD28 and IL2 mediated 
activation. Using CNS3 deficient mice, it was shown that the CNS3 region has a 
profound role in the induction of FoxP3 in all Treg cells reflected by an impaired 
development of thymic and peripheral derived Treg cells.64  
Therefore, not only the expression of FoxP3 determines the Treg phenotype, but also 
the molecular modification of the gene impacts the composition, size and 
maintenance of the Treg cell population.  
2.5.1.2 CD25 
CD25, the α subunit of the high affinity IL2 receptor (IL2R) was the first marker for 
Treg cells.42 The expression of CD25 is induced by an activating TCR signal. 
Furthermore, signaling through the IL2R also can mediate the expression of CD25 in 
positive feedback mechanisms. IL2R signaling mediates Stat5 activation, which can 
further lead to the activation of CD25 transcription. Furthermore, in FoxP3+Treg 
cells, FoxP3 acts as direct positive activator of the CD25 gene.69 CD25 expression is 
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required for the development and function of Treg cells and CD25 deficient mice 
develop lymphoproliferative disorders and autoimmune diseases.47 Even though 
CD25 is constitutively high expressed on Treg cells, CD25 can be upregulated on 
effector T cells after activation. Furthermore within the FoxP3+ Treg cell population, 
different levels of CD25 expression were observed.69 Altogether, CD25 is an 
important but not exclusive marker for Treg cells.  
2.5.1.3 GITR 
GITR belongs to the tumor necrosis factor-receptor (TNFR) family and is 
constitutively expressed on the surface of all Treg cells, but is also upregulated on 
effector T cells after TCR stimulation70,71 Even though GITR deficient mice are not 
suffering from autoimmune diseases72, the numbers of Treg cells are reduced. In turn, 
in mice overexpressing GITR ligand on B cells, the numbers of FoxP3+ Treg cells are 
higher compared to wild type mice. It was shown that the accumulation of Treg cells 
was due to an increased proliferation.73 In addition, GITR expressing T cells from 
FoxP3tg mice are suppressive, independent of their CD25 expression.50 Interestingly, 
the adoptive transfer of GITR depleted CD4+ T cells into lymphopenic hosts resulted 
in death caused by a severe autoimmune inflammation while CD25 depleted CD4+ T 
cells only caused colitis. Based on these observations, GITR is suggested as a more 
convenient marker for Treg cells than CD25.71 
2.5.1.4 PD1  
The receptor PD1 (CD279) is an immunoglobulin (Ig) superfamily member and binds 
to PD ligand1 (PDL1) expressed on hematopoietic and nonhematopoietic cells and 
tissues, as well as PDL2, which is only expressed on hematopoietic cells. PD1 is 
expressed in the thymic development in DN thymocytes during the TCRβ 
rearrangement.74 In the periphery, PD1 can be expressed on several hematopoietic 
cells including CD4+ and CD8+ T cells. In T cells, PD1 is induced by high TCR 
signaling and remains highly expressed in presence of persistent antigen stimulation. 
In effector T cells, PD1 expression is a marker for non-functional, exhausted, death 
prone T cells.75 Furthermore, follicular regulatory T cells, a population derived from 
the Treg cell pool and specified in the regulation of humoral immunity, express high 
levels of PD1.76 Additionally, it was suggested that PD1 is important for the 
induction of pTreg cells but analysis of PD1 deficient mice revealed that PD1 has no 
impact on thymic or peripheral Treg cell development.77 However, a recent study 
Introduction 
 -22- 
investigating thymic and peripheral Treg cells addressed a higher PD1 expression to 
Treg cells of thymic origin.78 
2.5.2 Development of Treg cells in the thymus 
First evidence for the thymic origin of Treg cells was already given with the 
thymectomy of neonates leading to autoimmune diseases. The development of thymic 
Treg (tTreg) cells was found to be dependent on several factors like TCR stimulation, 
antigen presenting cells, cytokines and co-stimulation.  
It is thought that Treg cells have TCRs with an increased affinity for self-antigens 
compared to conventional CD4+ T cells. The importance of TCR stimulation for the 
development of Treg cells was first given by the finding that transgenic mice, 
expressing a single TCR (DO11.10) recognizing the foreign antigen chicken 
ovalbumin, do not develop Treg cells.79 First hints of a self-reactive TCR repertoire 
of Treg cells were then given by the higher response of CD25+CD4+ Treg cells to 
viral superantigens.80 Several studies reported that TCR transgenic mice only 
developed Treg cells when the cognate antigen was also expressed in the thymus. 81-83  
Furthermore, Treg cells do not develop when the transgenic TCR has a lower affinity 
for the transgenic expressed antigen in the thymus.81, 82 The self-reactivity of Treg 
TCRs was also assessed in a system where TCRs from Treg or naïve CD4+ T cells 
were isolated and retrovirally transduced into Rag-/- TCli TCRtgIII  T cells. These cells 
then were adoptively transferred into lymphopenic hosts. T cells expressing TCRs 
from Treg cells underwent increased homeostatic proliferation compared to T cells 
expressing TCRs from naïve T cells, indicating a higher self-reactivity of Treg cells.85 
Recently, a mouse expressing green fluorescence protein (GFP) driven by the 
promoter of the transcription factor Nur77 was generated (Nur77GFP).86 Nur77 
expression can be correlated with the strength of the TCR signal. Thus, the GFP 
expression correlates with the TCR signal strength in these mice. FoxP3+ Treg cells in 
Nur77GFP mice were shown to express higher amounts of GFP than naïve CD4+ T 
cells.86 Furthermore, tTreg cells express higher levels of CD5 on their surface.16, 87 
CD5 expression was described to quantitatively correlate with the TCR signal 
intensity.88 Taken together, these results strongly suggest that Treg cells are skewed 
towards a TCR repertoire for self-antigens but the distinct antigens have not been 
identified yet. It was demonstrated that Aire mediated expression of self-antigen in 
mTECs drives the thymic development of tTreg cells. Mice deficient for Aire 
III TCli TCRtg: transgenic TCR, specific fort the human invariant chain-derived CLIP peptide (hCLIP) in the context of 
IAb.84  
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expression are suffering from severe autoimmune inflammation, comparable to scurfy 
disease.89 In addition, not only the affinity of the self-antigen but also the avidity, the 
amount of expressed and presented self-antigens in the thymus, impacts the 
development of Treg cells.90 
In addition, the Treg cell development is also dependent on the local milieu. This 
includes the presence of cytokines most importantly IL2, but also TGFβ, IL15 and 
IL7 seem to play a role in a proper development of tTreg cells. As previously 
described, IL2 signaling through CD25 expressed on Treg cells, induces the 
expression of FoxP3 and provides survival signals.68 In addition, co-stimulation via 
CD28 is important for the efficient generation of fully functional tTreg cells. In CD28 
deficient mice, tTreg cells were dramatically reduced. This was only partially 
observed when CD28 was knocked out specifically on Treg cells. However, CD28 
deletion on Treg cells leads to the slow progression of autoimmune driven diseases 
similar to scurfy disease (section 2.8.1) indicating the importance of co-stimulation 
for the development of tTreg cells.91 Taken together, thymic development is 
dependent on the TCR signal strength, the antigen, the antigen-presenting cell, the 
cytokine milieu and the co-stimulatory signals.  
2.5.3 Development of Treg cells in the periphery 
Treg cells can develop in the periphery from naïve CD4+ T cells.92 Naïve CD4+ T 
cells transferred into congenic hosts can convert into Treg cells. The conversion 
seems to be independent from the thymus since the same experiment in 
thymectomized mice leads to the same induction of pTreg cells.93 The differentiation 
of pTreg cells in vivo can be induced when naïve CD4+ T cells are stimulated with 
low doses of their cognate antigen, but not when stimulated with a low affinity 
peptide.94 The TCR specificity of pTreg cells is not clearly resolved yet, but it is 
suggested that these cells express most dominantly TCRs for non-self antigens, 
although specificity for self-antigens cannot be excluded.92 However, the best-studied 
cases of in vivo pTreg cell generation are Treg cells induced in the gut with TCR 
specificities for microbiota-derived antigens since re-colonization of germfree mice 
with bacteria increases numbers of colonic Treg cells. The induction of pTreg cells 
was shown to be dependent on TGFβ; administration of TGFβ blocking antibodies 
prevented the induction of Treg cells. Additionally, these pTreg cells were highly 
protective against colitis.95,96 A recent study investigating TCRs specific for colonic 
bacterial isolates described that naïve CD4+ T cells expressing these colonic bacteria-
reactive TCRs converted to pTreg cells, specifically in the lamina propria of the 
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colon.97 In the gut, pTreg development was also shown to be dependent on retinoic 
acid (RA) promoting a TGFβ dependent conversion. Furthermore, specialized 
CD103+ dendritic cells in the gut and mesenteric lymph nodes (mLN) can facilitate 
the conversion process.98 In addition, metabolic products from the microbiota like 
short-chain-fatty-acids, e.g. butyrate, was shown to promote the conversion from 
naïve CD4+ T cells to Treg cells in vivo and in vitro.99-101 In addition to TGFβ, as for 
tTreg cells, IL2 is required for the development and function of pTreg cells.69 
Furthermore, for the in vitro conversion of naïve CD4+Tconv cells to Treg cells, the 
presence of IL2 is indispensible.102 However, the stability of pTreg cells seems to be 
much lower than the stability of tTreg cells. Especially under lymphopenic 
conditions, where IL2 availability is probably limited, the stability of FoxP3 
expression in pTreg cells was much lower and a greater proportion of pTreg cells lost 
FoxP3 expression compared to tTregs.92, 103 
In general, antigen presentation by specialized APCs in the presence of an optimal 
microenvironment containing soluble factors seems to be crucial for the pTreg 
development. 
2.5.4 Helios and NRP1, markers to distinguish tTreg from pTreg cells? 
Both, peripheral and thymic derived Treg cells express high levels of CD25, GITR, 
CTLA4 and FoxP3 and thus are not distinguishable. To learn more about different 
functional and regulatory properties of these two subsets, extensive research on 
specific markers was performed. Within the scope of this research, two markers were 
identified.  
The first described marker to define tTreg cells was Helios, a transcription factor of 
the Ikaros family. Initially, a higher Helios expression in FoxP3+ Treg cells compared 
to conventional CD4+ T cells (Tconv cells) was described in 2006104 and shown to be 
independently from FoxP3 expression.105 Treg cells from Helios deficient mice do 
not show essential differences in the suppressive capacity compared to wild type 
mice.105 However, Helios was identified to bind to the FoxP3 promoter in human 
Treg cells and its expression by small interfering RNA (siRNA) oligonucleotides 
resulted in the downregulation of FoxP3 and the suppressive functions of these 
cells.106 Another study reported that all Treg cells in the thymus express Helios, 
whereas in the periphery, only 70% of Treg positive for Helios.107 This indicates that 
in the periphery only 70% of Treg cells have thymic origin whereas 30% are 
converted from naïve CD4+ T cells in the periphery.107 Additionally, in germfree 
mice, the majority of Treg cells in the lamina propria express Helios.97 Furthermore 
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the Treg-specific demethylated region (TSDR) is fully demethylated in Helios+ Treg 
cells but only partially in Helios- Treg cells.108 Even though all data indicated that 
Helios is as a marker for tTreg cells, a further study argued that Helios rather serves 
as a marker for activated T cells.109 Initally, in vitro and in vivo induced Treg cells 
were reported not to induce Helios expression107 though, it is possible under certain 
conditions in vitro and transiently in vivo.110, 111 While the reliance on Helios as a 
tTreg cell marker dropped, neuropilin 1 (Nrp1), a receptor for members of the 
vascular endothelial growth factor (VEGF) family as well as for the semaphorin 
family, first detected in 2004112, was suggested as a tTreg specific marker78, 113. 
Equally to Helios deficient mice, Nrp1 deficient mice do not show defective Treg cell 
development.114 Nrp1 was detected to be a high-affinity receptor for LAP, LAP-
TGFβ1 and active TGFβ1. In combination, Nrp1 and TGFβ are promoting Treg cell 
activity by enhancing the TGFβ downstream signaling via Smad2/3.115 Nrp1+ Treg 
cells are suggested to be induced in the thymus and Nrp1- Treg cells in the periphery. 
However, both have a similar suppressive function.78, 113 The use of Nrp1 as a marker 
for tTreg cells seems to be as controversial as Helios, since Nrp1 expression can be 
induced in activated T cells, similarly to Helios, under certain in vitro, although 
others disclaimed this.78 Recently, a concomitant analysis of Helios and Nrp1 serving 
as a marker for tTreg cells in naïve mice suggested Helios as a more reliable marker 
for tTreg cells than Nrp1.116 In addition, several studies showed that Helios 
expressing Treg cells have a higher suppressive function than Helios negative 
counterparts.111, 116, 117 However, both markers can be induced under certain 
conditions and thus, other markers need to be identified to clearly distinguish between 
tTreg and pTreg cells. 
2.5.5 TCR repertoire diversity of tTreg, pTreg and Tconv cells 
The affinity of TCR for self-antigens expressed on Treg cells is not yet fully defined. 
It is widely accepted that TCR diversity plays an important role in the thymic 
selection and also in the differentiation of Treg cells. Several studies suggested that 
the TCR repertoire of Treg cells and naïve CD4+ T cells are mostly not overlapping, 
while a small percentage of overlapping TCRs are found within both T cell 
populations.85, 118 Treg cells and naïve CD4+ T cells can be easily separated by flow 
cytometry using Treg cells co-expressing FoxP3 and GFP, while the separation of 
tTreg and pTreg cells is more challenging, since specific markers are controversially 
discussed. Nevertheless, assuming that Treg cells from the intestinal mucosa contain 
mostly pTreg cells, Treg cells isolated from the gut and from other tissues were 
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compared. TCR repertoire analysis implied that pTreg cells in the gut have a distinct 
repertoire from Treg cells derived from other tissues.97 In another study, Nrp1 was 
used to distinguish between tTreg (Nrp1high) and pTreg (Nrp1low) cells. In line with 
the previous report, the TCR repertoires of tTreg and pTreg cells was different from 
each other and different from the TCR repertoire of Tconv cells.92 
The most used technique to study TCR repertoire is complementarity-determining 
region 3 (CDR3) sequencing. To limit the overall diversity of the repertoire, mice 
expressing fixed transgenic TCRβ chains are used. From these mice, different cell 
populations can be isolated and the CDR3 sequences of the TCRα chains can be 
analyzed. The diversity is normally illustrated by using the Morisita-Horn similarity 
index, in which values from 0 to 1 represents low to high similarity between two data 
sets.92, 97 
2.5.6 Treg cells, different origin, different location, different functional properties? 
The development of tTreg and pTreg occurs from different precursor cells at different 
locations. For both, similar factors are indispensable for their development. First, for 
the FoxP3 induction and thus the Treg lineage commitment, TCR stimulation is 
required, while in tTreg and pTreg cells FoxP3 expression is not induced by the same 
TCR signal strength for self-antigens. Thymic Treg cells require an intermediate to 
high affinity TCR for self-antigens, while pTreg cells probably have lower TCR 
affinities for self-antigens. Second, in the thymus, TGFβ has an antiapoptotic effect 
on tTreg cells but is not required, while in the periphery, TGFβ is required for the 
development of pTreg cells. TGFβ induces Smad binding to the FoxP3 locus and 
directly promotes the transcription of FoxP3 in pTreg cells. Third, IL2 is highly 
required for the generation of both Treg cell populations, while tTreg cells are more 
stable in the absence of IL2 than pTreg cells. The instability of FoxP3 expression in 
pTreg was shown in a lineage reporter system where pTreg cells could be 
distinguished from “ex pTreg cells” because of the distinct expression of the 
fluorescent reporters YFP and GFP.119 The decreased stability of the FoxP3 
expression in pTreg cells could serve as a mechanism to control ongoing 
inflammation followed by a decline when the immune responses are terminated. This 
means that this may allow pTreg cells to revert back to Tconv cells when the 
infllamation is cleared, and serves as a mechanism of short-term suppression in local 
inflammation.92  
The functional properties of tTreg and pTreg cells were studied in different 
experimental setups.  
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In general, the deletion of tTreg and pTreg cells, in FoxP3 deficient mice (section 
2.8.1) leads to the development of severe autoimmune driven multi-organ 
inflammation. This disease is, with high evidence, controlled by tTreg cells, while 
pTreg cells have a minor role. The depletion of Treg cells in the absence of 
microbiota (germfree FoxP3DTR mice)  leads to the same multi organ inflammation as 
observed when Treg cells are depleted in specific pathogen free (SPF) housed mice. 
The only difference was reported in a delayed onset of gut inflammation and an 
acceleration of exocrine pancreatitis when Treg cells were depleted from germfree 
mice.120 pTreg cells were described to be efficient in controlling the islet-specific 
autoimmune response in NOD.CD28-/- mice78 and microbiota specific pTreg cells can 
prevent efficiently from colitis.95, 96 Furthermore, in mice, in which CNS1 of the 
foxp3 gene is knocked out, the development of pTreg is inhibited. This deficiency 
dose not lead to the development of severe immunopathologies as observed in scurfy 
mice, but CNS1 deficient mice are suffering from allergic type Th2 inflammation at 
mucosal interfaces like the lung and gut and females display increased embryo 
abortion in combination with increased immune cell infiltration during allogeneic 
pregnancy.62-64, 121 Given the data, it suggests that tTreg cells are important to control 
the immune homeostasis and autoimmunity, while pTreg cells have spezialized 
functions dependent on the type of inflammation, but with a primary role in the 
control of mucosal immunity and fetal tolerance.92 In contrast to this, a recent study 
denied that tTreg cells sufficiently suppress chronic inflammation and autoimmunity 
in the absence of pTreg cells. The adoptive transfer of tTreg cells into FoxP3 
deficient neonates was not sufficient to maintain tolerance, but when tTreg cells were 
co-transferred with naïve CD4+ T cells tolerance could be established because 15% of 
naïve CD4+ T cells converted into pTreg cells and established tolerance together with 
the tTreg cells.122 However, it seems to be difficult to draw clear conclusions out of 
the used model, since the behavior of effector T cells in scurfy mice is inconsistent.92  
Even though, an extensive amount of research has been done on the question how 
tTreg and pTreg cells function and whether they have differences in their behavior 
due to their different TCR specificity or their origin, the lack of highly specific 
markers to distinguish between tTreg and pTreg makes it speculative. Because of this, 
Treg cells have been categorized by the expression of different surface markers and 
their localization into different tissues independently of their origin (Fig.3).123 The 
most promoted categorization at the moment is the separation of Treg cells according 
to the activation marker CD44 and the lymph node homing receptor CD62L. By 
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using these two markers, Treg cells can be broadly divided into central Treg (cTreg) 
cells expressing CD44loCD62L+ and effector Treg (eTreg) cells CD44hiCD62Llo/-.28 
cTreg cells are quiescent and mainly located in the secondary lymphoid tissues. They 
express high levels of CD25 and are dependent on IL2. In contrast, eTreg cells are 
highly proliferative, prone to apoptosis, the dominant Treg population in 
nonlymphoid tissues and are lower in CD25 expression. Their maintenance is IL2 
independently mediated by TCR and co-stimulatory signals. Additionally, a 
population called memory Treg (mTreg) cells is suggested. This population is 
maintained without antigen in the target tissue after resolution of the disease, mTreg 
cells are able to attenuate subsequent autoimmune reactions are maintained by IL7 
secreted by stromal cells.30, 123 
 
2.6 Suppression mechanisms of Treg cells  
The mechanisms of how Treg cells works are still not fully understood. It is widely 
accepted that Treg cells have an important role in the maintenance of peripheral 
tolerance and in the prevention of autoimmune diseases. Thus, a profound knowledge 
of how Treg cells work is of great importance.  Several studies indicated the 
importance of TCR stimulation of Treg cells in peripheral lymphoid organs, allowing 
them to become effector Treg cells and to obtain suppressive capacity.81, 82, 124 Two 
very recent studies gave direct evidence that TCR stimulation of Treg cells is 
indispensable for the suppressive function in vivo and in vitro. Levine et al. showed 
that the suppressive function of Treg cells was diminished after TCR ablation, in a 
mouse model where the expression of the TCR could be inducible ablated in Treg 
Figure 3: Multiple mechanisms of Treg cell maintenance.  
Central Treg cells (cTr) access paracrine IL-2 in secondary lymphoid tissues (left), maintenance of effector 
Treg cells (eTr) in non-lymphoid tissues depends on continued TCR/ICOS signals (middle), and memory Treg 
cells (mTr) in the skin are supported by IL-7/IL-7R-mediated survival signals (right). Adapted from 123  
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cells. In these TCR ablated Treg cells, the Treg cell phenotype was not altered.125 
Schmidt et al. corroborated these results by showing that an impaired TCR 
downstream signaling resulted in an impaired suppressive function of Treg cells.126 
How TCR stimulation is linked to the suppressive capacity of Treg cells has not been 
clarified yet. However, several mechanisms mediating suppression were found and 
extensively investigated. The basic mode of actions can be grouped into four different 
mechanisms and are described in the following sections (Fig.4) 
2.6.1 Suppression mediated by inhibitory cytokines 
Treg cells can secrete inhibitory cytokines e.g. IL10, IL35 and TGFβ, which directly 
inhibit the proliferation of antigen-activated naïve T cells.127 Even though blocking of 
IL10 or the deficiency in IL10 production by Treg cells was not affecting their 
suppressive function in vitro127, Treg cell specific IL10 deficient mice suffered from 
inflammation of the colon and from increased allergic lung inflammation and hyper-
reactivity. This indicates that IL10 has a crucial role in the regulation of inflammation 
at sites where inflammatory responses are induced by pathogens.128 Indeed, studies of 
mouse models for inflammatory bowel disease (IBD) showed that the IL10 secretion 
of Treg cells was crucial for the prevention of colitis.129   
The importance of TGFβ for the suppressive function of Treg cells is controversially 
discussed. Some studies show that the high amounts of soluble and membrane bound 
TGFβ, produced by Treg cells, impacts the control of autoimmunity130 while others 
did not find a significant TGFβ mediated suppression.131 Treg cells lacking TGFβ or 
the blocking of TGFβ did not impair the suppressive function in vitro. Also CD4+ T 
conventional (Tconv) cells lacking TGFβ receptor can be normally suppressed.127 
However, several studies showed that TGFβ has a crucial role in the prevention of 
colitis.132 Additionally, secreted TGFβ is necessary for the development of peripheral 
or in vitro induced Treg cells and also has a non redundant role in the maintenance of 
Treg cells in general.133 A recently discovered cytokine is IL35, which is composed 
by pairing of Epstein-Barr virus-induced gene3 (Ebi3) and IL12a. Treg cells deficient 
for either Ebi3 or IL12a do not suffer from autoimmunity but have impaired 
suppressive functions in vitro and failed to resolve IBD in vivo.134    
2.6.2 Suppression mediated by cytolysis 
Treg cells were described to have some cytolytic capacities, mediated by the 
expression and secretion of ganzyme A and B in a perforin-dependent or independent 
mechanism.135-137 Apoptosis of effector T cells was also shown in a contact-
Introduction 
 -30- 
dependent mechanism, mediated through a TRAIL-DR5 (tumor-necrosis-factor-
related apoptosis-inducing ligand -death receptor 5) pathway.138  
2.6.3 Suppression by modulating APCs 
Another mechanism by which Treg cells can promote suppression is by the direct 
interaction with APCs leading to the induction of tolerogenic APCs. One mechanism 
is mediated by the expression of CTLA4 on Treg cells. The importance of CTLA4 
mediated tolerance is shown by the observation of the spontaneous development of 
severe autoimmunity in mice deficient for Treg cell specific CTLA4 expression. Treg 
cell mediated suppression via CTLA4 can be induced by a process called trans-
endocytosisIV leading to the downregulation of CD80/CD86 on the APC.139 
Additionally, CTLA4 induced signaling can increase the expression of indoleamine 
2,3-dioxygenase (IDO) in certain DC subsets. IDO leads to the starvation of effector 
T cells and can directly arrest the cell cycle. Furthermore, IDO was shown to have 
potential to convert effector T cells into Treg cells.140, 141 Similarly, Treg cells can 
drive DCs to produce less IL6 but more IL10, resulting in a immunosuppressive 
cytokine milieu.142 The adhesion molecule Lymphocyte-activation gene 3 (LAG3), 
expressed on Treg cells, is discussed to influence the activation of DC cells. Even 
though blocking or deficiency of LAG3 resulted in less suppressive Treg cells, LAG3 
deficient mice are not suffering from signs of autoimmune disease.131, 143 
Furthermore, expression of lymphocyte function-associated antigen 1 (LFA1) on 
Treg cells, was described to support the formation of stable immunological synapse 
and as a consequence, physically out-compete naïve T cells from getting activated. 
Subsequently, LFA1-mediated interaction of Treg and APC cells, leads to the 
downregulation of CD80 and CD86 on the APCs.144, 145 
2.6.4 Suppression by metabolic disruption 
The fourth mechanism of how Treg cells suppress effector T cells can be summarized 
as the suppression by metabolic disruption of effector T cells. One possibility of how 
the metabolism of effector T cells is mediated by adenosine nucleosides, released 
from Treg cells. Released adenosine activates the adenosine receptor 2A on the 
effector T cell, leading to the suppression of effector T cell functions, including the 
inhibition of IL6 secretion, but inducing TGFβ release. This in turn promotes a milieu 
favorable to convert effector T cells into Treg cells.146 Additionally, it was shown that 
Treg cells could directly transfer cyclic AMP (cAMP) into effector T cells through 
IV A process where particles (e.g. receptors) from one cell are taken up into another cell is called trans-endocytosis. 139 
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membrane gap junctions. High levels of cAMP could lead to a dampening of IL2 
transcription and less proliferation of suppressed effector T cells.147 However, these 
mechanisms are not so extensively examined and need further investigation. Another 
mechanism, which is broadly discussed and still not fully solved, is the idea that Treg 
cells can act as a “sink” for IL2 due to their expression of high levels of CD25. This 
could lead to the deprivation of activated T cells for IL2. IL2 is needed to induce 
proliferation, subsequent differentiation and survival of T cells.127 
 
2.7 IL2 and Homeostasis of Treg cells 
IL2, a cytokine secreted primarily by activated CD4+ T cells, but also naïve CD8+ T 
cells, DCs, and thymic cells and was the first molecularly cloned T cell growth factor. 
IL2 binds to and signals via a receptor complex composed by either three (high 
affinity receptor) or two (intermediate affinity receptor) distinct subunits. The high 
affinity receptor is composed of IL2Rα (CD25), IL2Rβ (CD122) and the common γ-
chain (γc, CD132), while the intermediate affinity receptor is composed of CD122 
and γc and lacking CD25. Independent from their binding affinity for IL2, both 
complexes are fully competent to signal.148 The γc is not only important for IL2R 
formation but also combines with other cytokine receptor chains to form complexes 
for IL4, IL7, IL9, IL15 and IL21.149 As previously described, prior to the discovery of 
FoxP3, CD25 was used as the marker for Treg cells since it is highly expressed on 
these cells and seemed to be important for their development. However, mice lacking 
IL2, IL2Rα or IL2Rβ expression were generally immunocompetent and are able to 
resolve experimental viral infections or can reject cardiac and islet cell allografts. 
Figure 4: Summary of basic mechanisms used by Treg cells (adapted from127) 
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Within 3-6 weeks of age, all mice start to show massive enlargement of lymph nodes, 
spleen and gut associated lymphoid tissue caused by the polyclonal expansion of T 
and B cells, resulting in death due to fatal colitis or severe hemolytic anemia.150 
FoxP3 GFP reporter mice lacking IL2 signaling (IL2 or IL2Rα deficient mice) 
showed that Treg cells were present in the thymi and in the periphery of these mice 
but at much lower frequencies compared to unmanipulated mice151, giving evidence 
that IL2 signaling is important for the maintenance of Treg numbers in the 
periphery.150 The progression of a fatal lymphoproliferative disease in mice lacking 
IL2 signaling indicates that effector T cells are not dependent on high affinity IL2 
signals. Indeed, peripheral proliferation of effector cells is mainly dependent on IL7, 
constitutively produced by stromal cells.152 However, Treg cells were shown to have 
a higher basal proliferation rate compared to Tconv cells. It is not known, whether 
this high proliferation rate is driven by self-reactivity or by the FoxP3 transcriptional 
program per se.152 Regardless of this, the high turn over of Treg cells is 
counterbalanced by a higher apoptosis rate. The Bim (Bcl-2-interacting mediator of 
cell death) pathway, induced by FoxP3 dependent phosphorylation, can be rescued by 
IL2. IL2 signaling leads to the upregulation of pro-survival proteins, antagonizing the 
pro-apoptotic function of Bim.152 Since Treg cells are not capable to produce IL2, 
because FoxP3 and Helios acts as direct repressors of the IL2-locus153, other cells 
than Treg cells must secrete IL2. The main producers of IL2 are CD4+ T cells, 
especially after receiving activating signals. However, a recent study suggests that 
about 10% of naïve CD4+ T cells have a high baseline of self reactivity, sufficient to 
drive IL2 transcription but not sufficient to induce proliferation.154, 155 Thus, under 
homeostatic conditions, Treg cells are dependent on the (limited) IL2, secreted by 
CD4+ T cells. The amount of IL2 is enough to balance proliferation and apoptosis of 
Treg cells and keeping the IL2 production by CD4+ T cells low. Infections can 
interrupt these homeostatic conditions and results in CD4+ T cells activation, 
expansion, and therefore higher IL2 secretion. This leads to higher proliferation and 
reduced apoptosis of Treg cells. Consequently, the enhanced suppressive capacity of 
the expanded Treg cell population leads to the suppression of the activated CD4+ T 
cells and therefore, reduced IL2 levels. This in turn results in limited IL2 and 
therefore in higher apoptosis and lower proliferation of Treg cells. The system returns 
to homeostasis (Fig.5).152 
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2.8 Treg cells in diseases  
Extensive studies on Treg cells have been done and revealed the importance of Treg 
cells in the prevention of autoimmunity by establishing and maintaining 
immunological self-tolerance156, oral tolerance157, maternal tolerance158, pathogen 
induced immunopathology159, transplantation tolerance160, suppression of allergy and 
asthma161 and inhibition of antitumor immunity162. Even though, knowing the 
importance of Treg cells to control autoimmune diseases, it is not fully understood 
how and which Treg cells can suppress different diseases. In the further sections I 
highlight the role of Treg cells in the aspects of first, the pathology of FoxP3 
deficiency (section 2.8.1), and second, Treg cells in IBD (section 2.8.2).   
2.8.1 FoxP3 deficiency, IPEX and the scurfy mouse 
To maintain self-tolerance in mice and men, FoxP3 expressing Treg cells are 
indispensable.52, 53 Humans, bearing a mutation in the foxp3 gene, suffer from severe 
autoimmune diseases. Because the foxp3 gene is located at the X chromosome, males 
are more affected than females. The so-called IPEX (immune disregulation, 
polyendocrinopathoy, enteropathy, X-linked) syndrome is characterised by the 
neonatal onset of systemic multi-organ inflammation and patients can suffer from 
diarrhea, insulin-dependent mellitus, eczematous dermatitis, anemia, 
thrombocytopenia, tubular nephropathy and neutropenia.163, 164 IPEX mutations are 
rare and can affect different positions of the foxp3 gene and results in different severe 
effects on Treg cells. The severity of the symptoms can vary within patients and 
among families an also depends on the environment and age of the patient. The 
disease is usually lethal in infancy but the survival also depends on the severity of the 
mutation.163  
Infection-induced defects in TReg cell homeostatic correc-
tion. Another avenue for disease to develop from dis-
turbed TReg cell homeostasis is through perturbations of 
the IL-2-dependent feedback loop by infection. In the 
homeostatic context, TReg cells are major consumers of 
IL-2; indeed, competitive consumption of IL-2 is pro-
posed to be one of the functional mediators of TReg cell 
suppression, as it limits levels of IL-2 available for both 
conventional T cells111 and natural killer cells112. During a 
normal infection, IL-2 production correlates with inflam-
matory cytokine production113, allowing TReg cell numbers 
to track with inflammation. This process limits immune 
pathology113 and serves to shut down the immune 
response after the levels of effector cells subside (FIG. 5a,b). 
However, in exceptional cases the direct relationship 
between inflammatory cytokines and IL-2 production 
can break down. The prime example of this is seen dur-
ing Toxoplasma gondii infection, which can cause lethal 
Figure 5 | Models for TReg cell homeostasis disorders triggered by infection. a ^  +n the normal regulator[ T|(TReg) cell 
homeostatic state, a low activity balance is generated by limiting interleukin-2 (IL-2) production from conventional CD4+ 
T|cells This partial +L- deHicienc[ results in balanced proliHeration and apoptosis in T
Reg
 cells, which in turn keep IL-2 
production by CD4+ T|cells low b | This state of low activity balance can be temporarily suspended by an infection, resulting 
in CD4+ T|cell eZpansion and actiXation 1ne component oH this actiXation is the production oH eZcess +L- which allows 
T
Reg
 cell expansion. As a consequence of T
Reg
 cell expansion, the enhanced suppressive capacities shut down the CD4+ T|cell 
response until IL-2 becomes limiting. Finally, T
Reg
 cells contract via IL-2 deficiency and the system returns to homeostasis. 
c | This normal process can be derailed through several processes. First, if the immune response is primarily of a T helper 17 
(T*) t[pe in nature eZpression oH Aiolos inhibits the production oH +L- 5econd strong inHlammator[ production oH 
interferon-γ (IFNγ) or IL-27 can reduce IL-2 production. Third, shedding of CD25 into the soluble CD25 isoform may 
sequester bioactive IL-2. Fourth, activated CD8+ T|cells ma[ eHHectiXel[ compete Hor aXailable +L- owing to high C& 
expression. Under these conditions, T
Reg
 cells may experience severe IL-2 deficiency and contract rather than expand. The 
loss of suppressive function may then spur further inflammatory activation and lead to an autoinflammatory feedback loop.
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Figure 5: Models for Treg cell homeostasis and disorders triggered by infection/inflammation. 
a) Homeostatic conditions b) temporarily suspended homeostatic condition by an infection (adapted from152) 
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The homologous disease in mice is described as the lethal X-linked 
lymphoproliferative disorder and naturally arises in the scurfy mouse strain, where a 
2 base pair (bp) mutation of the foxp3 gene leads to a loss-of-function mutation and 
results in the total absence of Treg cells.48,165 The critical contribution of lymphocytes 
in the scurfy multi-organ inflammation was demonstrated by the inhibition of the 
disease when the scurfy mutation was bred on the Rag1-/- or Rag2-/- genetic 
background.166, 167 Furthermore, breeding the scurfy mice onto the CD4-/- or the β2m-/-
V background, demonstrated that CD4+, and not CD8+ T cells, induce the multi-organ 
inflammation. The disease onset in scurfy mice, lacking CD4+ T cells was delayed, 
but progressed normally in β2m deficient mice.169 Additionally, the administration of 
anti-CD4 mAb also resulted in a milder and delayed multi-organ inflammation.169   
Even though scurfy mice are deficient in Treg cells what results in uncontrolled 
expansion of polyclonal CD4+ T cells with a broad TCR repertoire, only eyes, skin, 
lungs, liver and tail are inflamed.167 Common autoimmune diseases such as diabetes, 
arthritis or colitis are not observed. This can be explained with the fact that scurfy 
mice die within 4 weeks of age. The early death or pre-weaning conditions (probably 
protection via IgA in mother milk) could prevent from the progression of other 
diseases.48, 167 The prolongation of the lifespan (up to 20 weeks) of scurfy mice, by 
the introduction of the apoptosis-preventing Faslrp/lrp gene, or by the transfer of scurfy 
LN cells into Rag1-/- recipients resulted in severe inflammation of skin, lung and 
liver, but also of stomach, pancreas, small intestine, salivary gland, accessory 
reproductive organs and colon.170, 171 This indicates that scurfy mice have a large 
repertoire of inflammation inducing T cells. Experiments, manipulating the TCR 
repertoire by breeding a tg foreign Ag-specific TCR into scurfy mice, altered the 
scurfy phenotype. This indicates that the recognition of antigen is indispensable for 
the onset of disease. Specifically, TCRtg scurfy mice bred on the Rag-/- background 
did not develop multi organ inflammation, because only the monoclonal foreign Ag-
specific TCR is expressed and the cognate antigen is lacking in the periphery. Scurfy 
mice on a quasi monoclonal background (TCRtg scurfy Rag+) had a prolonged 
lifespan, but developed multi organ inflammation with a delayed onset, compared to 
polyclonal scurfy mice.  Even though a tg TCR reduces the endogenous TCR gene 
rearrangement, it does not block it. Thus, in quasi monoclonal scurfy mice, a decent 
fraction of CD4+ T cells expresses a dual TCR allowing them to develop an 
endogenouse TCR repertorie. These cells where shown to proliferate in the periphery 
V β2m: β2 microglobulin, a component of MHC class I, mice lacking β2m cannot develop CD8 T cells. 168 
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(but not in the thymus) and evoked the multi-organ inflammation. The delayed onset 
is caused by the quantity of generated cells in the thymus. For the development of the 
multi organ inflammation, sufficient TCR affinity for endogenouse antigens is 
required. This means that positively selecting antigens are no sufficient to induce 
multi organ inflammation, even in the absence of Treg cells. In a study, using the 
endogenouse viral superantigens (VSAg) as the primary self antigens, they showed 
that the absence of functional FoxP3 in scurfy mice caused preferential accumulation 
of autoreactive T cells.54 Additionally, TCR repertoires analysis from TCRβtg scurfy 
mice showed that activated scurfy CD4+ T cells preferentially used TCRs found in the 
TCR repertoire of Treg cells from TCRβtg wild type mice.172 In two studie where 
FoxP3 Treg cell precursors were identified by the co-expression of a the mutated 
FoxP3 and the eGFP reporter in the FoxP3 locus, they suggesed that the scurfy 
disease is caused by CD4+ T cells from the conventional and not from the Treg cell 
pool because the scurfy Treg wannabe cells did not proliferate after adoptive transfer 
into T cell deficient hosts.173, 174 However, it is not clear which T cell population is 
promoting the induction of multi organ inflammation  and how TCR affinity for self 
or foreign antigen is linked to the onset of different pathologies observed in scurfy 
mice. We will address this question in the third part of this thesis.  
In scurfy mice, the absence of functional FoxP3 does not lead to the absence of 
probably highly self -reactive “Treg cell should-bes”. Therefore, it seems to be more 
appropriate to study the absence of Treg cells in FoxP3DTR mice. In these mice, the 
diptheria toxin receptor (DTR) is controlled under the FoxP3 promoter and enables 
the specific ablation of FoxP3 expressing cells by the administration of deptheria 
toxin.52, 53 
2.8.2 Treg cells in IBD 
The intestine mucosal tissues are the largest mucosal surfaces in the body. The 
maintenance of the immune homeostasis is an ongoing challenge, since these tissues 
are in direct contact with the external environment and the tolerance to commensal 
bacteria, food and potential pathogens must be maintained. At the same time, the 
intestine must be permeable to allow the absorption of nutrition. To cope with this 
task, a complex immune network, including intestinal epithelial cells, macrophages, 
DCs, conventional T cells and Treg cells, has developed. Treg cells play a crucial role 
in the maintenance of this intestinal homeostasis and the protection from diseases.132, 
159 The interruption of this tightly controlled system can induce severe inflammations 
in the gut, summarized as IBD, and is mediated by activated CD4+ T cells.159, 175 In 
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mice, the transfer of naïve CD4+ T cells into T cell deficient hosts can induce a 
microbiota-driven colitis (mimics human IBD).159, 175 Evidence for a microbiota-
driven disease is given by the observations that the adoptive transfer of naïve CD4+ T 
cells into germfree Rag-/- mice does not result in the development of colitis.176   
Treg cells have been identified to prevent the onset of colitis when co-transferred 
with naïve CD4+ T cells, or even are able to cure the colitis when adoptively 
transferred after the onset of the colitis.177 Furthermore, it was shown, that mice with 
impaired Treg function or development, observed in IL2-, IL10-, or in some reports 
TGFβ- deficient mice, suffer from severe IBD. IL2- deficient mice develop multi-
organ inflammations, including colitis150 and IL10- deficient mice mainly develop 
spontaneous colitis176. TGFβ- deficient mice do not develop colitis per se, probably 
due to their early death within 4 weeks of life, but have an increased susceptibility to 
dextran-sulfate induced colitis178. Additionally, transfer of TGFβ receptor deficient 
CD4+ T cells into lymphopenic mice resulted in colitis.179 IL10 and TGFβ are crucial 
for the induction and homeostasis of (microbiota specific) pTreg cells180, because of 
that it seems highly evident that the generation of this population impacts the 
maintenance of the intestinal homeostasis. Although Treg cells were also found in the 
intestine of germfree mice, the frequency of this population is up to 3 fold lower 
compared to colonic Treg cells in conventional mice.97 The Treg population in the 
intestine of germfree mice seems to be generated in the thymus, since the majority of 
Treg cells express Helios.96, 97, 107 Furthermore, colonic Treg cells from conventional 
mice, but not from germfree mice, can specifically respond to antigens from the gut 
microbiota.97 In addition, Treg cells from conventional mice protect better from T 
cell-mediated colitis than Treg cells isolated from germfree mice.181 Altogether 
indicates that the induction of Treg cells with TCRs specific for the microbiota or 
gut-derived antigens are crucial for the maintenance of the intestinal homeostasis.  
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3 Material and Methods 
3.1 Materials and Reagents 
3.1.1 Reagents 
β-mercaptoethanol (β-me)      Gibco 
RPMI-1640 (phenol red, L-glutamine, 25mM HEPES)  Gibco 
Fetal Calf Serum (FCS)      Amimed 
Non essential ammino acids (NEAA)  (100x)    Gibco 
Sodium Pyruvate (100x)     Gibco 
L-Glutamine (100x)      Gibco 
Penicillin – Streptavidin (100x)     Gibco 
Bovine Serum Albumin (BSA)      Sigma Aldrich 
NOPIL        Mepha Pharma AG 
DMSO        Sigma Aldrich 
3.1.2 Material 
Polystyrene 96 well round bottom plate, sterile   Corning Incorp 
Cell Strainer Nylon 70µm, sterile     Corning Incorp 
CellTrics® filter 50µm      Sysmex 
Polystyrene tissue culture dish (100 x 20mm), sterile  Corning Incorp 
Polystyrene round-bottom tube 5ml    Corning Incorp 
Polypropylene conical tubes 15ml, 50ml, sterile   Corning Incorp 
Polypropylene round-bottom tube 5ml, sterile   Corning Incorp 
Transwell Permeable supports (no. 3470)   Corning Incorp 
Polystyrene 24 well flat bottom plate, sterile   Corning Incorp 
3.1.3 Instruments 
BD FACSCanto™II      BD Bioscience 
BD FACSAria™III      BD Bioscience 
BD Influx™        BD Bioscience 
Corning® LSE™ Mini Microcentrifuge    Corning Incorp 
DynaMag™ 15 (1ml-15ml) magnet    Invitrogen 
DynaMag™ 50 (1ml-50ml) magnet    Invitrogen 
Heraeus™ Megafuge™ 16R     Thermo Scientific 
Heraeus™ Multifuge™ 3 S-R  Kendro Laboratory 
Products 
Maxisafe 2020 Class II       Biological Safety Cabinet 
HERACell™ 150i CO2 incubator     Thermo Scientific 
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Metrohm 691 pH meter       Metrohm Schweiz AG 
Microcentrifuge 5417R       Vaudaux-Eppendorf AG 
Invertoscope ID03 microscope      Carl Zeiss AG 
Vortex-Genie® 2       Faust Laborbedarf 
Olympus BX61 Diana      Olympus AG 
3.1.4 Solutions and media 
1x PBS (pH7.3)   137 mM NaCl 
    8 mM  Na2HPO4*2H2O 
    2.7 mM  KCl 
    1.5 mM  KH2PO4 
 
Culture medium  1x  RPMI-1640 
    10%  FCS 
    1x  NEAA 
    1x  sodium pyruvate 
    1x  penicillin (100U/ml) – streptomycin 
(100µg/ml) 
    2mM  L-glutamine 
    5mM  ß-me   
 
BmDC medium     Culture medium 
    10x  GM-CSF hybridoma supernatant 
 
FACS buffer   1x  PBS   
3%   FCS 
 
Sorting buffer   1x   PBS 
0.1%   BSA 
 
Wash buffer    1x  RPMI-1640 
0.1%  BSA 
 
RBC lysis buffer   155mM  NH4Cl    9 x 
170mM  Tris-HCL, pH7.65 1 x 
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3.1.5 Antibodies 
CD3ε     145-2c11   BD Bioscience 
CD4    RM 4-5   BD Bioscience 
CD5    53-7.3   BD Bioscience 
CD8    53-5.8   BD Bioscience  
CD11b    M1/70   BD Bioscience 
CD11c    HL3   BD Bioscience  
CD19    ID3   BD Bioscience 
CD16/CD32   2.4G2   BD Bioscience 
CD25    PC61   BD Bioscience 
CD44    IM7   Biolegend 
CD45.1    A20   BD Bioscience / Biolegend 
CD45.2    104   BD Bioscience 
CD62L    Mel14   Biolegend 
CD69    H1.2F3   BD Bioscience  
CD80    16-10A1  Biolegend 
CD86    GL-1   Biolegend 
CD279 (PD1)   RMP1-30  Biolegend 
29F.1A12   Biolegend 
CD357 (GITR)    DAT-1    eBioscience  
YGITR765   Biolegend  
FoxP3    FJK-16s  eBioscience  
150D    Biolegend 
Helios    22F6   eBioscience 
NRP1    polyclonal  R&D Systems 
Vα2    B20.1    BD Bioscience   
Vα3.2    RR3-16   BD Bioscience 
Vα8.3    B21.14   BD Bioscience 
Vβ5    MR 9-4   BD Bioscience 
Vβ8    MR5-2    BD Bioscience 
α4β7 integrin   DATK32  BD Bioscience / Biolegend 
IA/E (blocking)   M5/114.15.2  Biolegend 
IAb (staining)   AF6-120.1  BD Bioscience  
pcJUN (S73)   D47G9   CellSignaling Technologies 
pERK (P-p44/42 MAPK) 197G2   CellSignaling Technologies 
pCD3ζ (pY142)   K25-407.69  BD Bioscience  
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3.1.6 Kits 
LIVE/DEAD Fixable Dead Cell Stain Kit    Life Technologies 
Cell TraceTM CFSE Cell Proliferation Kit    Life Technologies 
Dynabeads® Untouched™ Mouse CD4 Cells Kit  Life Technologies 
FITC BrdU Flow Kit      BD Pharmingen 
FoxP3/Transcription Factor Staining Buffer Set   eBioscience 
3.1.7 Cytokines and special material 
IL2 hybridoma supernatant (5x104 U/ml)   in house-product 
GM-CSF hybridoma supernatant     in house-product 
α - CD4 (rat IgM, clone RL172)     K.Hafen&G.Holländer 
α - CD8 (rat IgM, clone 31M)     K.Hafen&G.Holländer 
α – CDThy1.1 (rat IgM, clone T24)    K.Hafen&G.Holländer 
α – CDThy1.2 (rat IgM, clone HO)    K.Hafen&G.Holländer 
Recombinant mouse TGFb1     R&D Systems 
Diphtheria Toxin (DT)      Calbiochem 
Lipopolysaccharide (LPS)     Sigma Aldrich 
Low-Tox Rabbit Complement     Cedarlane 
AccuCheck Counting Beads      Molecular Probes 
3.1.8 Peptides 
Peptides were received lyophilized from Eurogentec and were diluted in DMSO to a 
concentration of 100µM. Stock solutions were kept at -80°C. Working solutions of 2 
µM, diluted in full medium, were kept at -20°C.  
 
3K (WT) NH2-FEAQKAKANKAVD-COOH 
P2A  NH2-FEAAKAKANKAVD-COOH 
P-1A  NH2-FAAQKAKANKAVD-COOH 
3.1.9 Mice 
All mice were between 5–12 weeks old and had a C57BL/6 genetic background 
except for FoxP3KO, which were used at 2 -3 weeks of age. CD45.1 congenic 
C57BL/6 (B6 Ly5.1), CD45.2 congenic C57BL/6 (B6), RIP-OVA mice expressing a 
membrane bound form of Ova under the control of the rat insulin promoter (RIP)17, 
182,52 OTII TCRtg mice recognizing IAb/OVA323-339183, B6.Nur77-GFP86, 
H2Ab1(Bm12) and FoxP3KO,174 mice were all obtained from The Jackson Laboratory 
(Bar Harbor, ME). 3BK506 TCRtg and 3BK508TCRtg mice recognizing IAb/3K and 
TripleKO mice deficient for MHC class II, invariant chain and Rag (referred here as 
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B6.MHCIIKO) were provided by P. Marrack and J. Kappler (Denver, USA) and are 
described elsewhere184. FoxP3DTR,52 mice were kindly provided by A. Rudensky 
(New York, USA) FoxP3eGFP and CD3ε-/- were kindly provided by T. Rolink 
(Basel, Switzerland) and single TCR β chain (OT-I Vβ5) transgenic mice kindly 
provided by D. Zehn (Lausanne, Switzerland) and are described elsewhere.185, 186,187 
ABM (anti bm12) mice were generated by E.Palmer and described previously188. 
Mice were housed under specific pathogen-free conditions and bred in our colony 
(University Hospital Basel) in accordance with Cantonal and Federal laws of 
Switzerland. Animal protocols were approved by the Cantonal Veterinary Office of 
Basel-Stadt, Switzerland.  
3.2 Cell preparation  
3.2.1 T cell isolation from lymphoid organs 
Mice were euthanized with CO2 suffocation and spleen, thymus, pooled peripheral 
lymph nodes (axillary, cervical, brachial and inguinal), pancreatic lymph node and/or 
gut draining mesenteric lymph nodes were isolated. Single cell suspensions were 
obtained by disrupting organs through a 70µm nylon cell strainer (BD) in wash 
buffer. Erythrocytes from spleen and thymus samples were lysed before further 
processing. Cell pellets were resuspended in 1ml RBC lysis buffer (mixture of 9 parts 
ACT I (155mM NH4Cl) and 1 part ACT II (170mM Tris-HCL, pH7.65) and 
incubated for 1min at RT. Reaction was stopped by diluting with medium follow by 
centrifugation and subsequent washing with medium. All steps were performed on ice 
and centrifugation of cells was performed at 300xg and 4°C for 10min unless 
otherwise indicated.  
3.2.2 Cell counting 
To determine absolute cell numbers, cells were counted either by using a Beckman 
Coulter Z2 particle counter (Beckman Coulter) or AccuCheck Counting Beads 
(Invitrogen) according to manufacturers instructions. In brief, cells were resuspended 
in a defined volume (500µl -1ml) of FACS buffer. In the following, 50 or 100 
of Accu Check Counting Beads were mixed with ten times less of cell suspension. 
Mixed suspension was measured and 5000 to 10000 Counting Beads were acquired.  
Due to higher SSC of counting beads, beads could be discriminated from the 
lymphocyte scatter signal. The difference in FSC/SSC allowed direct correlation of 
lymphocyte event number (LG) and counting bead event number (BG). 
c(Lymphocytes) = LG/BG x c(counting beads) x 10 (dilution factor)  
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3.2.3 Magnetic beat selection and fluorescence-activated cell sorting (FACS) 
Lymphocytes were isolated as described above. To enrich for CD4 T cells, the 
Dynabeads® Untouched™ Mouse CD4 Cells Kit (Invitrogen) was used according to 
manufacturers protocol. In brief, cell suspension was incubated with a cocktail of 
CD8 T cell, B cell, monocyte/macrophage, NK cell, dendritic cell, erythrocyte and 
granulocyte specific monoclonal rat IgG antibodies for 20 min at 4°C. Cells were 
washed with an excess of wash buffer and incubated for 15 min with magnetically 
labeled Mouse Depletion Dynabeads® before applying to the magnet. Supernatant 
with the untouched mouse CD4 T cells could be used for further downstream 
analysis.  
To isolate subpopulations of CD4+ T cells, cells were enriched as described above 
and were further separated with fluorescence-activated cell sorting (FACS). 
Therefore, cells were labeled with fluorochrome-coupled mAbs. In brief, cell 
suspension was adjusted to 20x106 cells/ml. To prevent unspecific labeling, Fc 
receptor blocking was performed using purified CD16/32 antibody (BD) for 10 min 
at 4°C followed by 10 min incubation with required fluorochrome-coupled mAbs at 
4°C. Cells were washed and resuspended in sorting buffer (20x106 cells/ml). Dead 
cells were excluded by DAPI staining previous to cell sort. FACS was performed 
using FACSAriaIII or Influx sorter (BD Bioscience)  
3.3 Flow cytometric analysis of lymphocytes 
All flow cytometric stainings were performed in 50µl FACS Buffer, at 4°C and cells 
were washed with 100µl FACS Buffer and centrifuged for either 3 min/350g or 
2min/1000g if not other indicated. 
3.3.1 Surface molecule staining  
To analyse the expression of surface antigens, lymphocytes either from cell cultures 
or directly from organs, were collected in FACS Buffer or transferred into 96-well-U-
shaped microtiter plates (Corning, Germany). Unspecific Fc receptor blocking was 
performed using s purified CD16/32 antibody (BD) for 10 min. To discriminate live 
and dead cells, cells were incubated with LIVE/DEAD near-IR dye (Life 
Technologies) in PBS for 10 min prior to surface antibody staining. Surface staining 
with required mixture of fluorocrome-labeled antibodies was then performed for 10 
min in FACS buffer. Then cells were either analyzed by flow cytometry or further 
processed for intracellular staining.  
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3.3.2 Intracellular molecule staining  
For detecting intracellular markers e.g. transcription factors, intracellular staining was 
performed using the FoxP3/Transcription Factor Staining Buffer Set (eBioscience) 
after the surface staining. Briefly, cells were fixed for 20 min in 100µl fixation buffer 
(1 part concentrate: 4 parts diluent) and then washed with 100µl permeabilization 
buffer (1x in H20). Then cells were incubated with a mixture of fluorocrome-labeled 
antibodes in permeabilization buffer for either 40min at RT or ≥1h at 4°C. Cells then 
were washed with permeabilization buffer and resuspended in FACS buffer prior to 
flow cytometric analysis.  
3.3.3 Intracellular staining of Bromodeoxyuridine (BrdU) 
Incorporation of BrdU was detected by using the BrdU Flow Kit (BD Bioscience) 
according to the manufacturers protocol with minor modifications. In brief, surface 
and intracellular staining was performed on single cell suspension as described 
before. Then, cells were fixed with 100µlCytofix/Cytoperm buffer for 10 min at 4°C 
and washed with 100µl BD Perm/Wash buffer. Further, the cells were incubated in 
100µl BD Cytoperm Plus buffer for 5min at 4°C, followed by a wash with 100µl BD 
Perm/Wash buffer and fixed again with 100µl Cytofix/Cytoperm buffer for 5min at 
4°C. After washing, cells were resuspended in 100µl DNAse I solution (300µg/ml) 
and incubated for 1h at 37°C. After washing with BD Perm/Wash, intracellular 
staining was performed with FITC-anti-BrdU mAb in BD Perm/Wash for 20min at 
RT. Before analysis by flow cytometry cells were washed in BD Perm/Wash and 
resuspended in FACS buffer. 
3.3.4 CFSE labeling of lymphocytes 
To asses the in vitro proliferation of different lymphocyte population magnetic bead 
enriched CD4 cells were adjusted to 2x106 cells/ml in PBS, 1ul/ml of CFSE solution 
(5mM in DMSE) was added to the cell suspension and incubated for 5-10 min at 
37°C. The reaction was quenched by adding 10 fold excess volume of ice cold 
FCS/Medium (1:1) and incubated for 5min on ice before centrifugation (10min, 
300g). After, cells were counted and used for further downstream applications.  
3.4 In vitro culture and experiments 
Cells were cultured in culture medium under sterile conditions at 37°C, 5% CO2. 
Used fetal calf serum (FCS) was heat inactivated for 30 minutes at 56°C to eliminate 
complement factors. 
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3.4.1 Generation of bone marrow derived DCs 
To generate mature DCs, femurs from 5-7 week old C57BL/6 or B6.MHCIIKO mice 
were dissected and bone marrow cells were isolated by flushing the bones with 
medium, using a 10ml syringe with 27Gx¾ needle (Terumo, Belgium). Cells were 
centrifuged (300g, 8min, 4°C) resuspended in BmDC-medium and filtered to obtain a 
clump free cell suspension. 2x106 cells/plate C57BL/6 or 3x106 cells/plate 
B6.MHCIIKO bone marrow cells were plated in 10ml BmDC-medium in 100mm cell 
culture dishes. Cultured cells were fed every third day with fresh BmDC medium and 
were cultured at least for 10 days before use. Before downstream application, the 
maturation of DCs was assesed by flow cytometry for CD11c, CD11b, CD80, CD86 
and MHC class II expression.  
3.4.2 In vitro autologous mixed lymphocyte reaction (autoMLR) 
To investigate the proliferation of CD4 subpopulations upon self-antigen recognition, 
autoMLR was performed. Two different setups were used: 
3.4.2.1 Contact setup 
1x105 mature syngeneic BmDCs were plated in 96-well-U-shaped microtiter plates 
(Corning, Germany) one day prior to CD4 cell isolation and incubated over night at 
37°C. The following day, CD4 T cells were isolated from pooled LN and mLNs. 
Magnetic bead purified CD4 cells were CFSE labeled and 3x105 cells were co-
cultured with BmDCs for up to 5 days at 37°C. Cell numbers, surface/intracellular 
molecule expression and proliferation were analyzed by flow cytometry. 
3.4.2.2 Transwell setup  
6x105 mature syngeneic BmDCs were plated in the lower well (24 well plate, 
Corning, Germany) one day prior to CD4 cell isolation and incubated over night at 
37°C. The following day, CD4 T cells were isolated from pooled LN and mLNs. 
Magnetic bead purified total CD4 cells (3x105 cells) or sorted Helios+Treg cells (2-
3x104 cells) were both CFSE labeled and cultured in a 6.5mm insert well with a 
perforated polyester membrane (0.4µm pore size, Corning, Germany). In some 
experiments, sorted 1.8x106 Tconv (CD4+GFP-) cells were co-cultured in the lower 
well. Cultures were analyzed after 5 days at 37°C. Cell numbers, surface/intracellular 
molecule expression and proliferation were analyzed by flow cytometry. 
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3.5 In vivo experiments 
All transferred cells were injected intravenously (i.v) into the tail vein in a total 
volume of 200µl PBS and all other administrated compounds (e.g. BrdU, DTx) were 
injected intraperitoneally (i.p) in a total volume of 100µl PBS if not other indicated. 
3.5.1 In vivo BrdU labeling 
To investigate the proliferation of different lymphocyte subsets in vivo, mice were 
injected i.p. with 0.5mg of BrdU in 200µl PBS every 12h for 3 consecutive days. The 
thymidine analog can incorporate into the newly synthesized DNA of dividing cells 
and therefore labels proliferating cells. The last injection was performed 12h before 
mice were sacrificed and required organs were isolated and prepared for further 
analysis by flow cytometry as described before. 
3.5.2 Generation of bone marrow chimeric mice 
Protocol was adapted from Koehli et al.17 Recipient mice (CD45.1/2) were lethally 
irradiated with 900 rad (GammaCell, Best Theratronics, CA). Bone marrow cells 
were isolated from femurs of 5-8 week old C57BL/6 mice (CD45.1) and OT-II 
RagKO (CD45.2). Red blood cells were lysed (RBC lysis Buffer) and bone marrow 
cells were filtered (70uq cell strainer, BD). Mature T cells were depleted by staining 
bone marrow cells with anti-CD4, anti-CD8, anti-Thy1.1 and anti-Thy1.2 (obtained 
from hybridoma supernatants, kindly provided by K.Hafen and G. Holländer) 
followed by incubation with complement (Low-Tox-M Rabbit Complement, 
Cedarlane, CA) at 37°C for 45 minutes. A mixture of 9:1 of C57BL/6 and OT-II 
RagKO bone marrow cells (4x106 total cells) were injected into irradiated recipient 
mice. These mice were treated with antibiotics (Nopil, Mepha Pharma AG) in the 
drinking water until 2 weeks before analysis. Then the mice were analyzed 12-14 
weeks after reconstitution. The congenic markers CD45.1 and CD45.2 were used to 
identify the T cells from the different origins.  
3.5.3 Skin transplantation model 
For the transplantation of the skin graft, recipient mice were under general anesthesia 
with isoflurane and received Dafalgan (Bristol-Myers Squibb SA) in their drinking 
water directly after transplantation. Mice were transplanted with a ca 1cm2 piece of 
tail skin donated from allogeneic Bm12 mice. Therefore a piece of skin from the 
same size was removed on the back of the recipient mouse and replaced with the tail 
skin. Grafts were glued using Histoacryl (Aesculap AG) and were covered with finger 
stripes (Hansaplast, Beiersdorf). To avoid the graft from sticking on the stripe, the 
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stripes were coated with Vaseline. Bandages were removed after 7 days. To allow 
complete wound healing, in experiments where mice were challenged with naïve 
ABM T cells, cells were adoptively transferred (i.v.) earliest 14 days after bandage 
was removed. The appearance of the graft was observed until rejection and for 
maximal up to 100 days using following scoring system: 3 (no rejection), short hair, 
black stripe, shiny greyish appearance; 2 (first signs of inflammation), small red area, 
loss of hair shine and dryness; 1 (progressed inflammation), large red area, no black 
stripe and dryness; and 0, rejected.  
3.5.4 Treg depletion and rescue of FoxP3DTR mice 
To investigate the suppressive ability of different Treg populations in an autoimmune 
driven disease, FoxP3 DTR mice were depleted from FoxP3 expressing cells by 
diphtheria toxin (DTx) as these cells co-express the diphtheria toxin receptor (DTR) 
under the control of FoxP3.  
Therefore mice were injected every other day i.p. with 50µg/kg DTx for the first two 
injections or 25µg/kg for following injections for 10-12 days. In some groups 2.5x105 
sorted Treg cells (isolated from pooled LNs and mLNs as described before) were 
injected i.v. 3 days prior to first DTx injection. One day after last DTx injection, mice 
were sacrificed and required organ samples were isolated and prepared for further 
analysis. 
3.5.5 Adoptive transfer inflammatory bowel disease (IBD) model 
3.5.5.1 Induced Treg competent setup 
To asses the suppressive potential of different Treg population in a commensal 
antigen-driven disease, CD45.1 congenically marked 3.2x105 sorted naïve C57BL/6 
CD4 T cells (CD4+CD25-, isolated from pooled LNs and mLNs as were adoptively 
transferred into T cell deficient (CD3KO) mice. In some groups, CD45.2 
congenically marked 0.8 x105 sorted Treg cells were co-transferred with the sorted 
naïve CD4 Tcells (isolated from pooled LNs and mLNs as described before). Weight 
of the mice was determined weekly. To avoid differences due to daily fluctuations, 
weight was determined always at the same time of the day. Mice were sacrificed 
when initial bodyweight droped more than 20% or latest  after six weeks. Required 
organ samples were isolated and prepared for further analysis. The congenic markers 
CD45.1 and CD45.2 were used to identify the T cells from the different origins. 
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3.5.5.2 Induced Treg depleted setup 
To define the suppressive potential of different Treg population without the help of 
possible induced Treg cells from the naïve CD4 T cell pool, IBD was induced as 
described above but instead of naïve C57BL/6 CD4 T cells, 3.2x105 sorted naïve 
FoxP3 DTR CD4 T cells (CD45.1) were adoptively transferred in presence or 
absence of 0.8 x105 sorted Treg cells (CD45.2) into CD3KO recipients.  
To continuously deplete possible converting Tregs, mice were injected every third 
day with low dose of DTx (10ug/kg). Mice were weighed weekly at the same time of 
the day and sacrificed when initial bodyweight droped more than 20% or latest  after 
six weeks. Required organ samples were isolated and prepared for further analysis. 
The congenic markers CD45.1 and CD45.2 were used to identify the T cells from the 
different origins. 
3.5.6 Scurfy disease transfer model 
Newborn hemizygous FoxP3KO male pubs from heterozygous FoxP3KO female 
mice crossed with CD57BL/6 male mice developed a severe multi organ 
inflammation within 2 weeks of age and die shortly after onset. To identify potential 
scurfy disease causing cells, different cell populations from pooled LNs and mLNs of 
2-3 week old sick FoxP3KO male mice were sorted and 5x105 cells were adoptively 
transferred into T cell deficient (CD3KO) mice. Mice were weighed weekly at the 
same time of the day and were observed for signs of skin-inflammation at the tail and 
the ears. When the initial bodyweight droped more than 20% or latest after six weeks, 
mice were sacrificed. The required organ samples were isolated and prepared for 
further analysis.  
3.6 Data analysis 
Flow cytometry was performed on a FACScantoII by using the FACSDiva software 
(BD Bioscience) while FACS analysis was performed with the FlowJo software (Tree 
Star). Histological pictures were taken on the Olympus BX61 Diana and analyzed 
with the ImageJ software (NIH). Graphs and statistical analysis (unpaired-t-test, one-
way-ANOVA or Kaplan-Meier Log-rank (Mantel Cox) test, where indicated) were 
done with Prism (GraphPad Software Inc.) 
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4 Aim of Study 
Regulatory T cells are key players in maintaining lymphocyte homeostasis and 
preventing autoimmune disease. Their indispensability is best appreciated in mice and 
humans lacking Treg cells. FoxP3 KO (scurfy) mice and patients with IPEX 
syndrome suffer from excessive lymphocyte activation, multi organ lymphocyte 
infiltration and colitis, leading to death at an early age. Over the past years, extensive 
research has been carried out which classified Treg cells based on their origin, 
activation status and expression of surface markers as well as their ability to migrate 
into certain tissues. Treg cells, generated in the thymus, have been shown to have a 
TCR repertoire skewed towards self-reactivity while peripheral induced Treg cells 
were thought to have a more commensal specific TCR repertoire. However, it is still 
not clear how their degree of self-reactivity contributes to their development and 
functional capabilities.  
The aim of this study was to identify Treg cell populations with differing degrees of 
self-reactivity and to understand how these Treg cell subsets maintain lymphocyte 
homeostasis. 
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5 Results  
5.1 The FoxP3 transgenic (tg) mouse: A model to learn more about 
regulatory T cells 
The FoxP3 transgenic mouse was developed in the laboratory of Steven Ziegler and 
Fred Ramsdell in 2001 where they generated five different transgenic mouse lines.48 
For this study the FoxP3tg line 2826 on the B6 genetic background was used. The 
2826 FoxP3tg mouse line was described to expresses 16 copies of a 30.8kb BAC 
transgene containing a cosmid construct containing the entire foxp3 gene along with 
18kbp of 5’ sequences and 4kbp of 3’ sequences. Because the gene is controlled by 
its own regulatory elements, the expression parallels that of the endogenous gene with 
respect to tissue distribution.48, 50 In previous reports, the FoxP3tg mouse was 
described to be healthy and did not show any signs of disease.  
In our hands, FoxP3tg mice on a heterozygous background for the FoxP3 transgene 
also showed normal development and any progression of disease for more than 20 
weeks. Surprisingly, when we crossed the FoxP3tg mouse on a homozygous FoxP3tg 
background, these mice showed developmental deficiencies and a severe ataxic 
phenotype, characterized by a shaking gait and general difficulties of hind limb 
control. Because cells, expressing FoxP3, tightly regulate the immune system, we 
wondered, whether the observed phenotype was caused by an immunological defect. 
Neither the adoptive transfer of homozygous FoxP3tg lymphocytes into Rag2-/- hosts 
nor the reconstitution of lethally irradiated Rag2-/- with FoxP3tg bone marrow 
induced the ataxic phenotype in recipient mice. We therefore excluded that an 
immunological defect causes the observed phenotype. Next, we wondered, whether 
the integration site of the BAC transgene could cause an unexpected knock out and 
leads to the phenotype in the homozygous mouse. Therefore, we performed extensive 
thermal asymmetric interlaced (TAIL) PCR, a nested PCR technique to identify 
unknown integration sites in the genome.189 Due to the high copy numbers (16 
copies) of the transgene, we only were able to find tandem sites of the transgene but 
not the genomic flanking site. Because of this, we cannot exclude that the ataxic 
phenotype is the consequence of unlucky integration site in the genome. A further 
possibility for the ataxic phenotype we addressed to regulatory functions of FoxP3 
outside the immune system.190 In previous reports, FoxP3 was described to act as a 
negative regulator for the proto-oncogene ErbB2.191 Mice deficient for ErbB2 showed 
a similar phenotype as observed in homozygous FoxP3tg mice.192 The disease 
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showed in ErbB2 deficient mice was caused by a defect in the muscle spindle 
formation and lead to the described ataxic phenotype. We performed H&E staining of 
frozen tissue sections of the soleus, isolated from B6, heterozygous and homozygous 
FoxP3tg mice. Preliminary data indicated that homozygous FoxP3tg mice have 
clearly reduced muscle spindle formation compared to B6 mice. Heterozygous 
FoxP3tg mice had slightly reduced muscle spindle formation. These results indicate 
that FoxP3 is expressed, to some extend, in muscles and the overexpression of FoxP3 
downregulates ErbB2.  
Taken together, we conclude that the observed phenotype was either caused by an 
untoward integration of the transgene or a muscular malfunction and not an 
immunological problem. Based on these results, we decided to perform further 
experiments with FoxP3tg mice on a heterozygous background.  
5.1.1 Characterization of heterozygous FoxP3tg mice  
5.1.1.1 Thymic phenotype of FoxP3tg mice 
We first analyzed the thymic development of FoxP3tg and B6 control mice where we 
could not observe any defect in FoxP3tg mice reflected by comparable thymus 
cellularity of FoxP3tg and B6 mice (Fig.6a). In flow cytometric analysis of live 
thymocytes for CD4 and CD8b expression (Fig, 6b,c) we could not find significant 
differences between frequencies or cell numbers of double negative (DN, CD4-
CD8b-), double positive (DP, CD4+CD8+), CD4 single positive (CD4SP, 
CD4+CD8b-) or CD8SP (CD4-CD8+) cells between FoxP3tg and B6 mice  
(Fig.6b,c)  
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Figure 6: FoxP3tg mice do not have an impaired thymic development. 
a) Representative dot plots of live thymocytes from B6 and FoxP3tg mice analyzed by flow cytometer. Thymocytes 
were stained for CD4 and CD8b that define DN (CD4-CD8b-), DP (CD4+CD8b+), CD4SP (CD4+CD8b-) and 
CD8SP (CD4-CD8b+) cells. b) Cellularity of thymocytes from B6 (black) or FoxP3tg (grey) mice and c) frequency 
(upper row) and cell numbers (lower row) of DN, DP, CD4SP and CD8SP of live thymocytes from B6 (black) or 
FoxP3tg (grey) mice. Statistical analysis was performed using an unpaired student’s t test. Error bars show SEM. ns= 
not significant.  
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In a next step, we then analyzed FoxP3 expression in DN, DP, CD4SP and CD8SP 
thymocytes of B6 and FoxP3tg mice. FoxP3 is not expressed in DN cells (not shown) 
and only in a small percentage of DP cell in both, FoxP3tg and B6 mice (Fig. 7a,b top 
panels). In B6 mice we detected about 3% of FoxP3 expressing CD4SP thymocytes 
whereas in FoxP3tg mice, frequency and cell numbers of this population was 
increased up to 10 fold (Fig. 7a,b middle panels). As expected, only a small fraction 
of FoxP3+ CD8SP cells was detected in B6 mice compared to almost 30% in FoxP3tg 
mice (Fig. 7a,b lower panel).    
 
 
 
This data shows that thymic development in FoxP3tg mice is not impaired. 
Frequencies as well as cell numbers of CD4SP and CD8SP cells in the thymus of 
FoxP3tg mice are not different from B6 mice. However, in FoxP3tg mice, a higher 
frequency of CD4SP and CD8SP cells express FoxP3, compared to B6 mice.  
 
Figure 7: Expression of FoxP3 in B6 and FoxP3tg thymocytes 
a) Representative dot plots of live thymocytes from B6 and FoxP3tg mice analyzed by flow cytometry for FoxP3 
expression in DP (CD4+CD8b+), CD4SP (CD4+CD8b-) and CD8SP (CD4-CD8b+) cells b) Frequency (left) and cell 
numbers (right) of DP, CD4SP and CD8SP live thymocytes from B6 (black) and FoxP3tg (grey) mice. Statistical 
analysis was performed using an unpaired student’s t test. Error bars show SEM, n=5-7. **, P < 0.01; ***, P < 0.001, 
ns= not significant. 
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5.1.1.2 Peripheral Phenotype of FoxP3tg mice 
Next, we investigated the distribution of adaptive immune cells namely, CD4 T cells, 
CD8 T cells and CD19+ B cells in B6 and FoxP3tg mice. We isolated lymphocytes 
from peripheral lymph nodes (axillary, cervical, brachial and inguinal, LN) 
mesenteric LN (mLN) as well as the spleen and performed flow cytometric analysis. 
Frequency and absolute cell numbers of CD4 and CD8 T cells in LN, mLN and 
spleen are markedly reduced in FoxP3tg compared to B6 mice (Fig. 8a,c) whereas 
frequencies of CD19 positive cells are increased in LN and mLNs (Fig. 8b,c) In the 
spleen, FoxP3tg and B6 mice express similar frequencies of CD19 positive 
splenocytes (Fig.8b,c). The absolute number of CD19 positive cells is not different 
between FoxP3tg and B6 cells isolated from LN, mLN or spleen (Fig. 8c). 
 
 
 
 
 
 
 
Figure 8: FoxP3tg mice have less T cells than B6 mice. 
Representative dot plots of live lymphocytes isolated from peripheral lymph nodes (LN), mesenteric LN (mLN) and 
spleen from B6 and FoxP3tg mice analyzed by flow cytometry. Lymphocytes were stained for a) CD4, CD8b and b) 
CD19. c) Frequency (left column) and cell numbers (right column) of CD4+ T cells, CD8+ T cells and CD19+ B cells 
of live lymphocytes from B6 (black) and FoxP3tg (grey) mice. Statistical analysis was performed using an unpaired 
student’s t test. n=5-7.*, P < 0.05 ; **, P < 0.01; ***, P < 0.001;  ****, P < 0.0001; ns= not significant. 
Results I 
 
 -54- 
In previous studies, Kasprowicz et al identified, by confocal microscopy, up to 80% 
of FoxP3+ CD4+ T cells in the spleen and LN of FoxP3tg mice, compared to 5% of 
FoxP3+CD4 T cells identified in the spleen and LN of littermate controls. Therefore, 
in a next step, we analyzed FoxP3 expression in CD4 T cells isolated from LN, mLN 
and spleen of FoxP3tg and B6 mice by flow cytometry. Our result confirms the 
previously reported data. Up to 80% of FoxP3tg CD4 T cells isolated from LN, mLN 
or spleen express FoxP3, but only 10% of B6 CD4 T cells express FoxP3 (Fig. 9a). 
Even though the frequency of FoxP3 expressing CD4s in FoxP3tg mice is vastly 
higher than in B6 mice, the difference in absolute cell numbers is diminished (Fig. 
9b). 
 
 
Figure 9: FoxP3tg mice have higher frequencies but similar numbers of FoxP3+ CD4 T cells compared to B6 mice. 
a) Representative dot plots of live lymphocytes isolated from peripheral lymph nodes (LN), mesenteric LN (mLN) and 
spleen from B6 and FoxP3tg mice analyzed by flow cytometer. CD4+ cells were analyzed for FoxP3 expression. b) 
Frequency (left column) and cell numbers (right column) of FoxP3+ CD4 T cells from B6 (black) and FoxP3tg (grey) 
mice. Statistical analysis was performed using an unpaired student’s t test. n=5-7.*, P < 0.05 ;  ****, P < 0.0001; ns= not 
significant. 
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Taken together, frequencies and cell numbers of peripheral T cells are significantly 
lower, while frequencies but not numbers of B cells are different in FoxP3tg 
compared to B6 mice. In turn, frequencies of peripheral CD4+ FoxP3+ T cells are 
vastly higher in FoxP3tg mice, but absolute cell numbers are not much higher 
compared to cell numbers found in B6 mice. 
5.1.2 Cellular phenotype of FoxP3tg mice is regulated by cell intrinsic 
mechanisms.  
Previous reports indicated that FoxP3 expression is not only limited to 
lymphocytes.190 FoxP3 overexpression, in FoxP3tg mice, may influence non-
lymphoid cells and indirectly leads to the cellular phenotype observed in FoxP3tg 
mice. To evaluate whether the reduced frequencies of peripheral T lymphocytes is 
regulated by cell intrinsic or extrinsic mechanisms we generated bone marrow (BM) 
chimeras. Lethally irradiated, congenically marked B6 (CD45.1) mice were 
reconstituted with BM isolated from FoxP3tg mice (CD45.2). Cells isolated from 
thymus (Fig. 10a) and periphery (LN and Spleen, Fig. 10b) were analyzed 10 to 12 
weeks after reconstitution and compared to either unmanipulated B6 thymocytes (Fig. 
10a) or FoxP3tg cells isolated from LN or Spleen (Fig. 10b). As expected, the 
distribution of CD4 and CD8 expressing thymocytes, developed from FoxP3tg BM 
cells (CD45.2), are comparable to unmanipulated B6 (Fig. 10a top) or FoxP3tg (Fig. 
6b) thymocytes.  Moreover, in chimeras, FoxP3tg derived CD4SP cells (CD45.2) 
express about 10 times more FoxP3 (Fig. 10a bottom) than unmanipulated B6 CD4SP 
(Fig. 10a bottom) and have about the same percentage of FoxP3+CD4SP cells 
compared to unmanipulated FoxP3tg mice (Fig. 7a). In peripheral lymphocytes 
isolated from LN or spleen of chimeras, frequencies of CD8b, CD19, CD4 and 
CD4+FoxP3+ from FoxP3tg cells (CD45.2) are indistinguishably from frequencies of 
the same cell subsets found in unmanipulated FoxP3tg mice (Fig. 10b) 
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These results show that the observed reduced frequencies of CD4+ and CD8+ T cells, 
found in FoxP3tg mice, are caused by cell intrinsic and not by cell extrinsic 
mechanisms. Furthermore, these results indicate that FoxP3 transgene activity 
influences mainly peripheral lymphocytes rather than thymic development of T cells.  
5.1.3 Evaluating the suppressive function of FoxP3tg cells in an allogeneic skin 
transplantation model 
To evaluate the suppressive function of FoxP3tg Treg cells, we used the Bm12 skin 
graft model. A spontaneous three point mutation in the antigen presenting groove of 
the IA molecule  (IAbm12) was shown to induce an alloimmune response within 14 
days when Bm12 skin was transplanted on the back of B6 mice (IAb)193, 194 (Fig. 11a, 
12b). In T cell deficient mice (e.g. Rag2-/-) Bm12 allograft are tolerated for up to 100 
days but rejection could be induced within 12 days by the adoptive transfer of 2x104 
Bm12 mutation specific TCRtg CD4 T cells (Vα2/Vβ8 TCR, named as ABM 
cells)194 (Fig. 11b and 12c) 
 
 
 
Figure 10: Non-lymphoid cells are not responsible for altered cellular phenotype in FoxP3tg mice. 
a) Representative FACS analysis of CD4 and CD8b expression in thymocytes from B6 CD45.2 mice (left) and B6 
CD45.1 lethally irradiated hosts reconstituted with BM derived from FoxP3tg mice (right) while bottom panels shows 
the expression of CD45.2 and FoxP3 on CD4SP thymocytes in respective mice. b) Histograms shows frequencies of 
live CD45.2 CD8b, CD19, CD4 and CD4 FoxP3 cells in LN and Spleen of FoxP3tg (CD45.2, grey) or indicated B6 
(CD45.1)/FoxP3tg (CD45.2) chimeric (black) mice. Statistical analysis was performed using an unpaired student’s t 
test. n=4-7, error bars show SEM. *, P < 0.05, ns= not significant. 
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To investigate the suppressive function of FoxP3tg lymphocytes in vivo, FoxP3tg or 
control B6 mice received a Bm12 skin graft at d0. B6 control mice rejected grafts 
within 14 days whereas FoxP3tg tolerated the grafts for up to 50 days (Fig.12b). We 
then wondered, whether tolerance was due to the suppressive function of FoxP3+ CD4 
or because of too few of FoxP3 negative effector CD4+ T cells in FoxP3tg recipients 
(Fig.7). To address this, the same FoxP3tg or control Rag2-/- recipients received 
2x104 ABM cells. Rag2-/- recipients rejected grafts within less than 14 days whereas 
FoxP3tg recipients did not reject the skin graft for another 30 days (Fig.12c). To rule 
out that the tolerance of skin grafts was not caused by an insufficient priming of 
ABM T cells, the same FoxP3tg or control Rag2-/- recipients were challenged with 
2x104 ABM cells, followed by an injection of 1x106 B cells (i.v.) and LPS (25µg i.p.) 
one day later. FoxP3tg recipients did not reject the grafts for 20 days whereas Rag2-/- 
recipients rejected grafts within 7 days. (Fig.12d) Regarding the result, that the 
challenge with primed ABM cells did not mediate graft rejection in FoxP3tg 
recipients, we considered that the absence of the antigen in the skin graft as a 
possibility for the robust tolerance. Thus, we re-transplanted the Bm12 skin graft 
from the FoxP3tg recipients onto Rag2-/- recipients. Rag2-/- recipients with “re-
transplants” or “fresh transplants” then were challenged with 2x104 ABM cells. Both, 
“re-transplants” and “fresh transplants” were rejected within 12 days after 
challenging.  
These results strongly indicate that FoxP3tg mice are tolerant, and most probably 
mediated by the suppressive functions of FoxP3+ CD4 T cells.  
 
 
Figure 11: Scheme of B6/Bm12 skin graft model. 
Immunosufficient (B6, “full mouse”) or immunodefficient (Rag2-/-, “empty mouse”) mice reacting differently on 
received skin allograft. “Full mice” reject Bm12 allograft within 14 days whereas “empty mice” are tolerant while 
rejection of graft can be induced within 12 days by adoptive transfer of ABM cells.  
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5.1.4 Phenotype of FoxP3tg Treg cells 
Using the Bm12 skin transplantation model, we showed that FoxP3tg mice tolerate 
the allogeneic skin grafts up to 100 day and even primed, graft specific CD4 effector 
cells did not induce graft rejection in these mice, whereas B6 mice reject allogeneic 
skin grafts within two weeks. Peripheral tolerance, including the suppression of auto 
reactive cells (e.g. ABM cells in the Bm12 model), is mediated by FoxP3 expressing 
CD4 cells which are phenotypically characterized by the expression of several extra- 
and intra- cellular molecules e.g. CD25, NRP1, GITR, CD44, CD69, CD62L, PD1 
and Helios. To evaluate if FoxP3tg Treg cells exhibit a higher suppressive phenotype 
than B6 Treg cells, splenocytes from B6 and FoxP3tg mice were evaluated for the 
expression of these markers. In B6 mice (Fig. 13, B6 Treg cells, solid black line) 
CD4+FoxP3+ Treg cells are characterized, amongst others, by a higher expression of 
CD25, Helios, NRP1, GITR CD44, CD69, and PD1 and lower expression of CD62L, 
compared to B6 CD4+FoxP3- (Tconv) (B6 Tconv, dashed gray line) cells. FoxP3tg 
Treg cells (Fig. 13, solid red line) share to some extend similarities with B6 Treg 
cells, and show higher CD25 and GITR expression than B6 Tconv cells. 
 
 
 
 
 
 
 
 
 
However, the 
expression of CD25 and GITR on FoxP3tg Treg cells are lower than on B6 Treg 
cells. Furthermore, CD69, PD1 and CD44 are not upregulated on FoxP3tg Treg cells. 
Helios and NRP1 are two markers for thymic derived Treg cells, were only 
marginally expressed on Foxp3tg Treg cells while in B6 mice, the majority of Treg 
cells express Helios and Nrp1. This indicates that FoxP3tg Treg cells have a different 
Figure 13: FoxP3tg Treg cells have “intermediate” Treg phenotype compared to B6 Treg cells. 
CD4+ FoxP3+ splenocytes from FoxP3tg (red) or B6 (black) and CD4+FoxP3- (grey dashed) from B6 mice were 
analyzed for the expression of activation markers CD25, CD44, CD62L and CD69 (upper row) and Treg markers 
Helios, NRP1, GITR and PD1 (lower row). Histograms show expression of the indicated markers. 
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origin than B6 Treg cells. Overall, FoxP3tg Treg cells a have an “intermediate” Treg 
phenotype compared to B6 Treg cells. 
We further analyzed Treg cells isolated from thymus, LN, mLN and Spleen from 
FoxP3tg and B6 mice for the expression of Helios. In the thymus of B6 mice more 
than 90% of all FoxP3+CD4SP cells express Helios while in peripheral CD4+FoxP3+ 
cells, only 70% express Helios. In comparison, the vast majority of FoxP3tg Treg 
cells were Helios negative, irrespective of their origin (Fig. 14a). Even though the 
frequencies of Helios+ Treg cells are significantly higher in B6 than in FoxP3tg Treg 
cells, the absolute numbers of total Helios+ Treg cells is comparable in both mouse 
lines (Fig. 14b). Helios+ Treg cells from FoxP3tg mice express CD44, CD62L, CD69, 
CD25, NRP1, GITR and PD1 almost equal to Helios+ Treg cells from B6 mice. (Fig. 
14c) 
Figure 14: FoxP3tg Helios+ Treg population has a “true” Treg phenotype and similar number as found in B6 mice. 
CD4+ FoxP3+ cells from FoxP3tg and B6 mice were analyzed a) for Helios expression in cells isolated from thymus, 
lymph nodes (LN), mesenteric lymph nodes (mLN) and spleen. b) Graphs display frequency (upper panel) and cell count 
(lower panel, left) of Helios+ Treg cells from LN, mLN and spleen as well as of pooled organs (lower panel, right) of 
FoxP3tg (gray) and B6 (black) mice. c) Histograms show CD4+FoxP3+Helios+ or CD4+FoxP3- cells analyzed for CD44, 
CD62L, CD69, CD25, NRP1, GITR and PD1 from FoxP3tg and B6 mice.  Statistical analysis was performed using an 
unpaired student’s t test. n=4, error bars show SEM. *, P < 0.05 ; **, P < 0.01; ***, P < 0.001; ns= not significant. 
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Together, these results show that Helios+ and Helios- Treg cells from FoxP3tg mice 
have a Treg phenotype. However, the Helios+ fraction reflects more the Treg 
population found in B6 mice. Although FoxP3tg mice have much lower frequencies 
of Helios+ cells, in both mice, about the same number of Helios+ Treg cells are found. 
This indicates that Helios+ Treg cells from FoxP3tg mice develop in the thymus from 
negative selection, similarly to Helios+ Treg cells from B6 mice. In contrast, Helios- 
Treg cells in the Foxp3tg mouse are positively selected and are driven to express 
FoxP3 because of the transgene.  
5.1.5 Limitation of negative selection limits the development of Helios+Treg cells in 
FoxP3tg mice. 
To investigate the consequences of negative selection limitations on the development 
of Helios+ Treg cells in FoxP3tg mice, we generated mice where thymocytes are only 
limited or not negatively selected in the thymus. For these experiments, we used the 
3BK506 TCRtg (TCRtg) mouse strain, bearing a transgenic TCR recognizing the 3K 
peptide in the context of IAb. The 3K peptide is a variant of the Eα peptide; 
containing three point mutations were amino acids were substituted with lysine 
(K).195 By crossing FoxP3tg with these TCRtg mice, we generated mice with limited 
negative selection. The CD4SP cells in the thymus have a fixed TCR Vβ chain but 
because of the active Rag gene, the TCR Vα chain still can be rearranged and allows 
negative selection. Breeding the FoxP3tgTCRtgRag+ mouse on a RagKO background 
resulted in mice where negative selection was abolished. This is mediated by the 
complete deletion of the Rag gene and the absence of the cognate antigen in the 
thymus.  
In the thymus of FoxP3tg mice around 25% of all CD4SP cells are FoxP3+ and about 
4% co-express Helios. In cells isolated from peripheral lymphoid organs, the majority 
(80%) of all CD4 cells expresses FoxP3 and between 5-10% co-expressing Helios 
(Fig.15 and Fig.14b). When negative selection is limited (FoxP3tgTCRtgRag+), or 
absent (FoxP3tgTCRtgRagKO), the frequency of thymic and peripheral FoxP3 
expressing CD4(SP) cells is lower compared to frequencies in FoxP3tg polyclonal 
mice but still vastly higher compared to B6 mice. (Fig. 7, 9) Helios+ Treg cells seem 
to be more affected than the Helios-Treg cell population.  In FoxP3tgTCRtgRAG+ 
mice (limited negative selection), the Helios+Treg cell population is tiny, but still 
detectable within thymic and peripheral CD4 cells, whereas in FoxP3tgTCRtgRAGKO 
mice Helios+ Treg cells are completely missing.  
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This data indicates that the development of Helios expressing Treg cells in FoxP3tg 
mice is driven by negative selection in the thymus and seems not to be influenced by 
the expression of the FoxP3 transgene. Helios- Treg cells seem to be less affected by 
the altered negative selection of thymocytes and are more influenced by the FoxP3 
transgene. Thus, we hypothesize that Helios+ Treg cells have a higher affinity for 
self-antigens than Helios- Treg cells and Tconv cells in FoxP3tg and B6 mice.  
 
  
  
 
 
 
Figure 15: Limiting negative selection limits the development of Helios+Treg cells in FoxP3tg mice.  
Dot plots shows representative staining of thymocytes (upper row) and lymph node cells (lower row) of 
FoxP3tg, FoxP3tg 3BK506TCRtgRag+ (FoxP3tgTCRtg Rag+) and FoxP3tg 3BK506TCRtg Rag KO 
(FoxP3tgTCRtg RagKO) mice for FoxP3 and Helios. For FoxP3tg, numbers represents percentages of 
live/CD4SP or live/CD4 respectively in the designated gates. For 3BK506TCRtg mice, numbers represents 
percentages of live/CD4SP/vb8+ or live/CD4/vb8+ respectively in the designated gates. 
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5.2 Studies on the self-reactivity of different Treg cell populations 
5.2.1 Autologous Mixed Lymphocyte Reactions (autoMLRs) - an in vitro model to 
study self-reactivity - 
To test the hypothesis that Helios+ Treg cells have a higher affinity for self-antigens 
than Helios-Treg and Tconv cells, we made use of an established in vitro model to 
test self-reactivity of cells. AutoMLR experiments have been described the first time 
more than 30 years ago196, 197 and have become an important tool to study self-
reactivity in vitro 198-201. The mechanisms, how autoMLRs work are not yet fully 
understood. In general, it is believed that CD4 T cells respond to self-antigens, 
presented by MHC class II molecules on syngeneic APCs.202. 
We therefore wondered whether Helios+ Treg, Helios- Treg and Tconv cells from B6 
or FoxP3tg mice respond differently on self-antigens presented by syngeneic APCs. 
Previous studies suggested DCs as the most potent stimulators in autoMLRs.201, 203, 204 
Based on this, we used an autoMLR model where bone marrow derived DCs 
(BmDCs) generated from syngeneic (B6 background) BM served as stimulator cells. 
BmDCs showed a mature phenotype, characterized by the high expression of the 
surface molecules CD11c, CD80, CD86 and IAb (MHCII) (data not shown)205. As 
responder cells, CFSE labeled, magnetic bead enriched total CD4 cells, containing 
Helios+Treg (red), Helios-Treg (brown) and Tconv (blue) cells, isolated from pooled 
LNs from B6 or FoxP3tg mice were used (Fig. 16b). BmDCs and total CD4 cells 
were co-cultured in a 1:3 ratio and CFSE dilution of different CD4 T cell populations 
was analyzed after 5 days by flow cytometry (Fig. 16a).   
After 5 days of culture, Helios+ Treg cells from B6 and FoxP3tg mice proliferated the 
most compared to Helios-Treg and Tconv cells, reflected by the higher CFSE dilution 
of Helios+Treg cells (red line) compared to Helios-Treg (brown line) and Tconv (blue 
line) cells (Fig. 16c, lower panels). The analysis of “precursor frequencies going into 
division” (% dividing cells) shows that Helios+ Treg (red) cells of B6 and FoxP3tg 
mice proliferate significantly more than Helios- Treg (brown) and Tconv (blue) cells 
from B6 or FoxP3tg mice respectively. However, transgenic Helios+ Treg cells 
respond less than B6 Helios+ Treg cells while Helios- Treg and Tconv cells do not 
respond differently (Fig. 16d).  
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Figure 16: Helios+ Treg cells proliferate almost exclusively in autologous mixed lymphocyte reactions (autoMLR)  
General setup of autoMLR experiments a) Magnetic beads enriched CFSE labeled CD4 cells isolated from pooled LNs were 
co cultured with mature syngeneic BmDCs for 5 days before flow cytometric analysis. b) Representative dot plots for FoxP3 
and Helios expression of freshly isolated CD4 cells from B6 (left) and FoxP3tg (right) mice.  c) ,d) autoMLR experiment 
using CD4 cells isolated from B6 or FoxP3tg mice co cultured with B6 BmDCs for 5 days. c) Representative dot plots for 
FoxP3 and Helios expression (upper panels) and histograms (lower panels) for CFSE dilution of Helios+ Treg (Helios+ 
FoxP3+ CD4+, red), Helios- Treg (Helios- FoxP3+ CD4+, brown) and Tconv (Helios- FoxP3-CD4+, blue) cells of B6 (left) or 
FoxP3tg (right) CD4 cells. d) Graph displays percentage of dividing Helios+ Treg (red), Helios- Treg (brown) and Tconv 
(blue) cells. Statistical analysis was performed using an unpaired student’s t test. N≥9, error bars show SEM. *, P < 0.05 ; 
**, P < 0.01;  ****, P < 0.0001; ns= not significant. 
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5.2.2 Absence or blocking of MHC class II on BmDCs abolished proliferation of 
Helios+Tregs 
In order to confirm that the observed proliferation of B6 and FoxP3tg Helios+Treg 
cells, described above, is driven by TCR:MHCII interactions and not by an 
interaction with co-stimulatory molecules expressed on mature BmDCs e.g. CD80 
and CD86,18 we used three different experimental setups to test this. 
First, we performed the autoMLR as described above (and see Fig.16a) but used 
BmDCs from B6 mice lacking MHCII expression (B6.MHCIIKO). The lack of MHCII 
on BmDCs diminished the proliferation of Helios+ Treg cells, Helios- Treg and Tconv 
cells from both, B6 and FoxP3tg CD4+ cells (Fig.17a,b).  
 
 
Even though B6.MHCIIKO BmDCs showed comparable expression of co-stimulatory 
molecules (e.g. CD80 and CD86, not shown) we wanted to rule out that the knock out 
of MHCII leads to unexpected functional alterations in these BmDCs. Therefore, we 
performed the autoMLR as described before (and see Fig.16a) with B6.BmDCs in 
presence of an MHCII (IAb) blocking antibody (5ug/ml). Blocking of MHCII on 
B6.BmDCs resulted in the complete blocking of proliferation in all CD4+ T cells 
from both, B6 and FoxP3tg mice (Fig.18).   
 
Figure 17: Absence of MHC class II on BmDCs diminishes proliferation of Treg cells. 
AutoMLR experiment using CD4 cells isolated from B6 or FoxP3tg mice co-cultured with B6.MHCIIKOBmDCs for 5 
days. a) Representative dot plots for FoxP3 and Helios expression (upper panels) and histograms (lower panels) for 
CFSE dilution of Helios+ Treg (Helios+FoxP3+CD4+, red), Helios- Treg (Helios-FoxP3+CD4+, brown) and Tconv 
(Helios-FoxP3-CD4+, blue) cells of B6 (left) or FoxP3tg (right) CD4 cells. b) Graph displays percentage of dividing 
Helios+ Treg (red), Helios- Treg (brown) and Tconv (blue) cells. Statistical analysis was performed using an unpaired 
student’s t test. N≥9, error bars show SEM. *, P < 0.05 ; ns= not significant.  
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Although autoMLR experiments using MHCII deficient BmDCs or blocking of 
MHCII on B6 BmDCs clearly influenced the proliferative response of all CD4+ T 
cells, we wanted to rule out that soluble factors (e.g cytokines), produced by BmDCs, 
influences the proliferation. Therefore, we established a “transwell autoMLR” 
(Fig.19a). In this setting, the insert and bottom well were separated by a perforated 
membrane with 0.4µm pore size that effects that soluble factors can pass, but cells 
remains separated. The magnetic beads enriched CFSE labeled CD4 cells isolated 
from pooled LNs of B6 or FoxP3tg mice were cultured in the insert well, while 
B6.BmDCs were cultured in the bottom well for 5 days before analysis by flow 
cytometry. To maintain the “1:3” ratio of BmDC:CD4+ T cells used in the previous 
experiments, DC numbers had to be scaled up by six fold because the bottom well 
was six fold bigger than the insert well. The separation of B6 or FoxP3tg CD4 cells 
from B6.BmDCs abolished the proliferation of all CD4+ T cells cultured in the insert 
well. This is reflected by the loss of Helios+Treg cells (Fig.19b, upper panels) 
compared to freshly isolated CD4+ T cells (Fig.16b), the lacking CFSE dilution and 
the very low frequencies of dividing cells (Fig.19c) compared to autoMLRs where 
CD4+ T cells could interact with B6.BmDCs (Fig.16c,d).  
Figure 18: Blocking of MHC class II on BmDCs diminishes the proliferation of all CD4 T cell 
populations.  
AutoMLR experiment using CFSE labeled CD4 cells isolated from B6 or FoxP3tg mice, co-cultured with 
B6.BmDCs in presence of IAb blocking antibody (5µg/ml) for 5 days. Representative dot plots for FoxP3 and 
Helios expression (upper panels) and histograms (lower panels) for CFSE dilution of Helios+ Treg 
(Helios+FoxP3+CD4+, red), Helios- Treg (Helios-FoxP3+CD4+, brown) and Tconv (Helios-FoxP3-CD4+, blue) 
cells of B6 (left) or FoxP3tg (right) CD4 cells.  
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Taken together, our data shows that from enriched total CD4+ T cells, cultured on 
syngeneic B6.BmDCs Helios+ Treg cells highly proliferate whereas only a small 
fraction of Helios-Treg and Tconv cells are proliferating. The proliferation of all 
populations is abolished when first, MHCII is knocked out on BmDCs, second, 
MHCII is blocked on B6.BmDCs or third when we abolished direct contact to 
B6.BmDC by using a transwell culture system. These results are true for CD4+ T cells 
isolated from B6 and FoxP3tg mice. Because we observed similar results with CD4+ 
T cells from B6 and FoxP3tg mice, we decided to perform further experiments with 
CD4+ T cells from the unmanipulated B6 mouse only.  
 
Figure 19: CD4 T cells do not proliferate without direct B6.BmDCs contact.  
Setup of transwell autoMLR experiments a). Magnetic beads enriched CFSE labeled CD4 cells isolated from 
pooled LNs were cultured in the insert of a transwell system while B6.BmDCs were cultured in the bottom 
well for 5 days before flow cytometirc analysis. Insert and bottom wells are separated by a perforated 
(!0.4µm) membrane. b),c) Transwell autoMLR experiment using CD4 cells isolated from B6 or FoxP3tg 
mice (insert) cultured with B6 BmDCs (bottom well) for 5 days. b) Representative dot plots for FoxP3 and 
Helios expression (upper panels) and histograms (lower panels) for CFSE dilution of Helios+ Treg 
(Helios+FoxP3+CD4+, red), Helios- Treg (Helios-FoxP3+CD4+, brown) and Tconv (Helios-FoxP3-CD4+, blue) 
cells of B6 (left) or FoxP3tg (right) CD4 cells. c) Graph displays percentage of dividing Helios+ Treg (red), 
Helios- Treg (brown) and Tconv (blue) cells. N=5.  
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5.2.3 Helios+ Treg cells need “support” from Tconv cells to proliferate 
The Helios+ Treg cell population was the most proliferative population in the 
previously performed experiments; using total CD4 cells cultured on B6.BmDCs. 
This supports the hypothesis that Helios+Treg cells have a higher TCR affinity for 
self-antigens than Helios-Treg or Tconv cells. To further confirm these observations, 
we performed autoMLR experiments with sorted Helios+Treg cells. Sorting for 
intracellular markers e.g. Helios and FoxP3 would require the perforation of cells, 
what kills the cell. Therefore, we had to develop a sorting strategy, which does not 
require intracellular staining. Using B6.FoxP3eGFP mice where all FoxP3 expressing 
cells are labeled with GFP in combination with the surface markers GITR and PD155 
we were able to sort a Treg population with a purity of >85% for Helios expression. 
To obtain this enriched Helios+ Treg cell population, magnetic bead enriched CD4+ T 
cells from pooled LNs from several B6.FoxP3eGFP mice were sorted for CD4+, 
GFP+, GITRhigh and PD1high (Fig. 20a). 
To asses their proliferative capacity induced by self-antigens, CFSE labeled sorted 
Helios+ Treg cells were co-cultured with either B6.BmDCs or B6.MHCIIKO BmDCs 
in a 1:5 ratio (Tregs:DCs) for 5 days. A small fraction of sorted Helios+ Treg cells 
divided when cultured on B6.BmDCs (Fig. 20b) but not different from sorted Helios+ 
Treg cells that were cultured on B6.MHCIIKOBmDCs (Fig. 20c). The analysis of 
frequencies of dividing cells did not show differences between the two groups (Fig. 
20c).  
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Figure 20: Sorted Helios+ Tregs do not proliferate, independently from MHC class II expression on 
B6.BmDCs.  
a) Sorting strategy of Helios+ Tregs from B6.FoxP3eGFP mice. To obtain highly enriched Helios+Treg cells, 
magnetic bead enriched CD4 Tcells from pooled LNs from several B6.FoxP3eGFP mice were sorted for 
CD4+GFP+GITRhighPD1high (Helios+Treg cells). Purity of population for Helios expression was > 85%.  
AutoMLR experiment using sorted B6 FoxP3eGFP Helios+Treg cells co-cultured with B6 b) or B6.MHCIIKOBmDCs 
c) for 5 days. Representative dot plots for FoxP3 and Helios expression (left panels) and histogram (right panels) for 
CFSE dilution of sorted Helios+Treg cells. d) Graph displays percentage of dividing Helios+ Treg cells (red). 
Statistical analysis was performed using an unpaired student’s t test. N≥9, error bars show SEM. ns= not significant.  
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We then wondered whether Helios+ Treg cell proliferation is dependent on the 
presence of Tconv cells. To assess this, we reconstituted CFSE labeled sorted Helios+ 
Treg cells with sorted unlabeled Tconv cells (CD4+GFP- from B6.FoxP3eGFP mice) 
in a 1:10 ratio. Mixed CD4+ cells were then co-cultured with B6.BmDCs or 
B6.MHCIIKO BmDCs in a 1:3 ratio (CD4 cells:DCs) for 5 days (Fig. 21a). In the 
presence of Tconv cells, Helios+ Treg cells strongly proliferated in co-cultures with 
B6.BmDCs (Fig. 21b, left panels) but not with B6.MHCIIKO BmDCs (Fig. 21b, right 
panels). The analysis of frequencies of dividing cells (Fig. 21c) confirms a significant 
increase of proliferation in co-cultures with B6.BmDCs.  
 
 
 
 
 
 
 
 
 
 
Figure 21: Sorted Helios+ Tregs do proliferate in presence of MHC class II expressing B6 BmDCs when co-
cultured with sorted Tconv cells.  
a) Setup of experiment. 1:10 mixture of CFSE labeled sorted Helios+ Treg (CD4+GFP+GITRhighPD1high) and sorted 
Tconv (CD4+GFP-, unlabeled) cells isolated from B6.FoxP3eGFP mice were co-cultured with B6.BmDCs or 
B6.MHCIIKOBmDCs for 5 days. b) Representative dot plots for FoxP3 and Helios expression (upper panels) and 
histograms (lower panels) for CFSE dilution of Helios+ Treg (Helios+FoxP3+CD4+) cells. (c) Graph displays 
percentage of dividing Helios+ Treg cells (red). Statistical analysis was performed using an unpaired student’s t test. 
N=5, error bars show SEM. ***, P < 0.001. 
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The presence of Tconv cells restores the proliferation of sorted Helios+ Treg cells 
when cultured on B6.BmDCs, but not when cultured on B6.MHCIIKOBmDCs. 
Therefore, we wondered whether MHCII dependent stimulation of Tconv induces the 
secretion of a soluble factor initiating the proliferation of Helios+ Treg cells. To test 
this, we used the transwell autoMLR described before (see Fig. 19a). In contrast to 
the previous transwell autoMLR, sorted CFSE labeled Helios+ Treg cells were 
cultured in the insert well while sorted Tconv cells were cultured together with either 
B6.BmDCs or B6.MHC2KOBmDCs in the bottom well for 5 days. To maintain the 
“1:3” ratio of BmDC:CD4+ T cells used in the previous experiments, DC and Tconv 
cell numbers had to be scaled up by six fold as the bottom well is six fold bigger than 
the insert well (Fig. 22a). In the presence of Tconv cells and B6.BmDCs, Helios+ 
Treg cells proliferate (Fig.22b, left panels and c) but do not when BmDCs were 
deficient in MHCII expression (Fig. 22b, right panels and c). This finding supports 
our assumption that Tconv stimulated by B6.BmDCs secrete a soluble factor that 
induces the proliferation of the sorted Helios+ Treg cells.  
 
 
 
 
 
 
Figure 22: Sorted Helios+ Tregs proliferation is induced by (a) soluble factor(s) produced by Tconv cells.  
a) Setup of transwell autoMLR experiments. CFSE labeled, sorted Helios+ Treg cells (CD4+GFP+GITRhighPD1high) 
from B6.FoxP3eGFP mice were cultured in the insert while in the bottom well sorted Tconv (CD4+GFP-, unlabeled) 
from B6.FoxP3eGFP mice were co-cultured with B6.BmDCs or B6.MHCIIKOBmDCs for 5 days. b) Representative 
dot plots for FoxP3 and Helios expression (upper panels) and histograms (lower panels) for CFSE dilution of Helios+ 
Treg (Helios+FoxP3+CD4+) cells cultured either on top of sorted Tconv cells in presence of B6.BmDCs (left) or 
B6.MHCIIKOBmDC (right). c) Graph displays percentage of dividing Helios+Treg cells (red). Statistical analysis was 
performed using an unpaired student’s t test. N=3, error bars show SEM. **, P < 0.01. 
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As a proof of principle, we performed autoMLR experiments where CFSE labeled 
magnetic bead enriched CD4+ T cells from B6 mice were co-cultured for 5 days with 
B6.MHC2KOBmDCs with different dilutions of supernatant from 5 day co-cultures of 
sorted Tconv cells and B6.BmDCs (Fig. 23a).  Helios+ Treg cells but neither Helios- 
Treg nor Tconv cells proliferated. Additionally, Helios+ Treg proliferated in a dose 
dependent manner (Fig. 23b). 
 
Taken together, the proliferation of sorted Helios+ Treg cells is, most probably 
induced by (a) soluble factor(s) e.g. cytokine(s) secreted by Tconv cells given that 
MHCII is expressed on B6.BmDCs.  
5.2.4 Tconv cells secrete IL2 when stimulated with syngeneic BmDCs  
The most prominent cytokine that could promote the proliferation of Helios+ Treg 
cells is IL2. Normally, high levels of IL2 are secreted from lymphocytes after TCR 
signal induced activation. To evaluate if Tconv cells produce IL2 in autoMLR 
experiments, we cultured sorted Tconv cells with either B6.BmDCs or 
B6.MHC2KOBmDCs for 1-4 days and the IL2 concentration of the supernatant was 
determined. We detected IL2 in the supernatant of three-day cultures and even higher 
levels in the supernatant of four-day cultures. IL2 secretion was only detected when 
Tconv cells were cultured with MHCII expressing BmDCs (Fig. 24)  
 
Figure 23: Mainly Helios+Treg cell proliferation is induced by (a) secreted factor(s) produced by Tconv cells. 
(a) Setup of autoMLR experiments. Supernatant of cultures of sorted Tconv cells (CD4+GFP-, unlabeled) from 
B6.FoxP3eGFP mice with B6.BmDCs for 5 days was transferred in different dilutions to magnetic bead enriched 
CFSE labeled B6.CD4 T cells co-cultured with B6.MHCIIKOBmDCs. CFSE dilution was analyzed by flow cytometry 
at day 5. (b) Graph displays percentage of dividing Helios+ Treg (red), Helios- Treg (brown) and Tconv (blue) cells. 
Statistical analysis was performed using a one-way ANOVA test. N=2, error bars show SEM. *, P < 0.05, ns= not 
significant) 
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In experimental setups using B6.MHC2KOBmDCs (Fig. 17), B6.BmDCs + MHCI 
blocking antibodies (Fig. 18) or the transwell system (Fig. 19), Treg cells do not 
proliferate. Thus, we wondered whether in these conditions, the administration of 
exogenous IL2 restores the proliferation seen from Treg cells. In all conditions, the 
high proliferation of Helios+ Treg cells and the lower proliferation of Helios- Treg 
cells is restored by the administration of exogenous IL2 (50U/ml, Fig. 25).  
 
Figure 24: Tconv cells produce IL2 when co-cultured with MHCII expressing B6.BmDCs.  
Graph displays concentration of IL2 in the supernatant from co-cultures of sorted Tconv cells (CD4+GFP-) from 
B6.FoxP3eGFP mice and B6.BmDCs (black) or B6.MHCIIKOBmDCs for 1,2,3 or 4 days. Supernatant from different 
time points were harvested and analyzed for IL2 by BD™ Cytometric Bead Array (CBA). N=2, error bars show 
SEM.  
 
Figure 25: Exogenous IL2 can restore the proliferation of Treg cells when MHCII interaction is missing.  
Magnetic beads enriched CFSE labeled CD4 cells isolated from pooled LNs from B6 mice were cultured in presence 
of 50U/ml IL2 and either (a) B6.BmDCs, (b) B6.BmDCs + αIAb Ab (5µg/ml), (c) B6.MHC2KOBmDCs or (d) 
separated from B6 BmDCs in a transwell system for 5 days. Dot plots shows representative staining for FoxP3 and 
Helios expression (upper panels) and histograms (lower panels) shows CFSE dilution of Helios+Treg 
(Helios+FoxP3+CD4+, red), Helios-Treg (Helios-FoxP3+CD4+, brown) and Tconv (Helios-FoxP3-CD4+, blue) cells of 
B6 CD4 cells. Graphs displays percentage of dividing Helios+Treg (red), Helios-Treg (brown) and Tconv (blue) cells. 
Statistical analysis was performed using an unpaired student’s t test. N≥5, error bars show SEM. *, P < 0.05 ; **, P < 
0.01; ***, P < 0.001  ****, P < 0.0001; ns= not significant. 
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5.2.5 TCR affinity for self-antigens matters but Il2 rules proliferation 
Considering the result, that sorted Tconv cells can produce IL2 when stimulated with 
B6.BmDCs (Fig. 24) we can assume that in autoMLR experiments with unsorted total 
CD4 cells, Tconv cells serves as a source of IL2. Thus, IL2, and not a higher-affinity 
TCR signals drives the proliferation of Helios+ Treg cells in these settings (Fig. 16). 
However, it is striking that Helios+ Treg cells almost exclusively proliferate while 
Helios- Treg and Tconv cells do not (or less). The same is observed, when a high 
amount of exogenous IL2 is added to co-cultures with B6.BmDCs (Fig. 25a). This 
means that a competition for IL2 is excluded.  
Due to these observations, we wondered whether a different affinity for self-antigens 
of Helios+ Treg, Helios- Treg and Tconv cells results in e.g. better survival or 
upregulation of the activation marker CD25.  
To address this, we performed autoMLR experiments with CFSE labeled magnetic 
beads enriched CD4 cells from B6 mice, co-cultured with B6.BmDCs or 
B6.MHC2KOBmDCs for 1-4 days in the presence or absence of a high dose of 
exogenous IL2 (50U/ml). Cells were harvested at d1, 2, 3 and 4 of culture and were 
analyzed by flow cytometry for frequencies of dividing cells (Fig.26, left panels), cell 
numbers of live cells (Fig. 26, middle panels) and geometric mean fluorescence 
intensity (MFI) of CD25 (Fig. 26, right panels).  
In the absence of IL2 (Fig. 26a) about 20% of Helios+ Treg (red) and Helios- Treg 
(brown) cells proliferate at day 2 of culture. The observed proliferation is independent 
of the presence (B6.BmDCS, solid lines) or absence of MHCII (B6.MHC2KOBmDCs, 
dashed lines) on BmDCs. At later time points, only Helios+ Treg cells proliferate 
more and only when cultured with B6.BmDCs. Tconv cells (blue) do not proliferate 
at all (left panel).  Furthermore, only absolute numbers of live cells of Helios+ Treg 
cells increase but not of Helios- Treg cells and only when MHCII present (middle 
panel). Helios+ Treg cells highly upregulate CD25 expression when cultured with 
B6.BmDCs. This effect is diminished when cultured with B6.MHC2KOBmDCs. An 
upregulation of CD25 is also seen in Helios- Treg cells in the presence of B6.BmDCs 
but at a much lower level as Helios+ Treg cells do. CD25 expression on Tconv cells 
stays low in all conditions and at all time points of culture (right panel).  
The supplementation with high amounts of exogenous IL2 (Fig. 26b) fully restores 
the proliferation of Treg cells in co-cultures with B6.MHC2KOBmDCs. Even though, 
Helios- Treg cells also proliferate (36%), the frequency of proliferating Helios+ Treg 
cells is clearly higher (up to 60% of dividing cells) while Tconv cells do not divide 
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(left panel). Although, exogenous IL2 fully restores proliferation in cultures with 
B6.MHC2KOBmDCs, the high amount of IL2 do not support a better survival of 
either population in the presence or absence of MHCII expression on BmDCs. It 
looks like that Helios+ Treg cells from cultures with B6.BmDCs survive better than in 
cultures with B6.MHC2KOBmDCs. The cell numbers of viable Helios- Treg cells are 
not different in either condition (middle panel). Exogenous IL2 cannot restore the 
CD25 upregulation on Helios+ Treg cells in cell cultures where MHCII is not 
expressed on BmDCs. The same is seen for Helios- Treg cells, which also express 
CD25, but at a much lower level than Helios+ Treg cells. Exogenous IL2 is not 
influencing the expression of CD25 on Tconv cells (right panel).  
The analysis for all conditions at day four of culture is summarized in Fig. 26c. The 
bar graphs reflect the analysis for the percentage of dividing cells (left panel), cell 
numbers (middle panel) and gMFI of CD25 (right panel) of Helios+ Treg (red), 
Helios- Treg (brown) and Tconv (blue) cells in dependency of MHCII on BmDCs and 
in presence or absence of exogenous IL2 in the culture.  
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Figure 26: MHC class II expression on BmDCs seems to influence CD25 expression and survival of Treg cells.  
Magnetic beads enriched CFSE labeled CD4 cells isolated from pooled LNs from B6 mice were cultured in presence (b) 
or absence (a) of 50U/ml IL2 and either B6.BmDCs (solid line) or B6.MHC2KOBmDCs (dashed line) for 1, 2,3, or 4 
days. Helios+ Treg (red), Helios- Treg (brown) and Tconv (blue) cells were analyzed for the percentage of dividing cells 
(left panels), cell numbers (middle panels) and geometric mean fluorescence intensity (MFI) of CD25. (c) Graphs 
displays quantification of Helios+ Treg (red), Helios- Treg (brown) and Tconv (blue) cells for the percentage of dividing 
cells (left panel), cell numbers (middle panel) or MFI of CD25 (right panel) in absence or presence of MHCII or IL2 
respectively. Statistical analysis was performed using an unpaired student’s t test. N=3, error bars show SEM. *, P < 0.05 
; **, P < 0.01; ****, P < 0.0001; ns= not significant.  
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Contribution:  
B.S. and E.H. performed TCR sequencing and clonotype analysis of GITRlowPD1lowversus 
GITRhighPD1high peripheral Tregs (Figure 3, e-j) 
C.G.K. performed reaggregated thymic organ cultures and analysis (Figure S1) 
S.S. and K.K. performed lymphocyte staining and analysis of B6.FoxP3-GFP-Cre x FoxP3-
IRES-RFP mice (Figure S2) 
L.T. performed tissue sectioning and H&E staining of skin and colon samples (Figure 30d, 
31d)  
 
Abstract 
The importance of regulatory T cells (Tregs) in maintaining lymphocyte homeostasis 
is best appreciated in mice and humans lacking these cells. FoxP3 KO (scurfy) 
mice48, 49 and patients with immunodysregulation polyendocrinopathy enteropathy X-
linked (IPEX) syndrome206 suffer from excessive lymphocyte activation, lymphocytic 
infiltration into peripheral organs, and colitis leading to death at an early age. In 
healthy mice and humans, Tregs control homeostatic proliferation of conventional T 
and B cells and prevent colitis.52,79,122,175,207,208 Tregs have been classified based on 
their activation status, expression of surface markers and their ability to migrate to 
certain tissues28-31. CCR7+ Tregs localize to T cell zones in LNs28, while Tregs 
expressing the integrin αEβ7 migrate into inflamed tissues29. In humans, the 
proportion of activated and resting Tregs vary with age and the presence 
immunological disorders.31 While Tregs have been shown to express self-
reactive81,172,209 and foreign antigen reactive210 T cell receptors (TCRs), it’s not clear 
how their antigen specificity determines their regulatory function. Here we report two 
functionally distinct subgroups of Tregs with differing TCR affinities for self-
antigens. Triplehigh (GITRhigh, PD1high, CD25high) Tregs are generated through 
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negative selection and express higher affinity self-reactive TCRs. This population 
also proliferates in response to MHC II encoded self-antigens. In contrast, Triplelow 
(GITRlow, PD1low, CD25low) Tregs express lower affinity (but above the threshold for 
negative selection) self-reactive TCRs and are unable to proliferate on syngeneic 
antigen presenting cells (APCs). The TCR repertoires of Triplehigh Tregs, Triplelow 
Tregs and CD4 Tconvs are clearly distinct. Functionally, Triplehigh but not Triplelow 
Tregs control the extensive lympho-proliferation in mice acutely depleted of Tregs. 
Conversely, Triplelow but not Triplehigh Tregs control colitis by facilitating conversion 
of Tconv into induced Tregs (iTregs). The differing TCR affinities for self-antigens 
likely induce divergent developmental programs, generating two Treg populations 
with distinct regulatory properties. Finally, FoxP3 deficient (scurfy) mice contain 
Triplehigh and Triplelow CD4 T cells with distinct pathological properties. Triplehigh 
scurfy T cells proliferate extensively in peripheral LNs and infiltrate the skin while 
scurfy Triplelow T cells cause colitis and wasting disease.  
 
Results & Discussion 
As previous reports showed that the majority of thymic Tregs are Helios+ 106, 107 we 
examined this subset in polyclonal (B6), oligoclonal (MHC II restricted TCR 
transgenic, Rag+) and monoclonal (MHC II restricted TCR transgenic, Rag-/-) mice. 
The percentage of Helios+ Tregs is clearly decreased in strains with a limited TCR 
repertoire (Fig.27 a,b). In fact, Helios is expressed in thymocytes undergoing clonal 
deletion211 and the development of thymic (Helios+) Tregs is completely impaired in 
monoclonal mice lacking negative selection. To test this idea, bone marrow chimeras 
were generated where OT-II thymocytes developed in hosts expressing (RIP-mOVA) 
or lacking (B6) the cognate antigen, ovalbumin. OT-II thymocytes surviving negative 
selection in RIP-mOVA mice almost exclusively develop into Helios+ Tregs (Fig.27c 
upper row). In contrast, OT-II thymocytes developing in B6 hosts only generate CD4 
Tconv cells (Fig.27c, lower row). Along this line, Tregs develop in re-aggregate 
thymic organ cultures (RTOCs) only in the presence of negatively selecting cognate 
antigens (Fig.S1), consistent with results in Fig.27c. Finally, analysis of mice where 
thymus-derived Tregs are genetically marked, showed that >80% of thymus derived 
peripheral Tregs are Helios+ (Fig.S2)212.  
Taken together, these data imply that most thymic-derived, i.e. Helios+ Tregs are 
survivors of negative selection and for this reason express high affinity self-reactive 
TCRs (i.e. above the affinity threshold for negative selection12). This idea is further 
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supported by the observation that Helios+ Tregs cells proliferate more extensively 
than Helios- Tregs and CD4 Tconvs, both in vivo (Fig.27d) and in vitro (Fig.27e). 
Proliferation and survival of Helios+ Tregs is dependent on MHC II expression on 
APCs, confirming their self-reactivity (Fig.27e). 
Since Helios expression is not limited to thymus derived Tregs109,110,213 we looked for 
another set of markers to identify Treg subpopulations. Tregs express different levels 
of GITR and PD1 (Fig.27f). As GITRhigh, PD1high Tregs express more CD25 than 
GITRlow, PD1low Tregs, we refer to these populations as Triplehigh  (GITRhigh, PD1high, 
CD25high) and Triplelow (GITRlow, PD1low, CD25low) Tregs, respectively. Compared to 
Triplelow Tregs, their Triplehigh counterparts express more Helios, CD5 and Nur77-
GFP86; higher expression of the latter two markers indicates a high degree of self-
reactivity as a consequence of expressing high affinity TCRs (Fig.27f). Finally, 
similar to Helios+ Tregs, Triplehigh Tregs preferentially proliferate and survive on 
syngeneic MHC II expressing BM-DCs, consistent with a high degree of self-
reactivity (Fig.27f).86  
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Figure 27: Majority of Tregs are self-reactive.  
a) Flow cytometric analysis of FoxP3 and Helios expression on CD4SP thymocytes (upper row) and CD4+ LN T cells (lower row) from C57BL6, 
3BK506TCRtgRag+ (TCRtgRag+) and 3BK506TCRtgRagKO (TCRtgRagKO) mice. b) Numbers of CD4+FoxP3+Helios+ (red) and CD4+FoxP3+Helios- 
(brown) thymocytes (upper graph) and LN T cells (lower graph) from C57BL/6, TCRtgRag+ and TCRtgRagKO mice, n=4. c). Flow cytometric analysis 
of FoxP3 and Helios expression in OT-II derived, CD4SP thymocytes, peripheral LN and pancreatic LN cells of lethally irradiated RIP-OVA (upper 
row) and C57BL6 (lower row) recipients reconstituted with bone marrow cells from B6Ly5.1 and Ly5.2 OT-II mice (9:1) d) In vivo proliferation of 
CD4+ Tcells in C57BL6 mice. Percentages of proliferating (BrdU+) cells are shown, n=2. e) In vitro proliferation of CD4+ T cells on syngeneic 
BmDCs. Histograms (left) shows representative data for CFSE dilution of Helios+ Treg (red) Helios- Treg (brown) and CD4+ Tconv (blue) cells. Bar 
graph (right) shows numbers of proliferating cells, n=6. f) Left panel: Flow cytometric analysis of GITR and PD1 expression on CD4+/FoxP3GFP+ 
cells. Histograms show Helios, CD25, CD5 and Nur77-GFP expression on GITRhigh PD1high Tregs (red, Triplehigh Tregs) and GITRlow PD1low Tregs 
(brown, Triplelow Tregs). Middle panel: Histograms show representative data of CFSE dilution of Triplehigh Tregs (red) Triplelow Tregs (brown) and 
CD4+ Tconvs (blue) cultured on B6 or B6.MHCIIKO BmDCs, n=6. Right Panel: Bar graph (right panel) shows numbers of proliferating cells, n=6. 
*p≤ 0.05, **p≤ 0.01, ***p≤0.001, ****p≤ 0.0001 (Student’s t test). Error bars indicate means ± SEM.  
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Peptide affinity influences the development of Triplehigh and Triplelow Tregs (Fig.28). 
When B3K508 Rag-/- thymocytes were cultured on BmDCs in presence of TGFβ and 
IL-2, addition of the threshold ligand, P-1A, induced development of Triplelow CD4 
SP thymocytes and Tregs, while the higher affinity P2A induced a mixture of 
Triplelow (PD1high, GITRlow) and Triplehigh (PD1high, GITRhigh) CD4SP thymocytes 
and Tregs; finally the highest affinity peptide, 3K induced only Triplehigh (PD1high, 
GITRhigh) CD4SP thymocytes and Tregs. These data indicate that antigens with 
affinities just over the negative selection threshold induce the Triplelow phenotype, 
while antigens with affinities significantly higher than the negative selection 
threshold induce the Triplehigh phenotype (Fig.28a). Interestingly, antigens inducing 
Triplehigh development induce both ERK and cJun phosphorylation, while cells 
undergoing Triplelow development contain pERK but not pcJun (Fig.28b,c).  
 
Figure 28: Development of Triplehigh and Triplelow Tregs is dependent on TCR affinity. 
a) Representative flow cytometric analysis of GITR and PD1 expression on 3BK508tg CD4SP (upper row) or 
3BK508tg CD4SP FoxP3+ thymocytes 48h after stimulation with P-1A, P2A, 3K or no peptide presented on 
mature B6 BmDCs in presence of IL2 and TGFβ. (n=3). b,c) Phosphorylation of CD3ζ, ERK and cJUN in 
3BK508tg CD4SP stimulated with P-1A (dark grey line), P2A (bright red line), 3K (dark red line) or no peptide 
(light grey filled) was determined after 90min, 24 and 48h by flow cytometry. b) Representative histograms of 
fluorescence intensity in thymocytes after 24 and 48h of antigen stimulation and c) geometric mean fluorescence 
intensity after 90min, 24h and 48h.  (n=1-2) 
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Given their differing expression of CD5 and Nur77-GFP (Fig.27f), Triplehigh and 
Triplelow Tregs likely express different TCR repertoires.  The frequencies of Triplehigh 
and Triplelow Tregs in polyclonal and oligoclonal (single TCR β chain transgenic) 
mice were compared. Among thymic Tregs, there is a preponderance of Triplehigh 
Tregs in both strains (Fig.29 a-c).  However, among peripheral Tregs, the frequency 
of Triplelow Tregs was increased in polyclonal B6 mice, but not in oligoclonal, single 
TCR β chain (OT-I Vβ5) transgenic mice (Fig.29 a-c). Constraining TCR repertoire 
diversity clearly affects the frequencies of Triplehigh and Triplelow Tregs. Furthermore, 
analysis of Triplehigh Tregs, Triplelow Tregs and Tconvs in single TCR β chain 
transgenic mice shows a distinct pattern of Vα expression. 
The Vα2 and Vα3 families, but not the Vα8 family were expressed at different 
frequencies within these three subsets of CD4 T cells (Fig.29d), indicating a 
difference in their TCR repertoires. More subtle differences of Vα expression 
between the three CD4 subsets were observed in polyclonal B6 mice (Fig.29d). To 
directly compare the TCR repertoires of Tconv and both types of Tregs, all three 
populations expressing the Vα2 family (Fig.29e), were sorted from a second, 
independent single TCR β chain strain (Yae62, Vβ8.1, TCRα+/KO) and subjected to 
deep sequencing. The 500 most frequent clonotypes in each group were analyzed for 
their similarity (Fig.29f-h) and diversity (Fig.29i-j). Morisita-Horn analysis shows 
that the Tconv sequences from 3 individual mice are similar to each other but 
significantly different from Triplelow and Triplehigh Treg sequences (Fig.29f). This 
was observed with Triplelow sequences as well (Fig.29g). In contrast, the Triplehigh 
TCR sequences from three individual mice are different from each other and different 
from Tconv and Triplelow sequences (Fig.29h). Despite their significant sequence 
differences, the TCR repertoires of Tconvs and Triplelows are similarly diverse (Fig.29 
i,j). The repertoire of Triplehigh Treg TCRs may be less diverse, according to Shannon 
Entropy analysis. Deep sequencing showed that Triplehigh Tregs, Triplelow Tregs and 
Tconvs have clearly distinct TCR repertoires, implying that TCR specificity is 
important in selecting these Treg subtypes.  
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Figure 29: Triplehigh and Triplelow Tregs express different TCR repertoires.  
Flow cytometric analysis of GITR and PD1 expression in FoxP3+CD4SP thymocytes and FoxP3+CD4+ LN cells of B6 and single 
TCRβ chain (OT-I Vβ5tg, Rag+) mice. a) Representative contour plots, b) percentage of Triplehigh (red) and Triplelow (brown) 
Treg cells and c) ratio between Triplehigh and Triplelow Treg cells (n=7) d) Vα expression in Triplehigh Tregs (red), Triplelow Tregs 
(brown) and CD4+ Tconvs (blue) from isolated from splenocytes, n=4. **p≤ 0.01, ***p≤ 0.001, ****p≤ 0.0001 (Student’s t test) 
ns = not significant. Error bars show mean ± SEM. e) Vα2 expression in CD4 Tconv (blue), Triplehigh (red) and Triplelow (brown) 
Tregs. f) Morisita-Horn similarity analysis of Vα2+ TCR clonotypes from CD4 Tconvs (blue) compared to Triplelow (brown) 
Treg and Triplehigh (red) Treg clonotypes from three individual, single TCRβ chain (YAe62tg, TCRα+/KO, Rag+) mice. For the 
Morisita-Horn Index, values of 0 and 1 represent minimal and maximal similarity, respectively (see Methods for full description).  
g) Morisita-Horn similarity analysis comparing Vα2+ TCR clonotypes from Triplelow Tregs (brown) to CD4 Tconvs (blue) and 
Triplehigh Treg (red). h) Morisita-Horn similarity analysis comparing Vα2+ TCR clonotypes from Triplehigh Tregs (red) to CD4 
Tconvs (blue) and Triplelow Treg (brown). TCR diversity was analyzed by calculating Shannon Entropy (i) and Simpson 
Diversity (j) scores.  For Shannon Entropy analysis, higher H values indicated higher diversity; for Simpson Diversity analysis, 
the index ranges from 0 to 1 with 1 indicating high diversity (see Methods for full description). *p≤ 0.05, **p≤ 0.01, (Mann-
Whittney U Test) ns = not significant. Error bars show mean ± SEM. 
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To compare the regulatory properties of these two populations, FoxP3-DTR mice 
were acutely depleted of Tregs by injecting DTx; sorted Triplehigh or Triplelow Tregs 
from B6 mice, which are unaffected by DTx were then transferred to these recipients 
(Fig.S3). Triplehigh Tregs control the extensive proliferation of Tcells and B cells in 
peripheral LNs of mice depleted of their endogenous Tregs (Fig.30a), while Triplelow 
Tregs function poorly in this respect. In addition to controlling lymphocyte 
proliferation, Triplehigh Tregs limit the activation of Tconvs (Fig.30b). Taken 
together, these data show that Triplehigh Tregs, a subset expressing highly self-
reactive TCRs is effective in regulating the homeostatic activity of lymphocytes in 
peripheral LNs.  
To examine the ability of these Treg subsets to control colitis, CD3KO mice were 
injected with sorted CD4 Tconvs (Fig.S4), which as previously described175, 207, 208 
lost weight (Fig.30c, upper panel, solid blue line) and developed colitis (Fig.30d, 
upper left panel). Co-transfer of Triplelow (Fig.30c, upper panel, solid brown line; 
Fig.30d, upper middle panel) but not Triplehigh (Fig.30c, upper panel, solid red line; 
Fig.30d, upper right panel) Tregs prevented weight loss and limited lymphocyte 
infiltration of the colonic mucosa.  Analysis of LN cells from these mice indicated 
that co-transfer of Triplelow Tregs facilitated the conversion of some Tconv into 
induced Treg cells (iTregs) (Fig.30e,f). Mice receiving Triplelow Tregs had the highest 
percentage of iTregs (Fig.30e,f), only limited infiltration in the colonic mucosa 
(Fig.30d, upper middle panel) and maintained their weight (Fig.30c).  
To test whether iTregs were required to control colitis, CD4 Tconv cells isolated from 
FoxP3-DTR mice were transferred into CD3 KO mice (Fig.S6). These animals were 
treated with DTx to deplete any iTregs developing from Tconv. iTreg depletion 
accelerated weight loss and development of colitis (compare solid blue (upper panel) 
and dashed blue (lower panel) lines in Fig.30c). Co-transferred B6 Triplelow Tregs 
(unaffected by DTx) were unable to control the development of colitis when iTregs 
were depleted (compare solid brown (upper panel) and dashed brown (lower panel) 
lines in Fig.30c; compare upper middle and lower middle panels in Fig.30d). The data 
support the idea that Triplelow Tregs facilitate conversion of some CD4 Tconv into 
FoxP3+ iTregs, which in aggregate limit development of colitis. Taken together, the 
data argue for two populations of Tregs: Triplehighs, which control 
lymphoproliferation in peripheral LNs and Triplelows, which limit the development of 
colitis (at least in a lymphopenic setting). 
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Figure 30: TriplehighTregs and TriplelowTregs have different suppressive functions in vivo 
a) Ly5.1 FoxP3 DTR host mice were injected i.v. with no cells (black, n=10), B6 Triplelow Tregs (brown, n=4), B6 Triplehigh Tregs (red, n=6), or 
total B6 Tregs (green, n=3). FoxP3-DTR recipients and B6 control mice (gray, n=4) were treated every other day with diphtheria toxin (DTx) and 
analyzed at d11-13 after cell transfer. Bar graphs show numbers of host-derived, live, CD4+, CD8+ and B cells in peripheral LNs. *p≤ 0.05, **p≤ 
0.01, ***p≤0.001, ****p≤ 0.0001 (Student’s t test). Error bars indicate means ± SEM. b) Flow cytometric contour plots and bar graph show the % 
of naïve CD4 Tconvs (CD44) in mice described in a). n≥4 c) Upper graph shows percentage of weight change of CD3KO mice injected with no 
cells  (black, n=5), Ly5.1 B6 CD4+ Tconvs (blue, n=9) or Ly5.1 B6 CD4+ Tconvs co-transferred with Ly5.2 Triplelow Tregs (brown, n=9) or 
Triplehigh Tregs (red, n=6). Lower graph, Two additional groups received either Ly5.1 FoxP3DTR CD4 Tconvs alone (dashed blue, n=3) or Ly5.1 
FoxP3DTR CD4 Tconvs co-transferred with B6 Triplelow Tregs (dashed brown, n=3) and no cells  (black, n=5). Statistical analysis compares 
difference of weight change at 6 weeks following cell transfer. *p≤ 0.05, **p≤ 0.01(Student’s t test). d) Representative H&E staining of the colon 
from CD3KO mice adoptively transferred with cell populations indicated in c). e) Flow cytometric analysis of Ly5.1 B6 Tconv or Ly5.1 DTR 
Tconv cells six weeks after transfer from mice described in c). Contour plots show CD4/FoxP3 staining of transferred Tconv cells isolated from 
mesenteric or peripheral LNs. f) Bar graph shows percentage of Tconv-derived induced Tregs (iTregs) found in mesenteric or peripheral LNs. *p≤ 
0.05, **p≤ 0.01, ****p≤ 0.0001 (Student’s t test) ns = not significant. Error bars show mean ± SEM. 
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FoxP3 KO (scurfy) mice contained analogous populations of CD4 T cells despite 
their lack of a functional FoxP3 molecule. These mice contain GITRhigh, PD1high, 
CD25high (scurfy Triplehigh) and GITRlow, PD1low, CD25low (scurfy Triplelow) CD4 T 
cells. Scurfy Triplehigh T cells resembled B6 Triplehigh Tregs in terms of PD1, GITR, 
CD25, Helios, CD5 and CD62L expression (Fig.31a).  Given their lack of FoxP3 
expression and suppressive capacity, these cells can be described as Triplehigh Treg 
“wannabes”. On the other hand, scurfy Triplelow T cells resembled B6 CD4 Tconv 
cells with respect to their expression of these markers (Fig.31a).  
To investigate their pathological activities, scurfy Triplelow and scurfy Triplehigh CD4 
T cells were separately transferred into T cell deficient, CD3 KO hosts (Fig.S7). 
Scurfy Triplelow T cells promoted weight loss and colitis (Fig.31b,e). Moreover, they 
accumulate in mesenteric LNs (Fig.31c,d) where ~35% express α4β7, an integrin that 
enables homing to the gut (Fig.S8). In contrast, scurfy Triplehigh do not cause weight 
loss (Fig.31b) and preferentially accumulate in peripheral but not mesenteric LNs 
(Fig.31c,d).  Moreover, scurfy Triplehigh T cells induce massive inflammation in the 
skin but only minimal inflammation in the colon (Fig.31e). The behavior of Triplehigh 
Treg wannabes is reminiscent of bona fide Triplehigh Tregs. Both cell types are CD5 
high, Helios high, are likely survivors of negative selection, express high affinity self-
reactive TCRs and preferentially accumulate in peripheral LNs. However, in the 
absence of functional FoxP3, scurfy Triplehigh cells expand and induce skin 
inflammation (Fig.31e). These results suggest that the autoimmune pathology in 
scurfy mice may be a combination of two diseases. Lymphocyte infiltration into the 
skin is likely caused by scurfy Triplehigh cells, while colitis is induced primarily by 
scurfy Triplelows. A Treg-like population similar to scurfy Triplehigh cells has been 
observed173, 174, but here we demonstrated their ability to cause skin pathology. Scurfy 
Triplelows may be related to Triplelow Tregs or may be the equivalent of Tconv, which 
can also cause colitis.175, 208  
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Figure 31: Scurfy Triplehigh and scurfy Triplelow CD4 T cells induce different pathologies.  
a) FoxP3KO (Scurfy) mice contain Treg like cells. Left panel: Flow cytometric analysis of CD4 T cells showing scurfy Triplehigh 
(PD1high GITRhigh CD25high; orange gate) and scurfy Triplelow (PD1neg GITRneg CD25neg; purple gate) CD4 T cells. Additional 
panels: PD1, GITR, CD25, Helios, CD5, CD62L and CD44 expression in scurfy Triplehigh (orange solid), scurfy Triplelow, 
(purple solid), B6 Triplehigh Tregs (dotted red) and B6 CD4 Tconv (dotted blue) cells. b) Graph shows percentage of weight 
change of CD3KO recipients following adoptive transfer of no (black, n=3), scurfy Triplehigh (orange, n=8) or scurfy Triplelow 
(purple, n=8) CD4 T cells. c) Photographs of peripheral and mesenteric LNs from CD3KO mice transferred with scurfy Triplehigh 
(orange, n=8) or scurfy Triplelow CD4 T cells d) absolute number of scurfy CD4 cells in peripheral LNs and mLNs six week after 
cell transfer. e) Representative photographs and H&E staining of tail skin and colons of CD3KO recipient six weeks after adoptive 
cell transfer. B6 control mice are shown as well. Results are representative of 3 replicate experiments. *p≤ 0.05, ***p≤ 0.001 
(Student’s t test) ns = not significant. Error bars show mean ± SEM. 
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In summary, these data suggest that Triplehigh and Triplelow Tregs are generated as an 
offshoot of negative selection, but their different TCR affinities for self-antigens 
induce distinct differentiation programs generating these two Treg populations. The 
high affinity self-reactive TCRs expressed by Triplehigh Tregs likely drives their 
selection in the thymus and their proliferation and suppressive activity in peripheral 
LNs.30, 214 On the other hand, the lower (but above threshold) affinity self-reactive 
TCR repertoire expressed by Triplelow Tregs allows them to develop the capacity to 
maintain immunological homeostasis in the colon by facilitating the generation of 
iTregs from Tconvs.  It’s not clear if the lower affinity repertoire of Triplelow Tregs is 
already enriched for commensal specificities or more plausibly, commensal specific 
Triplelow Tregs expand upon exposure to commensal antigen in the gut.215 
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Methods  
Mice 
All mice were between 5–12 weeks old and had a C57BL/6 genetic background 
except for FoxP3KO, which were used at 2 -3 weeks of age. CD45.1 congenic 
C57BL/6 (B6 Ly5.1), CD45.2 congenic C57BL/6 (B6), RIP-OVA mice expressing a 
membrane bound form of Ova under the control of the rat insulin promoter 
(RIP)17,182,52 OTII TCRtg mice recognizing IAb/OVA323-339183, B6 .Nur77-GFP86 and 
FoxP3KO174 were all obtained from The Jackson Laboratory (Bar Harbor, ME). 
3BK506 TCRtg and 3BK508 TCRtg mice recognizing IAb/3K and Triple KO mice 
deficient for MHC class II, invariant chain and Rag (referred here as MHCII KO) 
were provided by P. Marrack and J. Kappler (Denver, USA) and are described 
elsewhere184. FoxP3DTR52 mice were kindly provided by A. Rudensky (New York, 
USA) FoxP3eGFP and CD3ε-/- were kindly provided by T. Rolink (Basel, 
Switzerland)  and single TCR β chain (OT-I Vβ5) transgenic mice kindly provided by 
D. Zehn (Lausanne, Switzerland) and are described elsewhere.185, 186,187 Mice were 
housed under specific pathogen-free conditions and bred in our colony (University 
Hospital Basel) in accordance with Cantonal and Federal laws of Switzerland. 
Animal protocols were approved by the Cantonal Veterinary Office of Basel-Stadt, 
Switzerland.  
 
Flow Cytometry and cell sorting 
Thymocytes and T cell were stained with LIVE/DEAD Fixable near-IR stain Kit 
(Invitrogen) and surface antibodies against CD3, CD4, CD5, CD8, CD19, CD25, 
CD44, CD45.1, CD45.2, CD62L, CD279 (PD1), CD357 (GITR), Vα2, Vα3, Vα8, Vβ5, 
Vβ8 and α4β7. Intracellular staining for FoxP3, Helios, pcJun (S73), pCD3ζ (pY142) 
and pERK(P-p44/42 MAPK) was performed using the FoxP3 staining kit 
(eBioscience). For BrdU experiments, mice were injected with 1mg/d BrdU (5-
bromodeoxyuridine, BD Bioscience) for 3 days and cells were then stained for 
incorporated BrdU using a BrdU Flow Kit (BD Bioscience) followed by staining for 
intracellular markers. All antibodies were purchased from BD Bioscience, 
BioLegend, eBioscience or CellSignaling Technology. For flow cytometric analysis, 
a FACS CantoII (BD Bioscience) and FlowJo software (TreeStar) were used. For cell 
isolation, CD4+Tcells were enriched using Dynabeads® Untouched™ Mouse CD4 
Cells Kit (Invitrogen) from cell suspensions from different sources (peripheral LN, 
mesenteric LN, spleen); subpopulations of enriched CD4 cells were further sorted on 
a FACSAriaIII or Influx cell sorter (BD Biosciences). Cell numbers were determined 
using AccuCheck Counting Beads (Invitrogen) according to manufacturer’s 
instructions. 
 
In vitro assays 
Bone marrow derived DCs (BmDCs) were generated from bone marrow cells of 5-7 
week old C57BL/6 or B6.MHCII KO mice. Bone marrow cells were cultured under 
maturation conditions for 10 days in full medium supplemented with GM-CSF 
(hybridoma supernatant). Autologous mixed lymphocyte reactions (auto-MLRs) were 
performed by co-culturing 1x105 syngeneic (B6 or MHCII KO) BmDCs with 3x105 
CFSE labeled (Life Technologies) magnetic bead enriched CD4 cells (Dynabeads, 
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Invitrogen) in 96-well-U-shaped plates for 5 days. For in vitro, Treg development 
experiments, 1x105 thymocytes from 3BK508tg mice were co-cultured with 1x105 B6 
BmDCs in the presence of IL2 (25U/ml, hybridoma supernatant) and recombinant 
mouse TGFβ1 (10ng/ml, R&D Systems) for 48h with or without 10-6M 3K 
(FEAQKAKANKAV), P2A (FEAAKAKANKAVD) or P-1A 
(FAAQKAKANKAVD) peptides (all obtained from Eurogentec). All in vitro assays 
were performed at 37°C in 5% CO2 using complete RPMI medium (GIBCO, Life 
Technologies). 
 
Generation of bone marrow chimeric mice 
For generating bone marrow chimeric mice, the protocol from Koehli et al.17 was 
adapted. Recipient mice (CD45.1/2) were lethally irradiated with 900 rad 
(GammaCell, Best Theratronics, CA). Bone marrow cells from 5-8 week old 
C57BL/6 mice (CD45.1) and OT-II RagKO (CD45.2) were isolated and depleted of 
mature T cells. A mixture of 9:1 of C57BL/6 and OT-II RagKO bone marrow cells 
(4x106 total cells) were injected intravenously (i.v.) into irradiated recipient mice. 
Mice were analyzed 12-14 weeks after reconstitution and treated with antibiotics 
(Nopil, Mepha Pharma AG) in the drinking water until 2 weeks before analysis. The 
congenic markers CD45.1 and CD45.2 were used to identify T cells derived from 
different donor bone marrows as well as the host. 
  
In vivo suppression assays  
FoxP3DTR mice were injected intra-peritoneally (i.p.) with Diptheria Toxin (DTx) 
(Calbiochem) every other day for 10-12 days (first and second injection 50µg/kg; 
subsequent injections 25µg/kg). In some groups, 2.5x105 sorted Treg cells from 
pooled LNs were injected i.v. 3 days prior to first DTx injection. Mice were analyzed 
one day after last their DTx injection. For colitis experiments, 6-10 week old T cell 
deficient CD3ε-/- mice received (i.v.) 3.2x105 sorted naïve CD4 T cells from pooled 
LNs of B6Ly5.1 (CD4+CD25-) or FoxP3DTR Ly5.1 (CD4+GFP-) mice. In some 
groups, 0.8 x105 sorted Treg cells from pooled LN were co-transferred. Recipients of 
naïve FoxP3DTR CD4 Tcells (CD4+GFP-) were injected every third day with DTx 
(10µg/kg), i.p.. For adoptive transfer of scurfy  CD4 T cells, 6-10 week old T cell 
deficient CD3ε-/- were reconstituted with 5x105 sorted CD4 subpopulations from 
pooled LNs of 2-3 week old sick (scurfy) FoxP3KO male mice. Recipient mice were 
weighed weekly at the same daytime and sacrificed when initial body weight droped 
more than 20% or at the latest six weeks after T cell transfer. The congenic markers, 
Ly5.1 and Ly5.2 were used to identify T cells from the different donors as well the 
host. Tissue samples were fixed in 4% paraformaldehyde, embedded in parafin, 
sectioned and stained with hematoxylin and eosin. 
 
Reaggregate thymic organ cultures 
Reaggregate thymic organ cultures were established from B3K508, MHC II KO 
thymocytes, which are arrested at the CD4+ CD8+ DP stage and thymic epithelial 
cells from B6 mice. Peptides were added at the following concentrations: 20 µM P-
1A, 2 µM P2A and 0.2 µM 3K. After 7d in culture, thymocytes were stained for CD4 
and FoxP3 and analyzed by flow cytometry.   
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Clonotype Analysis of GITRlow PD-1low versus GITRhigh PD-1high peripheral 
Tregs.   
Naïve CD4+ (CD4+ CD25- Foxp3- ), Triplelow Treg (CD4+ CD25low Foxp3+ GITRlow 
PD-1low) or Triplehigh Treg (CD4+ CD25high Foxp3+ GITRhigh PD-1high) T cell 
populations were sorted from 3 replicate groups (2 mice per group) of single TCRβ 
chain transgenic (B6.YAe62βtg+ TCRα+/-) mice were sorted to 98% purity (FACS 
Aria, BD Biosciences).  RNA was isolated using Trizol and precipitated with RNase 
free glycogen (Invitrogen) following the manufactures protocol.  cDNA was prepared 
using oligo-dT’s (Promega) and Omniscript RT kit (Qiagen).  cDNA was amplified 
with 20 rounds PCR with generic Vα2 primer (5’-
CCCTGGGGAAGGCCCTGCTCTCCTGATA-3’) and  TCR Cα primer (5’-
GGTACACAGCAGGTTCTGGGTTCTGGATG-3’). 1/10th volume of the first round 
PCR was amplified with an additional 20 rounds of PCR using barcoded primers, for 
post sequence identification of originating T cell population, containing Illunima PE 
read primer and P5/7 regions, respectively.  The resulting 300bp fragment was gel 
purified (Gene Clean II, MP Biomedicals) and sequenced on a MiSeq using a single 
read 250bp run (Illumina).  Sequence data sets were parsed by barcode using the 
program fastq-multx216 and clonotypes for each population were tabulated using 
TCRklass217.  
 
Similarity and Diversity of TCR clonotypes 
The similarity of TCRs utilized within each population was quantified using the 
Morisita-Horn similarity index, 0 (minimal similarity) and 1 (maximal similarity).  
The Morisita-Horn (M-H) similarity indexes were calculated by tabulating the 
frequency in which the top 500 clonotypes of an individual population from one 
replicate sample was found in all other populations, using EstimateS Ver9.1.0218 
software.  Statistical significance for M-H index values was assessed using a Mann-
Whittney U test, GraphPad Prism version 6.04. The diversity of TCR repertoire for 
each population was measured using the top 500 most frequent clonotypes.  The 
Shannon Entropy219 value for each sample was calculated as H = −Σpilog2 pi, 
where pi is the frequency of the clonotype within the top 500 clonotypes.  Lower H 
values indicate lower diversity.  Additionally, the Simpson's diversity index220 using 
the formula Ds = 1 − Σ[ni(ni − 1)]/[N(N − 1)], where ni is the TCR clone size of the ith 
clonotype and N is the total number of the top 500 clonotypes sampled.  The index 
ranges from 0 to 1 with 1 indicating high diversity.   
 
Further Statistical analysis 
Statistical analysis were performed using Prism 6.0 (Graphpad software). Students t 
test was used to asses statistical significiance. P-values ≤ 0.05 were considered 
significant (*p≤ 0.05, **p≤ 0.01, ***p≤0.001, ****p≤ 0.0001) P values >0.05; non-
significant (ns)  
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Supplementary Data 
 
  
Figure S2: Majority of thymic derived Tregs expresses Helios 
Representative contour plots of thymus derived, RFP+GFP+ Tregs sorted from lymph nodes (LN), mesenteric 
lymph nodes (mLN) or splenocytes. Each source of cells was pooled from four B6.FoxP3-GFP-Cre x FoxP3-
IRES-RFP mice.212 After sorting, cells were stained and analyzed for CD4 and Helios expression.  
Figure S3: Sorting strategy to obtain Triplehigh and Triplelow Tregs and experimental setup for Treg 
depletion and adoptive transfer into FoxP3DTR mice.  
a) Magnetic bead enriched CD4 cells isolated from pooled lymph nodes from 6-10 week old B6.FoxP3eGFP mice 
were sorted for CD4+ GFP+ GITRhigh PD1high (Triplehigh Tregs) and CD4+ GFP+ GITRlow PD1low (Triplelow Tregs). 
Purity of both populations was > 95%. b) To induce lymphoproliferation, FoxP3+ cells were depleted from 6-10 
week old FoxP3DTR mice by intra peritoneal (i.p.) injection of DTx every other day for 10 days (first two 
injections, 50µg/kg; subsequent injections, 25µg/kg) In some groups, 2.5x105 sorted B6 Triplehigh or B6 Triplelow 
Tregs cells (unaffected by DTx) from pooled B6 LNs were injected intravenously (i.v.) 3 days prior to first DTx 
injection. Mice were analyzed one day after last DTx injection. 
 
Figure S1: Thymic Tregs are developing in presence of negative selecting peptides but not with endogenous 
positive selecting peptides. Reaggregate thymic organ cultures were established from B3K508, MHC II KO 
thymocytes, which are arrested at the CD4+ CD8+ DP stage and thymic epithelial cells from B6 mice. Peptides 
were added at the following concentrations: 20 µM P-1A, 2 µM P2A and 0.2 µM 3K. After 7d in culture, 
thymocytes were stained for CD4 and FoxP3 and analyzed by flow cytometry.   
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Figure S4: Experimental setup for colitis induction and prevention in lymphopenic CD3KO mice.  
For colitis experiments, 6-10 week old T cell deficient CD3KO recipients received 3.2x105 sorted naïve CD4 
Tconvs (CD4+CD25-) isolated from pooled LNs of several B6 Ly5.1 mice (B6 Tconv). In some groups, 0.8 x105 
sorted Triplehigh or Triplelow Tregs from pooled B6 LNs were co-transferred along with Tconvs. Mice were 
weighed weekly at the same time of day and were sacrificed when they lost > 20% of their initial body weight or 
at six weeks following adoptive transfer. 
Figure S5: Triplehigh and Triplelow Tregs keep their phenotype in inflammatory conditions 
Analysis of Ly5.2 congenially labeled Triplehigh and Triplelow Tregs isolated from CD3KO mice, which were co-
transferred with Ly5.1 congenially labeled CD4 Tconvs (CD4+CD25-) six weeks before. a) Representative 
contour plots of Triplehigh (left panel) and Triplelow (right panel) Tregs isolated from LN, analyzed for GITR and 
PD1 expression. b) Cell numbers of Triplehigh (red) and Triplelow (brown) Tregs isolated from LN and mLN n≥5. 
ns = not significant (Student’s t test). Error bars show mean ± SEM. 
 
Figure S6: Experimental setup for depletion of iTregs generated during colitis induction. 
To inhibit iTreg generation during colitis induction, 6-10 week old T cell deficient CD3KO recipients were 
reconstituted with 3.2x105 sorted naïve CD4 Tconvs isolated from pooled LNs of several FoxP3DTR, Ly5.1 mice 
(FoxP3DTR Tconv). In some groups, 0.8 x105 sorted B6 Triplelow Tregs cells (unaffected by DTx) were co-
transferred along with Tconvs. To deplete Tconv-derived iTregs, recipients were injected i.p. every third day with 
DTx (10µg/kg). Mice were weighed weekly at the same time of day and were sacrificed when they lost > 20% of 
their initial body weight or at six weeks following adoptive transfer. 
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Figure S7: Sorting strategy and experimental setup for adoptive transfer of scurfy disease  
a) Sorting strategy to obtain scurfy Triplehigh and scurfy Triplelow CD4 T cells. Magnetic bead enriched CD4 T 
cells isolated from pooled lymph nodes from 2 week old, male FoxP3KO mice were sorted for CD4+ GITRhigh 
CD25high (scurfy Triplehigh) and CD4+ GITRlow CD25low (scurfy Triplelow) CD4 T cells. Purity of each population 
was > 95%. b) To transfer scurfy disease, 5x105 sorted scurfy Triplehigh or scurfy Triplelow cells were transferred 
i.v. into 6-10 week old CD3KO recipient mice. Mice were weighed weekly at the same time of day and were 
sacrificed when they lost > 20% of their initial body weight or at six weeks following adoptive transfer. 
Figure S8: Scurfy Triplelow cells expressing high levels of α4β7 integrin preferentially home to mLNs. 
Flow cytometric analysis of α4β7 integrin expression on live scurfy CD4 cells isolated from mesenteric lymph 
nodes (mLN) of CD3KO mice six weeks after receiving either scurfy Triplehigh (top panel, orange bar) or Triplelow 
(lower panel, purple bar) T cells, n=3. *p≤ 0.05 (Student’s t test). Error bars show mean ± SEM. 
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6 Discussion 
6.1 The FoxP3 transgenic (tg) mouse: A model to learn more about the 
development of different Treg cell subsets 
In the fist part of the thesis, we re-evaluated and further characterized Treg cells from 
the FoxP3tg mouse (line 2826), which was generated in 2001 in the laboratory of 
Ziegler and Ramsdell, at the same time when they and others linked the scurfy 
disease to the severe autoimmune disease “IPEX” in humans.48 In their initial study, 
they showed that the scurfy disease was rescued by crossing in the FoxP3tg. Even 
though these mice carried the scurfy mutation, they were healthy. This, result, among 
others, gave proved evidence that FoxP3 expressing cells are crucial for the function 
and development of suppressive regulatory T cells.48 In studies where FoxP3tg mice 
were used, these mice were reported to be healthy, and no pathologies were 
reported.48,50, 221-224 Surprisingly, when we bred FoxP3tg mice in our colony to a 
homozygous background we observed developmental deficiencies and an ataxic 
phenotype, which was detectable by a shaking gait and general difficulties of hind 
limb control. However, the pathology was most probably caused by either an 
integration of the transgene leading to an unexpected knockout when bred to a 
homozygous background or a muscular malfunction due to a disregulation of ErbB2 
caused by the overexpression of FoxP3 in muscle cells. For both hypotheses we 
found some indication but not full evidence. Anyhow, by the reconstitution of lethally 
irradiated Rag2-/- with BM from FoxP3tg mice we excluded that the ataxic phenotype 
was caused by defect in the hematopoietic compartment. Furthermore, the adoptive 
transfer of CD4+ T cells from sick FoxP3tg mice also did not induce the observed 
phenotype.  
The generation and characterization of the FoxP3tg mouse provided further evidence 
that FoxP3 acts as a master regulator for Treg cells.48 At that time, the analysis for 
Treg cells was based on the expression of CD25. Presently, FoxP3 is the most 
definitive marker for Treg cells. Since almost all studies, using the FoxP3tg mouse, 
were performed before the development of FoxP3 antibodies for flow cytometric 
analysis, we re-analysed the cellular phenotype of the heterozygous FoxP3tg mouse 
in the thymus and in secondary lymphoid organs. Our data confirms that FoxP3tg 
mice do not have obvious defects in thymocyte development. As reported previously, 
frequencies and numbers of CD4SP and CD8SP cells in the thymus of FoxP3tg mice 
are not altered. It was suggested that the transgene in these mice acts primarily on 
Discussion 
 
 -96- 
peripheral T cells since they could not observe alterations in the thymi of these mice. 
We detected an almost ten-fold higher frequency of FoxP3 expressing CD4SP and 
CD8SP cells in the thymi of FoxP3tg, compared to B6 mice, indicating that the 
FoxP3tg is already active in thymocytes.  
In line with previous reports, the frequencies and cell numbers of peripheral T cells 
are significantly lower. In secondary lymphoid organs, up to 80% of all CD4+ T cells 
express FoxP3.222-225 
Interestingly, although the majority of all CD4+ T cells are FoxP3+, we observed that 
the total numbers of FoxP3+CD4+ T cells are not much higher between FoxP3tg and 
B6 mice. Kasprowicz et al showed, that the overexpression of FoxP3 in the Foxp3tg 
mouse leads to an increased susceptibility to apoptosis following cell activation in 
vitro. The cell death was rescued by the administration of exogenous IL2.222 The low 
T cell numbers in FoxP3tg mice could be explained by a higher death rate in addition 
with a lower IL2 availability in these mice. FoxP3 was shown to be a suppressor of 
IL2 transcription and in line with that, FoxP3tg CD4+ T cells only secrete little IL2 
after TCR stimulation.50 According to the small numbers of Tconv cells in this strain, 
IL2 could be the limiting factor for the population size in vivo under homeostatic 
conditions. Evidence for that is given by two reports. First, it was suggested that IL2 
producing Tconv cells can sense and response to the IL2 levels and with that 
coordinate the homeostasis of activated Tconv cells and Treg cells.154 Second, Treg 
cells in the periphery can alter their proliferative and apoptotic rate dependent on the 
availability of IL2 under homeostatic conditions.226 In addition, we observed a higher 
frequency of B cells in the lymph nodes of FoxP3tg mice. The total B cell number 
was not significantly different between FoxP3tg and B6 mice and the higher 
frequency was only “virtually”, caused by the lower numbers of T cells in FoxP3tg 
mice. We showed that the observed reduced frequencies of CD4 and CD8 T cells 
found in FoxP3tg mice are caused by cell intrinsic and not by cell extrinsic 
mechanisms. We considered the idea that the overexpression of FoxP3 could 
influence cells other than lymphocytes based on the observation made with 
homozygous FoxP3tg mice. Additionally, another group suggested that FoxP3 is 
expressed on several epithelial cells and impacts the thymocyte development.190, 191 
However, studies from the Rudensky group but also our results from the BM 
chimeras of Rag2-/- mice reconstituted with FoxP3tg BM revealed this idea and 
showed that in T cells, FoxP3 acts cell intrinsically.227   
Discussion 
 
 -97- 
Functional analysis of FoxP3tg T cells demonstrated that the overexpression of 
FoxP3 is sufficient to induce suppressive function in CD4+ and to some extend in 
CD8+ T cells in vitro. Furthermore, breeding the scurfy or IL2Rβ-/- to the FoxP3tg 
genetic background rescue these mice from the development of multi organ 
inflammation in vivo.48, 50, 221, 225 The rescue of these mice does not fully imply the 
suppressive capacities of FoxP3tg cells in vivo. T cells of FoxP3tg mice are 
functionally impaired and reduced in numbers. Thus, the suppression of the multi 
organ inflammation could be caused by the reduced numbers of mature T cells and/ 
or their functional impaired phenotype and not by the suppressive function of 
FoxP3tg Treg cells per se.221 Therefore, suppressive function of FoxP3tg cells was 
not fully assessed yet in vivo. Our results from an allogeneic skin graft transplantation 
model showed that FoxP3tg cells are highly suppressive in vivo and can mediate long 
term tolerance to an allogeneic skin graft for up to 100 days even after challenging 
with in vivo primed, graft specific CD4 effector T cells.  
Phenotypically, Treg cells from FoxP3tg mice are somewhat in between Tconv and 
Treg cells from B6 mice. In unmanipulated mice, CD4+FoxP3+ Treg cells are 
characterized by the expression of CD25high, GITRhigh, Helioshigh, NRP1high, PD1high 
and have a more activated phenotype compared to B6.Tconv cells. In FoxP3tg Treg 
cells, the expression of CD25 and GITR is only slightly upregulated. This was 
surprising because FoxP3 directly induces the expression of CD25 and GITR.59 Also 
the expression of Helios and NRP1 in FoxP3tg Treg cells resembles more B6.Tconv 
than B6.Treg cells. Helios and Nrp1 are two controversially discussed markers to 
identify Treg cells that have developed in the thymus.78, 107, 113 After a long fight, 
Helios is suggested to be a more reliable marker for tTreg cells.116 Anyhow, in line 
with previous studies,78, 107, 113 the majority of B6 Treg cells are generated in the 
thymus and express Helios and Nrp1 while in FoxP3tg we detected a much lower 
frequency expressing Helios or NRP1. In contrast to that, we observed about the same 
number of Helios+ Treg cells in the secondary lymphoid organs of both mice. On top 
of that, other than the Foxp3tg.Helios- Treg cells, the phenotype of Helios+ Treg cells 
from FoxP3tg mice is very similar to the phenotype of B6.Treg cells. This indicated 
that the Helios- Treg cell subsets in FoxP3tg probably develop differently than 
B6.Helios- Treg cells, while Helios+ Treg cells probably have the same origin. Here 
we show that in FoxP3tg and B6 mice the restriction of the TCR repertoire and thus, 
negative selection, lead to a clear reduction of the Helios+ Treg cell population while 
the Helios- Treg population mostly was unaffected. In monoclonal FoxP3tg mice, all 
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thymocytes get positively selected; about 50% of peripheral CD4 cells still express 
FoxP3 (but not Helios). In contrast, B6 mice with a monoclonal TCR repertoire do 
not have Treg cells, caused by the absence of the cognate antigen in the thymus.79, 81-
83  
Thus, we hypothesised that Helios+ Treg cells seem to have a higher TCR affinity for 
self-antigens than Helios- Treg cells. Helios- Treg cells in turn, seem to have a lower 
TCR affinity for self-antigens than Helios+ Treg cells but probably still a higher than 
Tconv cells and Tconv cells have low-affinity TCRs for self-antigens.  
Here we showed in reaggregated thymic organ cultures (RTOCs) with B3K508tg 
MHCIIKO thymocytes and B6 TECs that Treg cells only developed in the presence of 
negative selecting peptides but not with endogenous positive selection peptides. In 
line with that, we showed in vivo by generating OTII/B6 mixed bone marrow 
chimeras with RIP-OVA or B6 recipients that OTII Treg cells only developed when 
their cognate antigen, OVA, was expressed in the thymus. In the absence of OVA 
expression in the thymus, all cells were positively selected and cells did not develop 
into Treg lineage. This is in line with previous reports where TCRtg Treg cells failed 
to develop when their cognate antigen was not expressed or when the TCR 
rearrangement was blocked.81-83 Furthermore, polyclonal Treg cells do not develop 
when AIRE mediated expression of self-antigen in mTECs is not provided. 89 
Moreover, we showed that all OII Treg cells generated in the chimeras, expressed 
Helios. This indicates that in the thymus, Treg selection in presence of a high-affinity 
ligand, results in Helios expression. Further evidence for that is given by a study of 
Daley et al. showing that the expression of Helios qualitatively differentiates CD4SP 
thymocytes making a positive versus a negative selection response in vivo. Helios 
expression is induced during negative selection but decreased during positive 
selection.211 In addition to that, both FoxP3tg and B6 mice have comparable Helios+ 
Treg numbers in secondary lymphoid organs, independent from the expression of the 
FoxP3 transgene in FoxP3tg mice. This is in agreement with the finding that Helios is 
independently expressed from FoxP3.105 The hypothesis of the TCR specificity of 
Helios+ Treg cells seems to be quite likely; meanwhile, defining the specificity of 
Helios- Treg cells is rather vague than clear. In FoxP3tg and B6 mice, a Helios- Treg 
population is detectable. In both mice, this population is low (compared to the 
periphery) in the thymus (B6~0.3%, FoxP3tg~25% among all CD4SP) and increased 
in the periphery (~10x in B6, ~3-4x in FoxP3tg).  
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In the FoxP3tg mouse, the high frequency (compared to B6 mice) of Helios- Treg 
cells is almost certainly induced by the overexpression of FoxP3. However, it does 
not explain why only a fraction of CD4SP thymocytes express FoxP3 in these mice. 
Since the FoxP3 transgene is controlled under its own regulatory elements48, it is 
possible that FoxP3+CD4SP cells have TCR affinities for self-antigens around/ close 
to the negative selection threshold, but induce TCR signals which are still strong 
enough to induce some FoxP3 expression. Because the FoxP3tg mouse carries a 
transgene of 16 copies of the entire FoxP3 gene, including all regulatory elements,48 a 
less strong TCR signal, than in a B6 mouse, could lead to the induction of FoxP3. It is 
known that FoxP3 can induce and stabilize its own expression, mediated by a positive 
feedback loop.64 In the periphery, the extremely high frequency of FoxP3+ CD4+ T 
cells (90% among CD4+ T cells) is probably caused by an increased conversion of 
conventional T cells. This could be mediated by the low-affinity response to self-
peptide-MHC ligands228 or non-self-antigens leading to the induction of the multiple 
FoxP3 genes from the transgene. 
In B6 mice, a small population of Helios- Treg cells among CD4SP cells in the 
thymus is present. Whether these cells are from thymic or peripheral origin is 
controversially discussed. Because Helios was suggested as a marker for thymic 
derived Treg cells107 it is possible that Helios- Treg cells are pTreg cells, recirculating 
into the thymus. A recent study addressed this question and showed by using GFP 
labelled recent thymic emigrants that within the Treg cell pool in the thymus, 
recirculating GFP negative Treg cells exists.229 Unfortunately, they did not stain for 
Helios but in contrast to Helios- Treg cells, the recirculating cells were described to be 
Nrp1high, CD25high and CD44high. Nevertheless, these results indicate that Helios- Treg 
cells most probably do not belong to the recirculating population and possibly can 
develop in the thymus. However, this does not tell more about their TCR specificity. 
We assume that Helios- Treg cells, in the thymus, have TCR affinities for self-
peptides at or just above the affinity threshold for negative selection. Evidence for 
that is provided by the circumstance that first, RTOCs with threshold ligands but not 
endogenous, positive selecting peptides induce Treg cells, second, FoxP3 induction 
does not depend on Helios expression,105 and third, Helios expression needs strong 
TCR activation.211   
However, in the periphery of B6 mice the frequency of Helios- Treg cells increases up 
to 10 fold compared to the thymus. It was shown that Treg cells could develop from 
naïve CD4+ T cells expressing most dominantly TCRs for non-self antigens in the 
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presence of an optimal microenvironment containing IL2 and TGBβ.92 These cells 
were mostly Helios negative in vivo.97, 107 More and more evidence indicates that 
within the positively selected naïve T cells, the strength of the interaction of a T cell 
with self-peptide-MHC complexes is not uniform.228 This could mean, that within 
positively selected cells, the affinity for self can vary from very low self to just below 
negative selection threshold. We could assume that the latter ones could preferentially 
commit to the pTreg population in presence of the optimal microenvironment.  
Considering our results, we suggest that Helios expression correlates with the 
strength of the interaction of a Treg cell with self-peptide MHC complexes and 
hypothesis that in the thymus of FoxP3tg mice (Fig. 32a), Helios- FoxP3- (blue) or 
FoxP3+ CD4SP (brown) are positively selected and low-affinity anti-self, while 
Helios+ FoxP3+ CD4SP (red) are high-affinity anti-self and can escape negative 
selection. After emigration of maturated transgenic thymocytes into the periphery, 
majority of naïve CD4+ T cells turn into FoxP3 expressing CD4+ T cells (brown) 
(forced by the expression of the FoxP3 transgene) while Helios+ FoxP3+ CD4 T cells 
were determined in the thymus.  
In B6 mice (Fig. 32b) the thymic selection processes results in low-affinity anti-self 
FoxP3- CD4SP (blue, positively selected) and self-reactive Helios+FoxP3+ CD4SP 
cells (red, escaping negative selection). A small population of intermediate-affinity 
anti-self Helios-FoxP3+ CD4SP cells (brown, threshold, escape negative selection?) 
can develop in the thymus, but these Helios-FoxP3+CD4+ T cells can also be 
generated from the conversion of naïve CD4+ T cells in the periphery, either induced 
by foreign or self-antigens in presence of IL2 and TGFβ.  
Figure 32: Treg development model in FoxP3tg and 
B6 mice.  
Development of Helios+ Treg (Helios+FoxP3+CD4+, 
red), Helios- Treg (Helios-FoxP3+CD4+, brown) and 
Tconv (Helios-FoxP3-CD4+, blue) cells in (a) FoxP3tg 
and (b) B6 mice.  
Discussion 
 
 -101- 
6.2 In vitro studies on the self-reactivity of different Treg cell populations; 
TCR affinity for self-antigens matters but Il2 rules it all 
In the second part of the thesis, we studied the self-reactivity of Helios+, Helios- Treg 
and Tconv cells from FoxP3tg and B6 mice. The investigations and results from the 
first part of this thesis led us to the hypothesis that Helios separates Treg cells with 
higher self-reactive TCRs from Treg cells with lower self-reactive TCRs. To test this, 
we re-established autoMLR experiments, an in vitro model to test self-reactivity, 
which has been described the first time more than 30 years ago. Syngeneic or 
autologous mixed lymphocyte reactions (autoMLRs) are defined as the proliferative 
response of lymphocytes, cultured with syngeneic non-T lymphocytes. Nussenzweig 
et al. demonstrate that DCs have the unique ability to induce the proliferation of 
autologous T cells in the absence of exogenous antigen.201 Furthermore, it is 
suggested that the presentation of self-antigen by MHC class II molecules on 
syngeneic DCs is responsible for the proliferation of autologous CD4+ T cells.202. 
Regarding this, we expected that Helios+ Treg cells should proliferate the most since 
we assumed them to express TCRs with high-affinities for self-antigens. Helios- Treg 
cells should proliferate less (than Helios+ Treg) or not while Tconv should not 
respond to self-antigens.  
As predicted, from enriched total CD4+ T cells, cultured on syngeneic B6.BmDCs, 
Helios+ Treg cells highly proliferated whereas only a small fraction of Helios- Treg 
and Tconv cells divided. These results were somewhat amazing. Our results were in 
line with the hypothesis that Helios+ Treg cells have a high-affinity for self-antigens 
and even the overexpression of FoxP3 seems not to influence the development of this 
population. However FoxP3tg cells divided less, frequencies of both, FoxP3tg and B6 
Helios+ Treg cells increased 10 fold compared to pre-culture conditions and 
proliferated significantly more than their co-cultured Helios- Treg and Tconv cells. 
We confirmed in three different experimental setups that the proliferation of Helios+ 
Treg cell, but also Helios- Treg cell from B6 and FoxP3tg mice, is highly dependent 
on the interaction with MHC class II, expressed on BmDCs and excluded that co-
stimulatory signals, e.g. CD28:B7 ligand interactions, induced the proliferation of 
Treg cells230. Furthermore, we showed in a transwell culture system that the 
proliferation of Treg cells was not mediated by IL2151, 154, 226, 231 or other cytokines 
produced by BmDCs 148,232  First, Treg cells were described to be anergic in vitro 
after TCR stimulation.231 In all experiments, we used CD4+ T cells from B6 and 
FoxP3tg mice and observed very similar behaviour of Helios+ Treg, Helios- Treg and 
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Tconv cells. For reasons of simplicity, and more physiologically we decided to 
continue with B6 CD4+ T cells only.  
We were somewhat surprised that sorted, Helios enriched Treg cells did not 
proliferate in co-cultures with B6.BmDCs, equally to co-cultures with 
MHCIIKO.BmDCs.  The previous experiments using total CD4+ T cells nicely 
suggested that the observed proliferation of Treg cells (especially Helios+ Treg cells) 
is induced by TCR-self-peptide-MHCII interactions independent of co-stimulation or 
cytokines secreted by BmDCs. However, previous reports showed that Treg cells do 
not divide after TCR stimulation but can be induced by exogenous administration of 
IL2.44, 79  
Indeed, we identified Tconv cells as the source of IL2 producing cells when co-
cultured on B6.BmDCs. First, we showed that the reconstitution of sorted, Helios 
enriched Treg cells regained their proliferative capacity when reconstituted with 
sorted, Tconv cells, co-cultured with B6.BmDCs. Second, sorted, Helios enriched 
Treg cells, cultured in the insert of a transwell system, without contact to the APCs, 
proliferated when purified Tconv cells were cultured with B6.BmDCs in the lower 
well of the transwell system. Third, from total CD4+ T cells, cultured on 
B6.MHCIIKOBmDCs, in presence of supernatant from sorted Tconv: B6.BmDCs co-
cultures, Helios+ Treg cells divided. Helios-Treg cells also divided but less than 
Helios+Treg cells while Tconv cells did not divide in all conditions.  
All together strongly indicated that in this in vitro model, the proliferation of Helios+ 
and Helios- Treg cells is dependent and most probably mediated by IL2, secreted by 
Tconv cells and not by a TCR interaction with self-peptides presented by MHCII 
molecules on BmDCs. Interestingly, Tconv cells secreted IL2 only, when MHCII was 
expressed on BmDCs. Therefore IL2 secretion was probably mediated by a low-
affinity TCR self-peptide MHCII interaction.  
As mentioned above, the concept that Treg cells proliferate in vitro in presence of IL2 
is not new.44, 79 Furthermore, studies from the 1980s already hinted that IL2 can be 
produced in autoMLRs.233 However, our findings mirror some recent findings made 
in vivo. They suggested the principle that about 10% of Tconv cells can produce IL2 
from weak self-antigen recognition, sufficient to drive the transcription of IL2 but not 
to induce their proliferation.154, 155 Thus, this little amount of IL2 is sufficient to 
induce strong proliferation in Treg cells especially Helios+Treg cells. This mechanism 
most probably also explains the high proliferation of CD25+CD4+ Treg cells when 
adoptively transferred into lymphopenic hosts.234 Very similarly to our in vitro 
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autoMLR experiments, it was reported that the proliferation of CD25+CD4+ T cells in 
lymphopenic hosts is dependent on MHCII expressed by the host cells.234, 235 We saw 
the same when we transferred total CD4+ T cells were into B6.Rag2-/-MHCIIKO 
recipients or B6.Rag2-/- (data not shown).  
Despite the importance of IL2 for the proliferation of Treg cells it is still not fully 
resolved whether the proliferation is just a consequence of IL2 consumption mediated 
by the constitutive expression of CD25, the α subunit of the high affinity IL2 
receptor, or whether self-reactivity driven influences this mechanism.  
 
It is striking that Helios+ Treg cells almost exclusively proliferate while Helios- Treg 
cells do not or less, even though both cell populations express FoxP3 similarly. We 
observed that ex vivo, Helios+ Treg cells have a higher CD25 expression than Helios- 
Treg cells. It is suggested that in Treg cells, FoxP3 directly mediates CD25 
expression.59 Indeed, our data shows, that FoxP3+CD4+ T cells from FoxP3tg mice 
express more CD25 than naïve CD4+ T cells from B6 mice, however, the 
overexpression of FoxP3 did not result in the same CD25 expression as recorded 
from B6 FoxP3+CD4+ T cells. This indicates that FoxP3 expression per se is not 
enough to induce Treg like CD25 expression. Given that CD25 is normally 
upregulated in activated T cells, after encounter their cognate antigen, one can 
assume that this is also true for Treg cells.69 Thus, the CD25 expression on Treg cells 
is probably a consequence of TCR stimulation and FoxP3 driven expression what 
could mean that Treg cells with higher affinity for self-antigens express higher levels 
of CD25. To make a complicated story even more complicated, IL2 also influences 
CD25 in a positive feedback loop.69 The administration of exogenous IL2 or Tconv 
cells re-established the proliferative capacity of Helios+ Treg and, to some extent, of 
Helios- Treg cells in all conditions where proliferation was abolished while Tconv 
cells did not proliferate. However, the upregulation of CD25 on Helios+ Treg and, to 
a smaller extent, on Helios- Treg cells, which is induced in co-cultures with 
B6.BmDCs, could not be restored in co-cultures with B6.MHCIIKOBmDCs by the 
administration of exogenous IL2. This implies that IL2 is not enough to compensate 
for a missing TCR signal that induce high levels of CD25 in Treg cells. Furthermore, 
Treg cells, in particular Helios+ Treg cells, cultured with B6.BmDCs, seems to 
survive better than in co-cultures with B6.MHCIIKOBmDCs. 
Considering all data, we suggest following model: (Fig. 33) Within the Treg pool, 
Treg cells with different affinities for self-antigens exists, Treg cells with the highest 
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affinities for self-antigens express FoxP3 and Helios while Treg cells with lower 
affinity for self-antigens or non-self antigens only express FoxP3. As a consequence 
of their affinity, these cells express different amount of CD25. In homeostatic 
conditions, these cells can response differently to IL2, secreted by Tconv cells, 
probably mediated by a low-affinity TCR self-peptide MHCII interaction. Even 
though, the proliferation in this system is driven by IL2, the TCR affinity for self-
antigens lays the basis for the response. 
6.3 Affinity for self-antigen selects regulatory T cells with distinct 
functional properties 
In the third part of this thesis, we investigated the functional properties of Treg cells 
with different TCR affinities for self-antigens. We identified Helios enriched 
Triplehigh (GITRhigh, PD1high, CD25high) Treg cells, expressing higher affinity self-
reactive TCRs and Helios negative Triplelow (GITRlow, PD1low, CD25low) Treg cells 
expressing lower affinity self-reactive TCRs.  
The idea, comparing different Treg subtypes for their TCR repertoire and their 
different functional properties is not new. It is widely accepted that Treg cells are 
differently selected and have a different TCR repertoire than Tconv cells.85, 118 
Furthermore extensive studies showed that Treg cells can have different origins e.g. 
thymus or periphery.78, 81-83, 93, 107, 113 Due to that, several groups tried to compare the 
TCR repertoire of these two populations. However, due to the lack of specific marker 
for tTreg and pTreg cells they assumed that pTreg cells are highly enriched in the 
colon. Repertoire analysis of colonic and peripheral Treg cells were performed and 
revealed different TCR repertories between these two populations.97 A recent study 
separating tTreg from pTreg cells by the expression of Nrp1, parallels our findings. 
They showed that the TCR repertoire of Nrp1 high and Nrp1low are different from each 
Figure 33: A model how Treg cells with different TCR affinities for self-antigens could behave differently 
in homeostatic conditions. autoMLR as an in vitro model for homeostatic conditions, syngeneic DCs (green), 
Tconv cells (weak-self TCR, blue), Helios+Treg cells (high-self TCR, red), Helios- Treg cells (intermediate/low-
self TCR, brown)  
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other and different from the TCR repertoire of Tconv cells.92 However, the main 
source of Nrp1 negative Treg cells are mucosa-generated, from Tconv cells, induced 
Treg cells.113  
In contrast to the previous reports, we assume that from Triplehigh and Triplelow Treg 
cells TCR affinities for self-antigens are different but still higher than from Tconv 
cells.  
Based on the results from the previous parts of this thesis, where we suggest that 
Helios expressing Treg cells have TCRs with high self-reactivity while Helios 
negative Treg express lower self-reactivity, but most probably above threshold or 
threshold, affinity self-reactive TCRs. Even though, Helios could serve as a marker 
for these two populations, it is not applicable since Helios is expressed intracellular 
and the identification and FACS sorting of Helios expressing cells would need 
perforation of the cells. This is not suitable for subsequent functional studies. We 
therefore established a sorting strategy to identify two Treg cells populations 
expressing distinct self-reactive TCR repertories. We identified Helios enriched 
Triplehigh (GITRhigh, PD1high, CD25high) Treg cells, expressing higher affinity self-
reactive TCRs and Helios negative Triplelow (GITRlow, PD1low, CD25low) Treg cells 
expressing lower affinity self-reactive TCRs. We determined the degree of self-
reactivity by the expression of CD5 and Nur77-GFP. The expression of Nur77 
expression correlates with the strength of the TCR signal86  and CD5 expression was 
described to quantitatively correlate with the TCR signal intensity.16, 87, 88 Both, CD5 
and Nur77-GFP are higher expressed in Triplehigh than in Triplelow Treg cells. In 
addition to that, similar to Helios+Treg cells, Triplehigh Treg cells proliferated and 
survived on syngeneic B6.BmDCs while Triplelow Treg cells poorly proliferated and 
did not survive. Furthermore, we showed, that the TCR repertories between Triplehigh, 
Triplelow and Tconv cells are clearly different from each other. This implied, that the 
TCR specificity is important for the selection of these Treg subtypes and it indicates 
that Triple low Treg are not just converted Tconv cells.  
The question how different population of Treg cells function and whether they have 
differences in their behaviour because to their different TCR specificity or their origin 
it is still not clear. Furthermore it is disputed whether different population of Treg 
cells specifically can prevent from different diseases.120, 122  
Here we report that Triplehigh but not Triplelow Treg cells control the extensive 
lymphoproliferation in mice acutely depleted of Treg cells. Conversely, Triplelow but 
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not Triplehigh Treg cells control colitis by facilitating conversion of Tconv cells into 
induced Treg cells (iTregs). 
The acute ablation of Treg cells in FoxP3DTR mice by the administration of diphtheria 
toxin in adult, healthy mice results in massive lymphoproliferation. It is suggested 
that the depletion of Treg cells in these mice leads to the activation of T cells specific 
for “self-antigens” including genome encoded self, environmental and food antigen. 
Evidence for that was given by the fact that (foreign) TCRtg T cells did not undergo 
activation upon Treg cell ablation.52We observed a massive expansion and activation 
of CD4+, CD8+ T cells and B Cells in the, lymph nodes and spleens, but not so much 
in the mesenteric lymph nodes (not shown), of affected mice. Subsequent treatment 
with DTx resulted in death within 14 days. The transfer of as little as 2.5x105 
Triplehigh Treg cells, but not Triplelow Treg cells, controlled the lymphoproliferation 
and activation of CD4+, CD8+ T cells and B Cells. It was reported that within less 
than 48h after Treg cell depletion, CD4+ T cells and DCs showed sings of 
activation.52 DC activation resulted in a 2-12 fold expansion, the upregulation of 
surface MHCII expression and the upregulation of the co-stimulatory molecules 
CD80 and CD86. This massive expansion and activation of DCs likely supports the 
expansion of T and B cells.236 Unfortunately we were not able to examine the homing 
receptor expression of Triplehigh Treg cells in this experimental setup. Anyhow, one 
could assume that Triplehigh Treg cells preferentially home to peripheral lymph nodes 
since this was the site where we saw the main suppression. We suggest three different 
mechanisms how Triplehigh, and not Triplelow, Treg cells could suppress acute 
autoimmune driven lypmphoproliferation. First, due to their expression of a high 
affinity self-antigen TCR, Triplehigh Treg cells may form stable contacts between Treg 
cells and antigen-bearing DCs, preventing from activation of Tconv cells.144, 145 
Second, Triplehigh Treg cells express high levels of CD25 and therefore may dampen 
the proliferation of activated Tconv cells by “stealing” IL2. Third, The ablation of 
Treg cells leads to the activation of DCs suggested to be mediated by the local 
production of Fms-like tyrosine kinase 3 (Flt3) Ligand by a not yet determined cell 
type.236 This activation may include the upregulation of PDL1 or PDL2 on DCs. 
Triplehigh Treg cells express high levels of PD1. Direct Treg:DC interaction via 
PD1:PDL1 or PDL2 may regulates DC activation turning them into “tolerogenic” 
DCs.22 Furthermore, Flt3L mediated increase of DC numbers effects the homeostasis 
of Treg cells in combination with IL2 and an not yet described contact-dependent 
DC-mediated signal.237 However this mechanism was described to be TCR signal 
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independent, but as we could show, the maintenance of high CD25 levels still need 
strong TCR stimulation.  All three mechanisms clearly favours Triplehigh Treg cells 
and Triplelow Treg cells would fail in either mechanism. However, all three 
mechanisms are possible, neither must be right. To resolve how Triplehigh Treg cells 
suppress acute autoimmune lymphophroliferation, further investigation has to be 
done. 
In contrast to the acute ablation of Treg cell, adoptive transfer induced colitis is a 
slow progressing disease; mediated by microbiota-specific CD4+ T cells. 159, 175  
The transfer of naïve CD4+ T cells into T cell deficient hosts induces colitis and 
weight loss within four to six weeks and was characterized by a massive cell 
infiltration into the colon. Various reports showed that the adoptive transfer of Treg 
cells, in particular microbiota-specific, prevents the onset or even cures from 
colitis.95, 96, 177 
Here we show that Triplelow Treg cells but not Triplehigh Treg cells controlled colitis 
by facilitating the conversion of Tconv into peripheral induced Treg cells. We only 
can make an assumption how Triplelow but not Triplehigh Treg cells can provide help 
to convert Tconv cells and prevent from colitis. To control colitis in this model, the 
conversion of Tconv to induced Treg cells is from great importance. We showed that 
the consecutive ablation of induced Treg cells resulted in earlier onset and more 
severe colitis even in the presence of Triplelow Treg cells. 
It is widely accepted that Treg cells can be induced from naïve CD4+ T cells and is 
from great importance in maintaining immune homeostasis especially at mucosal 
interfaces like lung and gut but also in maintaining fetal tolerance.62-64, 121 In the gut, 
naïve CD4+ T cells can be converted upon TCR stimulation in the presence of TGFβ 
and IL2 but also other compounds like RA or metabolic products from the microbiota 
like short-chain-fatty-acids, e.g. butyrate can mediate conversion.99-101 In addition to 
that and IL10 is one of the key players in maintaining homeostasis of the gut. IL10 
deficient mice are suffering from spontaneous colitis.176 To our knowledge, there is 
no study, showing that a particular Treg cell population can induce the conversion of 
Treg cells in vivo. It was shown that Treg cells support the conversion of naïve CD4+ 
T cells in vitro by secreting IL10 and TGFβ. Therefore, one mechanism how Triplelow 
Treg cells could support in vivo conversion could be mediated by secreting 
tolerogenic and converting cytokines like IL10, TGFβ but also IL35 134, 238. This 
would create a cytokine milieu, favouring the conversion of microbiota activated 
CD4+ T cells. Another possibility to promote conversion is indirectly induced via DC 
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modification. Triplelow Treg cells could interact with DCs, possible via CTLA4 and 
CD80/86 interactions, what could lead to the secretion of IDO or IL10 by DCs, 
mediating the conversion of activated CD4+ T cells into induced Treg cells.140, 141 
It is quite difficult to assume a specific suppression mechanism for Triplelow Treg 
cells. In contrast to Triplehigh Treg cells, Triplelow Treg cells are defined by what they 
do not expressed. It is also difficult to answer, why Triplehigh Treg cells do not 
mediate conversion. Therefore, to answer these questions, further investigation of 
these cells is indispensable.  
 
The high importance of Treg cells in maintaining immunological tolerance and 
homeostasis is probably reflected the best in FoxP3 deficient (scurfy) mice. That 
scurfy mice contain self-reactive T cells was first shown in a study, using the 
endogenous viral superantigens (VSAg) as the primary self-antigens. The absence of 
functional FoxP3 in scurfy mice caused preferential accumulation of autoreactive T 
cells.54 This is supported by two studies, where co-expression of the mutated FoxP3 
gene and the reporter eGFP in the FoxP3 locus identified FoxP3 Treg precursors. 
Both showed that GFP expressing cells share phonotypical similarities to Treg 
cells.173, 174 However, by transferring GFP expressing cells into T cell deficient hosts; 
they could not induce the scurfy disease. The transfer of GFP- cells resulted in colitis 
but not the scurfy disease.173 It is still not clear which T cell population is promoting 
the multi organ inflammation and how TCR affinity for self or foreign antigen is 
linked to the onset of different pathologies seen in the scurfy mouse. In this study, we 
show that FoxP3 deficient (scurfy) mice contain Triplehigh and Triplelow CD4 T cells 
with distinct pathological properties. Triplehigh scurfy T cells are very similar to 
Triplehigh Treg cells in expressing PD1, GITR, CD25, Helios, CD62L and also CD5 
what strongly indicates that Triplehigh scurfy T cells and Triplehigh Tregs cells share 
similar genetic identity and most probably also a self-reactive TCR repertoire. A 
previous report, analysing the TCR repertoires from TCRβtg scurfy mice revealed 
that activated scurfy CD4+ T cells preferentially uses TCRs found in the TCR 
repertoire of Treg cells from TCRβtg wild type mice.172 In contrast to previous 
reports, after transferring scurfy “Triplehigh Treg cell wannabes” into T cell deficient 
hosts, cells proliferate extensively in peripheral LNs and infiltrated in the skin, 
causing severe skin lesions and inflammation. Interestingly, the Shyr-Te group 
generated several scurfy mice with deficiencies for different interleukins. IL4-, IL6-, 
IL10-, Stat6- or Itgae (CD103)- deficient scurfy mice showed inflammation in the 
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skin, lung and liver whereas IL2 deficient scurfy mice were only suffering from liver 
inflammations but did not develop skin lesions.239 The absence of skin inflammation 
in these mice was not caused by a lack of INFγ or other inflammatory cytokines. 
They therefore suggested that IL2 acts as the main mediator in skin inflammations 
observed in scurfy mice. Triplehigh scurfy cells express high levels of CD25 and are 
probably dependent on IL2 secretion by other cells. Triplehigh scurfy cells are highly 
expressing Helios, a repressor for IL2 and cannot produce their own IL2.174 Their 
preference to home to the skin could may be explained with the secretion of IL2 
which was reported for several skin resident DCs.232 In contrast to Triplehigh scurfy 
cells, Triplelow scurfy cells do not mediate skin lesions. Triplelow scurfy cells are low 
in CD25 and probably not dependent on IL2. However, Triplelow scurfy cells induce 
colitis within 4 weeks when transferred to T cell deficient recipients, very similar to 
the colitis progression observed after the transfer of naïve B6 CD4+ T cells into T cell 
deficient recipients. It is difficult to say whether these cells are more like B6 Triplelow 
Treg cells or B6 Tconv cells. However, they are with great certainty microbiota 
specific. Germfree scurfy mice are less prone to develop colitis compared to mice 
hosed in specific pathogen conditons.214   
6.4 Conclusion and Outlook 
Within this thesis, we were able to define two different B6.Treg populations that 
seem to have different degrees of self-antigens. Our data suggests that high-affinity 
Treg cells are able to control the homeostatic proliferation of lymphocytes while low-
affinity self-reactive Treg cells support peripheral Treg conversion and maintain 
lymphocyte homeostasis in the colon. It would be very interesting to investigate the 
mechanism behind. Resolving the mechanism would help to understand how Treg 
cells with different origin and different TCR affinity can contribute to maintain 
lymphocyte homeostasis.  
We could show that different T cell populations induce the multi-organ-inflammation 
in scurfy mice. Our data suggests that uncontrolled highly self-reactive T cells induce 
sever skin pathology while low-self-reactive T cells induce colitis. Further 
investigation of inflammatory sites, other than the skin, would help to understand 
how different T cell population could induce different pathologies.  
It would be interesting to combine both models and to see whether B6.Triplehigh Treg 
cells are better suppressors for scurfy Triplehigh CD4+ T cells than B6.Triplelow Treg 
cells and vice versa.  
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7.3 List of Abbreviations 
AIRE autoimmune regulator 
APC antigen presenting cell 
β-me β-mercaptoethanol 
BAC bacterial artificial chromosome 
Bcl B cell lymphoma  
BCR B cell receptor 
BmDC bone-marrow derived dendritic cells 
BrdU bromodeoxyuridine 
BSA Bovine Serum Albumin 
cAMP cyclic adenosine monophosphate 
CD cluster of differentiation 
CDR3 complementarity-determining region 3 
CNS conserved non-coding sequence 
cTEC cortical thymic epithelial cells 
cTreg central Treg cells 
CTLA4 cytotoxic T-lymphocyte-associated protein 4 
CO2 carbon dioxide 
DC dendritic cells 
DN double negative 
DNA deoxyribonucleic acid 
DP  double positive 
DTR diphtheria toxin recptor 
DTx diphtheria toxin 
Ebi3 Epstein-Barr virus-induced gene 3     
eGFP enhanced green fluorescent protein 
eTAC extra thymic AIRE-expressing stroma cell 
eTreg effector Treg cells  
FACS fluorescence activated cell sorting 
FoxP3 forkhead box protein P3 
FCS Fetal Calf Serum 
GITR Glucocorticoid-Induced Tumor necrosis factor receptor 
GM-CSF granulocyte macrophage colony-stimulating factor 
gMFI geometric mean fluorescence intensity 
H&E hematoxilin& eosin 
i.p. intraperitoneal 
i.v. intravenous 
IAb MHC-class II (see MHC) 
IBD inflammatory bowel disease 
ICOS inducible costimulator 
IDO indoleamine 2.3-dioxygenase 
Ig immunoglobulin 
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IL interleukin 
IL2R interleukin 2 receptor 
INFγ interferon-γ 
IPEX Immune dysregulatrion Polyendocrinopathy Enteropathy x linked 
syndrome 
Itgea Integrin α E (CD103) 
ITAMs immunoreceptor tyrosine-based activation motifs 
KD dissociation constant 
LAG lymphocyte-activation gene 3 
LAT linker for activation of T cells 
LFA1 lymphocyte function-associated antigen 1 
LN lymph node 
LNSCs lymph node stromal cells 
LPS lipopolysaccharide  
MHC major histocompatibility complex 
mLN mesenteric lymph node 
mTEC medullary thymic epithelial cells 
mTreg memory Treg cells 
NEAA non-essential ammino acids 
NFAT nuclear factor of activated T cells 
NK natural killer cells 
NRP1 neuropilin 1 
PAMPs pathogen associated recognition patterns 
PBS phosphate buffered saline 
PD1 programmed death 1 
PDL programmed death ligand 
PRRs pattern recognition receptors 
pTreg peripheral regulatory T cell 
Rag recombination activating gene 
RBC red blood cell 
RIP rat insulin promoter 
siRNA small interfering ribonucleic acid 
SP single positive 
STAT signal transducer and activator of transcription 
TAIL thermal asymmetric interlaced 
TCR T cell receptor 
Tconv conventional T cells 
tg transgene 
TGFβ transforming growth factor-β 
Th helper T cell 
TLR toll-like receptors 
TNF tumor necrosis factor 
Appendix 
 
 -123- 
TNFR tumor necrosis factor-receptor 
TRAs tissue-restricted antigens 
Treg regulatory T cell 
tTreg thymic regulatory T cells  
Vα Vα chain 
Vβ Vβ chain 
VEGF vascular endothelial growth factor 
VSAg viral superantigens 
ZAP70 Zeta-chain-associated protein kinase 70 
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